Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3021337	p-tni	ng/l (ng/l)	52111	206454	0.00%
3021337	p-tni	— (—)	35143	73308	100.00%	Distribution not available
3021337	p-tni	ug/l (ng/l)	6729	22478	0.00%
3021337	p-tni	ng/l______ (ng/l)	3826	11560	0.00%
3021337	p-hstni	ng/l (ng/l)	1194	3261	0.00%
3021337	p-tnih	ng/l (ng/l)	1014	1974	0.00%
3021337	p-tni	ug/l______ (ng/l)	942	2118	0.00%
3021337	p-tnih	— (—)	344	440	100.00%	Distribution not available
3021337	p-tni-o	— (—)	213	237	100.00%	Distribution not available
3021337	b-tni-vt	— (—)	196	271	100.00%	Distribution not available
3021337	b-tnipika	ug/l (ng/l)	179	187	0.00%
3021337	p-tni	µg/L (ng/l)	178	377	0.00%
3021337	s-tni	— (—)	164	171	100.00%	Distribution not available
3021337	p-tnl	ug/l (ng/l)	105	179	0.00%
3021337	p-tnl	ng/l (ng/l)	100	124	0.00%
3021337	p-tni.	ug/l______ (ng/l)	86	107	0.00%
3021337	p-tni	ng/L (ng/l)	69	147	0.00%
3021337	s-tni	ng/l (ng/l)	61	63	0.00%
3021337	p-tni	UG/L (ng/l)	59	86	0.00%
3021337	tnlpika	ug/l (ng/l)	51	62	0.00%
3021337	b-tni-vt	ng/L (ng/l)	49	59	0.00%
3021337	p-tni.	ug/l (ng/l)	43	48	0.00%
3021337	tnipika	ug/l (ng/l)	34	39	0.00%
3021337	b-tni	— (—)	30	32	100.00%	Distribution not available
3021337	p-tni.	— (—)	27	28	100.00%	Distribution not available
3021337	p-tni-o	ng/L (ng/l)	24	26	0.00%	Distribution not available
3021337	b-tni-vt	µg/L (ng/l)	21	30	0.00%
3021337	tnipika	— (—)	20	20	100.00%	Distribution not available
3021337	p-tni	NG/L (ng/l)	11	23	0.00%
3021337	s-tni	µg/l (ng/l)	9	9	0.00%	Distribution not available
3021337	p-tni.	ng/l______ (ng/l)	6	6	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Intracranial injury

8392

51838

1.66

321.98

4.9

3.8

260.29

525.45

ng/l

7.59

6441

39575

DVT of lower extremities and pulmonary embolism

6402

40321

1.82

318.40

5.1

4.1

238.98

471.06

ng/l

5.49

5363

33135

Pulmonary embolism

4673

27352

2.03

317.87

5.3

4.2

247.81

405.34

ng/l

2.38

3977

22586

Shoulder lesions

10510

43160

1.59

317.75

4.5

3.6

268.92

578.50

ng/l

12.59

8030

33533

Cholelithiasis, broad definition with cholecystitis

12164

57337

1.53

315.99

4.5

3.8

323.22

491.80

ng/l

3.40

9177

44094

Pulmonary heart disease

4673

27424

2.03

314.99

5.3

4.2

247.81

440.02

ng/l

2.57

3977

22658

All anxiety disorders

8107

41167

1.67

314.76

4.2

3.4

234.09

476.34

ng/l

4.68

5026

28248

Cystitis

11341

46910

1.55

314.00

4.4

3.6

281.49

521.45

ng/l

7.08

8201

35073

Spondylopathies

10743

43876

1.57

309.76

4.6

3.6

299.71

592.88

ng/l

8.98

8423

34238

Subjective visual disturbances

3891

21684

2.14

308.61

5.1

3.8

244.41

409.21

ng/l

1.97

2886

16455

Hypertension

11734

34872

2.18

307.65

4.3

3.1

491.03

529.02

ng/l

0.17

9155

23654

Symptoms and signs involving the skin and subcutaneous tissue

10260

66035

1.61

307.65

4.6

3.8

267.35

483.26

ng/l

5.82

7361

49967

Neurological diseases, wide definition

3680

7853

2.64

307.65

3.7

2.7

373.29

851.46

ng/l

5.76

2275

5136

Angina pectoris

10198

31644

2.71

307.65

6.8

2.8

501.03

59.27

ng/l

5.94

9105

24901

Percutaneous Coronary Intervention

14984

40633

2.85

307.65

6.3

2.7

1099.69

72.92

ng/l

44.29

13220

30050

Major coronary heart disease event

15572

43910

2.64

307.65

6.2

2.8

1108.67

76.26

ng/l

45.98

13711

32738

Coronary atherosclerosis

11743

34492

2.71

307.65

6.3

2.8

1061.20

68.02

ng/l

29.57

10552

26692

Other antidepressants

14532

50604

1.59

307.65

4.4

3.7

272.92

578.73

ng/l

12.94

10787

38687

Conduction disorders

4831

17792

2.68

307.65

6.4

2.9

455.32

404.76

ng/l

0.32

4343

13857

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

15885

54208

2.35

307.65

5.2

3.3

456.30

516.35

ng/l

0.37

12681

39308

Other septicaemia, including avohilmo

6029

34448

1.89

307.65

6.1

3.8

327.59

514.21

ng/l

3.31

5312

28103

Substance abuse, excluding more controls

7651

40728

1.73

307.65

4.7

3.6

301.28

666.00

ng/l

12.48

5789

30999

Diarrhoea and gastroenteritis of presumed infectious origin

10128

59684

1.67

307.65

5.2

3.6

337.32

484.86

ng/l

2.81

7569

44307

Atrial fibrillation and flutter

5960

9890

5.36

307.65

5.5

2.0

482.56

34.66

ng/l

20.66

5156

6052

Bacterial infection, other or unspecified, including avohilmo

10274

46037

2.18

307.65

5.7

3.7

282.48

524.38

ng/l

8.88

8723

36264

Cardiomyopathy

3149

11900

3.62

307.65

7.4

2.9

604.61

460.01

ng/l

0.44

2961

9290

Bacterial pneumonia (organism specified)

7716

37996

2.21

307.65

6.0

3.9

383.06

494.34

ng/l

1.23

6604

30478

Opioids

14452

43675

1.90

307.65

4.3

3.2

298.19

598.81

ng/l

10.52

10408

31185

Coronary artery bypass grafting

4125

15040

2.53

307.65

6.8

3.0

1378.54

62.45

ng/l

9.30

3946

12764

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

14195

64798

1.51

307.65

4.8

3.6

296.51

497.60

ng/l

7.22

10263

48801

Implicit viral Sepsis

3896

17701

2.88

307.65

7.3

3.7

526.06

480.82

ng/l

0.07

3274

14233

Pacemaker

6381

33198

2.20

307.65

7.7

4.1

924.28

418.44

ng/l

2.92

5935

28660

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

15002

46056

2.22

307.65

5.1

3.2

367.68

529.57

ng/l

3.20

11926

33657

Other pulmonary diagnosis

11081

32719

1.88

307.65

4.3

3.0

338.85

614.61

ng/l

6.87

8223

23820

Major coronary heart disease event excluding revascularizations

11423

34584

2.80

307.65

7.4

2.9

1354.96

70.83

ng/l

38.77

10578

27356

Asthma (mode)

11272

32663

2.04

307.65

4.4

3.0

262.53

627.67

ng/l

11.13

8204

23806

Heart failure, strict

10677

39298

2.35

307.65

7.0

3.6

665.37

444.42

ng/l

1.58

10073

32586

Hypertension, essential

12080

34218

2.33

307.65

4.3

3.1

473.05

528.80

ng/l

0.27

9441

23358

Erysipelas

8446

47011

1.74

307.65

5.2

3.7

362.78

553.06

ng/l

3.29

7268

37399

Anxiety (asthma-related co-morbidities)

7998

38566

1.73

307.65

4.2

3.4

230.49

509.25

ng/l

5.76

5001

26658

Implicit bacterial Sepsis, including avohilmo

8910

36188

2.60

307.65

6.7

3.7

270.20

524.19

ng/l

10.57

7916

29632

Myocardial infarction, strict

8534

27039

2.91

307.65

7.6

2.9

1703.02

60.38

ng/l

73.44

8049

21750

Other arrhythmias

11976

36587

3.08

307.65

5.2

2.7

285.58

379.43

ng/l

1.85

9292

24934

Septicaemia

6703

36725

1.92

307.65

6.0

3.8

346.37

537.50

ng/l

3.71

5902

29788

Cough

5583

26516

2.25

307.65

4.8

2.8

301.79

669.46

ng/l

6.34

4217

20029

Coronary revascularization (ANGIO or CABG)

14887

40646

2.82

307.65

6.3

2.7

1113.20

72.97

ng/l

44.80

13132

30058

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

15484

63690

1.85

307.65

5.2

3.5

410.42

493.70

ng/l

1.15

12463

47118

Unstable angina pectoris

6333

24362

2.57

307.65

8.4

3.0

366.30

62.99

ng/l

8.32

5760

20037

Dizziness and giddiness

13041

54069

2.22

307.65

5.2

3.6

247.66

522.26

ng/l

12.46

10005

41138

Hypertensive diseases (excluding secondary)

7598

15585

3.41

307.65

4.2

2.0

447.38

45.31

ng/l

16.32

5643

8082

Stroke, excluding SAH

9343

42191

1.84

307.65

5.3

4.0

369.18

518.42

ng/l

2.05

8108

35049

Stroke, including SAH

9734

44089

1.81

307.65

5.2

3.9

375.49

514.98

ng/l

1.93

8400

36331

Implicit Sepsis

14167

52158

2.45

307.65

5.8

3.5

409.29

513.30

ng/l

0.73

11809

40005

Symptoms and signs involving the urinary system

11096

57070

1.62

307.65

4.9

3.9

383.86

486.95

ng/l

0.58

8851

44733

Convulsions, not elsewhere classified

3280

16221

2.32

307.65

4.7

3.2

246.80

690.29

ng/l

6.82

2486

12102

Oedema, not elsewhere classified

5099

26201

2.25

307.65

5.4

3.3

221.53

607.81

ng/l

8.94

4139

20850

Medical observation and evaluation for suspected diseases and conditions

9514

27599

1.97

307.65

4.4

3.3

355.72

603.03

ng/l

5.96

7096

21047

Oral corticosteroids

15651

61263

1.64

307.65

5.1

3.5

337.23

525.69

ng/l

3.71

11943

45432

Ischaemic Stroke, excluding all haemorrhages

8759

40553

1.83

307.65

5.4

4.0

375.59

511.87

ng/l

1.65

7610

33976

16265

56845

1.57

307.65

4.8

3.5

322.20

507.60

ng/l

5.14

12061

42905

Codeine

14216

43218

2.01

307.65

4.4

3.2

339.61

600.26

ng/l

6.36

10417

30963

Anaemias

3169

4567

5.46

307.65

4.7

1.5

436.73

59.42

ng/l

6.48

2179

2008

Tramadol

13167

41032

2.25

307.65

4.8

3.3

303.93

605.76

ng/l

10.74

10214

30287

Viral pneumonia

2256

9873

2.99

307.65

6.1

3.6

321.10

565.76

ng/l

1.29

1882

7655

All chronic kidney diseases

8436

41467

1.85

307.65

5.9

3.7

539.21

467.65

ng/l

0.60

7434

32834

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

16475

61098

2.07

307.65

5.2

3.4

422.44

498.86

ng/l

0.85

13276

43841

Fever of other and unknown origin

8538

39606

2.14

307.65

5.3

3.2

334.83

634.43

ng/l

7.20

6636

29847

Explicit Sepsis, including avohilmo

7128

37378

2.01

307.65

5.9

3.6

342.31

524.09

ng/l

4.38

6188

29703

Parasetamol

9946

28888

1.91

307.65

4.1

3.0

332.36

685.53

ng/l

8.40

7104

20442

Acute tubulo-interstitial nephritis

9192

49802

1.74

307.65

5.3

3.6

352.19

430.28

ng/l

0.81

7534

37519

Any mental disorder

15066

52762

1.54

307.65

4.3

3.6

284.64

578.81

ng/l

13.14

11238

39955

Other heart diseases, wide

17251

42308

3.08

307.65

5.0

2.7

613.50

372.29

ng/l

3.57

13586

27571

Other specific joint derangements/joint disorders

9998

41423

1.64

307.65

4.2

3.5

229.13

600.13

ng/l

16.92

7009

29382

Disorders of lipoprotein metabolism and other lipidaemias

14987

45825

2.40

307.65

4.8

3.4

485.87

518.21

ng/l

0.29

12334

34872

Certain infectious and parasitic diseases, including avohilmo

9670

31816

1.65

307.65

4.2

3.2

498.06

611.82

ng/l

0.49

7317

23328

Antihypertensive medication - note that there are other indications

7657

18496

2.43

307.65

3.9

2.2

457.50

225.76

ng/l

5.31

4911

9626

Viral Sepsis

3898

17722

2.88

307.65

7.3

3.7

525.74

480.45

ng/l

0.07

3276

14248

Implicit viral Sepsis, including avohilmo

5731

26958

2.73

307.65

6.6

3.6

437.40

457.97

ng/l

0.05

4788

21484

Diseases of arteries, arterioles and capillaries

10145

49124

1.71

307.65

5.7

3.9

638.28

449.56

ng/l

2.59

9017

40104

Asthma, hospital admissions 3, pneumonia

6107

33850

2.14

307.65

6.1

4.0

229.70

473.12

ng/l

6.33

5065

27222

Concussion

7182

29673

2.12

307.65

4.8

3.2

298.30

675.93

ng/l

9.20

5220

21360

Hypertensive heart and/or renal disease

4097

14776

2.45

307.65

6.1

3.4

372.71

518.05

ng/l

1.11

3828

12150

Excluding asthma or asthma-COPD overlap

11045

32719

1.87

307.65

4.3

3.0

360.59

614.61

ng/l

5.69

8211

23820

Oxycodone

6045

30306

1.96

307.65

5.7

3.6

192.42

614.85

ng/l

14.64

5076

24442

Heartburn

1913

7923

3.15

307.65

6.3

3.4

173.69

625.13

ng/l

3.11

1346

6213

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

9823

58162

1.63

307.65

5.0

3.9

330.32

482.51

ng/l

3.53

7993

46434

Disturbances of skin sensation

4069

21861

2.19

307.65

4.9

3.5

193.01

449.94

ng/l

3.46

2654

15468

Abdominal and pelvic pain

15055

45402

1.85

307.65

4.6

3.4

253.11

642.41

ng/l

21.21

10963

35284

Nausea and vomiting

4179

21381

2.24

307.65

6.0

3.5

224.43

517.71

ng/l

3.39

3219

17165

Abnormalities of heart beat

6732

23893

3.54

307.65

5.7

2.8

190.43

639.27

ng/l

12.59

5049

18073

Implicit bacterial Sepsis

8015

33820

2.57

307.65

6.9

3.7

274.12

523.63

ng/l

9.15

7187

27938

Pain, not elsewhere classified

4805

21087

2.83

307.65

5.6

3.2

270.71

565.66

ng/l

2.97

3404

15721

Gastrointestinal diseases

7358

22661

1.76

307.65

3.8

3.0

366.07

675.82

ng/l

4.68

4999

15898

Symptoms and signs involving cognition, perception, emotional state and behaviour

16739

60096

2.18

307.65

4.9

3.5

281.38

550.34

ng/l

11.80

12675

44709

Cerebrovascular diseases

11777

50531

1.86

307.65

5.1

3.9

373.72

497.37

ng/l

1.99

10054

40792

Other anxiety disorders

6085

31425

1.82

307.65

4.2

3.3

178.77

473.34

ng/l

7.45

3724

20934

Haemorrhage from respiratory passages

5630

22655

2.67

307.65

5.7

3.0

373.83

724.58

ng/l

5.95

4825

18421

Symptoms and signs involving the circulatory and respiratory systems

17595

35948

2.95

307.65

4.3

2.8

254.17

700.82

ng/l

20.89

12307

25828

Diseases of the respiratory system

8479

27008

1.71

307.65

4.1

3.1

341.14

615.45

ng/l

5.29

6294

19912

Constipation

13072

60148

1.62

307.65

4.8

3.8

246.58

516.02

ng/l

11.05

10259

46076

Persons encountering health services for specific procedures and health care

18467

56879

2.24

307.65

4.9

3.3

382.36

522.72

ng/l

1.55

13975

41061

ILD differential diagnosis

10991

32663

1.86

307.65

4.3

3.0

346.88

627.67

ng/l

6.90

8162

23806

Headache

10821

41259

2.37

307.65

4.9

3.1

201.45

617.02

ng/l

17.34

7172

29844

Vocal cord dysfunction

1742

5819

3.11

307.65

4.7

2.1

393.18

72.36

ng/l

3.45

1307

3639

Asthma, hospital admission 2, infections

9377

53869

1.94

307.65

5.4

3.8

225.92

482.95

ng/l

11.40

7181

40589

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

4784

7703

3.57

307.65

3.7

2.4

295.38

1330.36

ng/l

22.74

3243

5578

Gastro-oesophageal reflux disease

9765

55096

1.65

307.65

4.8

3.6

332.22

526.09

ng/l

3.67

7242

42310

Symptoms and signs involving the digestive system and abdomen

14996

45404

1.84

307.65

4.5

3.4

260.51

642.38

ng/l

15.65

10919

35286

Pain in throat and chest

19105

35475

4.30

307.65

5.1

2.8

242.02

699.23

ng/l

22.23

13793

25643

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

5523

14360

2.79

307.65

4.1

2.0

308.99

37.85

ng/l

9.94

3949

7528

Bacterial pneumonia, not elsewhere classified

7125

30491

2.56

307.65

6.1

3.6

370.42

530.29

ng/l

1.85

6122

24119

ILD medications

16165

59431

1.59

307.65

4.9

3.4

322.40

534.63

ng/l

7.99

12176

43528

Symptoms and signs involving the nervous and musculoskeletal systems

8470

55636

1.70

307.65

5.0

3.9

290.41

468.10

ng/l

4.42

6030

43236

Caries of dentine

3404

16944

2.30

307.65

5.5

3.7

463.20

646.96

ng/l

1.18

2744

13236

Metabolic disorders

16511

50380

2.33

307.65

4.8

3.4

429.73

511.47

ng/l

1.32

13229

36772

Type 2 diabetes, wide definition

11443

49193

1.61

307.65

4.9

3.6

478.70

476.56

ng/l

0.01

9454

38099

Syncope and collapse

8183

31762

2.64

307.65

5.4

3.3

251.68

638.46

ng/l

6.45

6585

25115

Complications of medical and surgical care

11084

64339

1.73

307.65

5.1

3.8

428.03

449.48

ng/l

0.09

8823

48833

Asthma (only as main-diagnosis)

10315

32434

1.99

307.65

4.6

3.0

257.43

617.51

ng/l

10.30

7557

23625

Asthma (diagnoses ohter than nonallergic)

13247

68258

1.75

307.65

4.8

3.7

244.20

502.21

ng/l

12.36

10003

50696

Any reimbursement code in KELA

6981

19847

1.92

307.65

3.8

2.3

483.39

384.50

ng/l

0.97

4625

11473

Dental caries

3892

18870

2.31

307.65

5.4

3.7

465.48

653.23

ng/l

1.37

3120

14681

Lumbar disc prolapse

8884

43580

1.66

307.65

4.4

3.5

291.64

582.23

ng/l

7.92

6601

33202

Non-invasive ventilation

7046

10066

10.88

307.65

5.2

2.0

435.80

80.16

ng/l

10.59

5513

6284

Valvular operations

2624

9645

3.81

307.65

5.9

3.0

2419.40

411.84

ng/l

9.20

2517

7784

Myocarditis

796

1866

6.08

307.65

11.4

2.0

366.19

70.70

ng/l

2.37

684

1145

Persons encountering health services for examination and investigation

8573

27605

1.69

307.65

4.1

3.3

532.85

603.34

ng/l

0.23

6398

21053

Pneumonia, organism unspecified

14938

57263

2.06

307.65

5.3

3.3

407.95

509.73

ng/l

1.21

12140

41476

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1652

4182

3.50

307.65

5.4

3.0

450.37

942.61

ng/l

4.45

1450

3346

Asthma

11563

32434

2.08

307.65

4.5

3.0

273.26

617.51

ng/l

9.97

8480

23625

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

14654

58450

1.76

307.65

5.2

3.3

751.73

399.52

ng/l

4.45

11624

42041

ILD medications: prednisolone, methylprednisolone, prednisone

15987

58844

1.65

307.65

5.0

3.4

301.35

534.06

ng/l

10.14

12158

43296

Heart failure and coronary heart disease

7572

25444

2.65

307.65

8.3

3.0

901.29

65.66

ng/l

9.22

7250

20982

Heart failure and antihypertensive medication

4737

8573

5.05

307.65

7.3

2.4

868.89

207.80

ng/l

2.88

4431

5929

Hypothyroidism, drug reimbursement

1556

3051

4.16

307.65

3.8

1.5

247.10

35.41

ng/l

3.16

1041

1384

Inflammatory bowel disease treatment related agents

16342

62395

1.58

307.65

4.9

3.5

332.57

526.78

ng/l

4.41

12346

45899

Asthma, including avohilmo

16709

65208

1.52

307.65

4.4

3.7

258.46

534.66

ng/l

14.75

12242

48708

All-cause Heart Failure

10467

38678

2.33

307.65

6.9

3.6

666.04

443.00

ng/l

1.56

9866

32107

Cardiovascular diseases

8906

15591

3.60

307.65

3.9

1.8

597.72

48.74

ng/l

25.49

5676

7154

Diverticular disease of intestine

11053

43042

1.80

307.65

4.8

3.7

425.44

539.78

ng/l

1.20

9028

34414

Heart failure, not strict

13449

44840

2.50

307.65

6.2

3.2

713.40

433.72

ng/l

2.95

12132

34389

Infections, IBD-co-morbidities

2352

5751

3.52

307.65

5.6

2.9

389.08

917.31

ng/l

6.08

1864

4196

Use of hypnotics and sedatives

14805

60503

1.51

307.65

4.4

3.7

322.34

531.87

ng/l

5.81

11192

45456

Sciatica+with lumbago

7366

41116

1.77

307.65

4.5

3.5

271.91

583.85

ng/l

7.37

5263

31290

Injuries to the head

16244

65570

1.60

307.65

4.5

3.7

300.39

520.26

ng/l

8.25

12483

48158

Emergency coronary revascularization (for ACS)

16212

45979

2.66

307.65

6.3

3.0

1060.39

133.66

ng/l

41.46

14381

34792

Complications of procedures, not elsewhere classified

12039

63690

1.69

307.65

5.0

3.7

379.14

459.31

ng/l

1.37

9417

47767

Disorders of gallbladder, biliary tract and pancreas

14425

61218

1.61

307.65

4.5

3.8

316.87

514.76

ng/l

5.26

10965

46800

Hypothyroidism, levothyroxine purchases

2561

4731

3.40

307.65

3.8

1.5

277.88

42.68

ng/l

6.23

1569

2059

Implicit Sepsis, including avohilmo

15204

54263

2.43

307.65

5.5

3.4

427.03

512.95

ng/l

0.60

12493

40699

Non-rheumatic valve diseases

7689

25498

2.64

307.65

5.6

2.9

1208.64

391.39

ng/l

9.24

6954

19367

Asthma-related pneumonia or sepsis

6107

33850

2.14

307.65

6.1

4.0

229.70

473.12

ng/l

6.33

5065

27222

Statin medication

8728

28653

1.89

307.65

4.3

2.9

522.62

295.10

ng/l

3.39

6430

18655

Other/unspecified dorsalgia

5573

31692

1.99

307.65

5.0

3.6

261.17

508.40

ng/l

3.38

4073

24258

Erysipelas, including avohilmo

11156

52620

1.76

307.65

5.0

3.6

353.84

537.31

ng/l

3.97

9457

40339

First line medication for Crohn's disease

15844

57115

1.62

307.65

4.8

3.4

289.24

553.77

ng/l

12.20

11880

41658

Asthma, unspecified (mode), excluding more controls

8462

27716

2.59

307.65

5.0

2.8

229.94

544.66

ng/l

14.73

6473

19697

Cerebrovascular diseases (FINNGEN)

5197

10687

4.41

307.65

4.8

2.0

470.13

33.03

ng/l

7.85

4141

6257

Other disorders of urethra and urinary system

10208

44877

1.76

307.65

4.7

3.6

242.46

500.08

ng/l

8.46

7654

33605

Cardiodefibrillation

5826

33636

2.11

307.65

5.7

4.3

405.80

515.74

ng/l

1.37

5371

28778

Low back pain

11897

47586

1.90

307.65

4.8

3.5

243.06

584.17

ng/l

13.82

8546

35448

Pain in joint

8520

28309

2.09

307.65

4.4

3.3

212.10

751.12

ng/l

22.21

6120

22124

Ischaemic heart disease, wide definition

14242

41803

2.64

307.65

6.1

2.9

1027.22

171.35

ng/l

28.69

12614

32074

Intracranial trauma

8411

29899

2.15

307.65

4.6

3.2

290.93

674.06

ng/l

11.06

6223

21452

Pain in limb

13898

47415

2.16

307.65

4.9

3.5

279.20

576.10

ng/l

10.98

10355

35282

Ischemic heart diseases

15332

41787

2.73

307.65

6.0

2.7

1045.79

73.00

ng/l

41.70

13318

30571

Malaise and fatigue

10255

34328

2.98

307.65

5.9

3.3

242.80

621.48

ng/l

7.64

8389

26616

COPD/asthma related infections

14669

46056

1.76

307.65

4.6

3.2

312.20

529.57

ng/l

7.07

10945

33657

Falls/tendency to fall

14203

50438

1.51

307.65

4.2

3.5

346.69

570.93

ng/l

5.53

10475

36095

Visual disturbances and blindness

7906

49649

1.81

307.65

4.9

3.9

401.12

443.62

ng/l

0.29

5927

38469

All kidney diseases

15065

62063

1.82

307.65

5.1

3.4

527.61

459.35

ng/l

0.40

12242

44678

Codeine or tramadol medication

17231

59049

1.76

307.65

4.5

3.6

338.50

522.77

ng/l

4.90

12879

43773

Migraine

6671

30199

1.91

307.65

4.0

3.1

245.89

420.68

ng/l

3.89

3773

20363

Other headache syndromes

6261

33852

2.14

307.65

4.8

3.4

202.02

443.17

ng/l

8.20

4162

24729

Other disorders of fluid, electrolyte and acid-base balance

4956

25579

2.17

307.65

6.2

3.7

245.94

473.48

ng/l

3.81

4290

20768

Other and unspecified anaemias

6811

39917

1.85

307.65

5.7

4.1

397.17

448.35

ng/l

0.38

5912

33332

Hypertensive Heart Disease

3738

13939

2.46

307.65

6.2

3.5

359.81

519.47

ng/l

1.16

3503

11533

Bleeding

12883

57260

1.78

307.65

5.3

3.8

406.79

502.75

ng/l

1.39

10748

44720

Disorders of thyroid, IBD co-morbidities

2299

6202

2.94

307.65

4.6

2.7

442.32

838.80

ng/l

0.92

1639

4237

Nerve, nerve root and plexus disorders

14868

64789

1.48

307.65

4.5

3.8

350.12

501.68

ng/l

3.82

11169

49060

COPD (mode)

4714

20087

2.16

307.65

5.8

3.3

372.25

634.31

ng/l

2.41

4162

16578

Pure hypercholesterolaemia

14471

43755

2.61

307.65

5.0

3.5

426.47

524.57

ng/l

1.58

12082

33800

All pneumoniae

17064

60634

2.12

307.65

5.1

3.3

411.47

501.76

ng/l

1.11

13677

43275

COPD differential diagnosis

10999

32674

1.87

307.65

4.3

3.0

346.96

627.70

ng/l

6.90

8168

23812

15002

46056

2.22

307.65

5.1

3.2

367.68

529.57

ng/l

3.20

11926

33657

Hypothyroidism (congenital or acquired)

2584

4752

3.42

307.65

3.8

1.5

275.01

42.56

ng/l

6.23

1589

2066

Myocardial infarction, without ST-elevation

7711

35171

2.55

307.65

8.5

3.9

883.25

421.15

ng/l

14.79

7338

30198

Other dorsopathies, not elsewhere classified

14484

48534

1.70

307.65

4.3

3.5

311.10

585.90

ng/l

9.99

10336

36044

Codes for special purposes

8978

48586

2.18

307.65

5.8

3.7

370.26

472.96

ng/l

0.82

7255

36379

Pulmonary heart disease, diseases of pulmonary circulation

5123

30130

2.02

307.65

5.5

4.2

471.23

418.31

ng/l

0.12

4393

24981

Diseases of arteries, arterioles and capillaries (FINNGEN)

4044

7805

4.74

307.65

5.8

2.0

755.91

33.25

ng/l

19.91

3611

4987

Non-ischemic cardiomyopathy

5228

19658

2.66

307.65

5.0

2.8

273.32

119.77

ng/l

1.04

4837

15736

Cardiomyopathy (excluding other)

2033

8597

3.09

307.65

7.1

3.1

717.25

412.43

ng/l

0.72

1912

6819

Valvular heart disease excluding rheumatic fever

7777

25610

2.66

307.65

5.6

2.9

1223.55

391.01

ng/l

9.76

7041

19437

Dorsalgia

14553

48457

1.76

307.65

4.5

3.5

310.35

586.17

ng/l

8.62

10339

36012

Provisional assignment of new diseases of uncertain etiology

8971

48536

2.18

307.65

5.8

3.7

370.59

473.46

ng/l

0.82

7248

36338

Polyarthropathies

9249

39335

1.65

307.65

4.8

3.6

421.61

593.44

ng/l

1.83

7391

29113

Migraine with aura

3394

16292

2.43

307.65

4.2

3.0

256.24

397.84

ng/l

1.33

1998

10365

Asthma-related pneumonia

6102

33783

2.15

307.65

6.1

4.0

229.80

472.40

ng/l

6.28

5060

27168

Lower back pain or/and sciatica

16105

66359

1.66

307.65

4.6

3.7

267.36

516.91

ng/l

10.47

11670

49811

Bronchitis

15819

65477

1.57

307.65

5.0

3.6

335.60

489.32

ng/l

4.02

11476

49195

Fall on same level

16134

58717

1.59

307.65

4.3

3.6

330.15

554.12

ng/l

6.99

12212

42129

Bacterial pneumoniae

7370

32204

2.48

307.65

6.1

3.6

391.56

531.37

ng/l

1.53

6313

25388

Asthma, unspecified (mode)

8817

31042

2.41

307.65

5.0

3.0

225.49

609.45

ng/l

13.57

6798

22845

Continuous positive airway pressure

2489

7276

3.46

307.65

6.1

2.1

967.05

97.86

ng/l

1.77

2143

5078

Other neurological diseases

11548

55404

1.85

307.65

5.0

3.9

345.02

486.77

ng/l

2.42

9319

44220

Paroxysmal tachycardia

3716

8787

4.59

307.65

6.0

2.0

526.69

40.07

ng/l

2.96

2989

5077

Pain (limb, back, neck, head abdominally)

10379

29474

1.96

307.65

4.2

3.3

304.93

750.83

ng/l

14.85

7668

23159

Venous thromboembolism

8209

51081

1.75

307.65

5.0

4.1

274.24

472.80

ng/l

4.44

6823

41372

Transient ischemic attack

8616

40335

2.01

307.65

5.3

4.0

324.75

497.91

ng/l

2.61

7216

33591

All influenza

4019

21453

2.22

307.65

6.1

3.5

295.39

547.33

ng/l

3.71

3252

16541

GASTRO-related operations

10930

32520

1.85

307.65

4.1

3.1

412.78

598.69

ng/l

1.10

7640

22854

Hypothyroidism and >3 levothyroxin purchases

2561

4731

3.40

307.65

3.8

1.5

277.88

42.68

ng/l

6.23

1569

2059

Other bacterial diseases, including avohilmo

16182

59540

1.92

307.65

5.0

3.4

305.25

534.51

ng/l

10.32

13136

43154

Other soft tissue disorders, not elsewhere classified

15144

48215

2.04

307.65

4.7

3.5

303.41

576.76

ng/l

9.29

11054

35750

Heart failure and bmi 25plus

5468

19672

2.25

307.65

7.2

3.8

651.84

402.82

ng/l

0.91

5200

16542

General symptoms and signs

17411

44988

2.23

307.65

4.5

3.1

262.03

635.11

ng/l

19.88

12603

32967

Other septicaemia

5851

33817

1.88

307.65

6.1

3.9

330.80

504.77

ng/l

2.90

5158

27640

Exposure to unspecified factor

15025

68438

1.64

307.65

4.4

3.7

356.45

500.63

ng/l

3.17

11589

50480

Renal tubulo-interstitial diseases

13680

60474

1.88

307.65

5.5

3.5

525.17

459.82

ng/l

0.35

11516

44556

Hypertensive diseases

11750

34884

2.18

307.65

4.3

3.1

490.19

529.17

ng/l

0.17

9169

23658

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8936

57941

1.69

307.65

5.1

3.8

454.99

449.38

ng/l

0.02

7145

44668

6546

38537

1.91

307.65

5.4

3.7

217.89

466.97

ng/l

7.56

4759

28077

Abnormalities of breathing

15738

35872

3.04

307.65

5.0

2.8

270.39

699.64

ng/l

17.59

11440

25782

Episodal and paroxysmal disorders

15872

51597

1.71

307.65

4.3

3.5

343.58

543.61

ng/l

2.12

11194

38714

Adjustment and management of implanted device

3930

15844

3.66

307.65

7.6

4.0

569.24

487.70

ng/l

0.16

3764

13723

Depression medications

3255

5006

3.71

307.65

3.5

1.5

223.32

37.03

ng/l

7.66

1908

2166

Soft tissue disorders

14171

48609

1.62

307.65

4.2

3.5

319.42

575.91

ng/l

8.69

10160

36016

Other heart diseases

8934

15636

4.92

307.65

5.4

2.0

711.58

50.84

ng/l

37.50

7223

8098

STROKE

9491

27567

2.88

307.65

4.8

2.5

367.51

63.45

ng/l

10.66

7618

19568

Other special examinations and investigations of persons without complaint or reported diagnosis

9080

27604

1.83

307.65

4.3

3.3

493.28

602.91

ng/l

0.43

6718

21052

Psychiatric diseases

13176

46552

1.52

307.65

4.3

3.6

299.89

610.28

ng/l

12.40

9901

35460

Aplastic and other anaemias

7286

42078

1.82

307.65

5.7

4.1

434.25

447.43

ng/l

0.08

6339

34953

Cardiac arrhythmias

11237

23059

4.02

307.65

4.8

2.1

467.23

74.96

ng/l

4.49

8408

13372

Hard cardiovascular diseases

15476

40427

2.84

307.65

5.8

2.7

992.53

70.67

ng/l

37.37

13235

28988

Persons encountering health services for specific procedures, not carried out

1550

5793

3.68

307.65

5.5

3.2

133.51

522.18

ng/l

8.89

1196

4146

Other functional intestinal disorders

7024

37572

1.94

307.65

5.3

3.6

274.53

468.75

ng/l

2.80

5356

29201

Care involving use of rehabilitation procedures

11810

51131

2.55

307.65

4.9

3.4

379.18

522.97

ng/l

0.93

9063

38537

Examination and observation for other reasons

9437

27310

2.25

307.65

4.4

3.3

361.36

603.36

ng/l

5.87

7210

20789

Intestinal infectious diseases, including avohilmo, including avohilmo

16741

64104

1.58

307.65

4.8

3.6

367.08

501.75

ng/l

1.30

12463

48363

COPD/asthma/ILD related infections

14669

46056

1.76

307.65

4.6

3.2

312.20

529.57

ng/l

7.07

10945

33657

Other bacterial diseases

15441

59689

1.96

307.65

5.2

3.5

318.32

526.70

ng/l

8.23

12871

44466

Other diseases of intestines

15355

54588

1.72

307.65

4.3

3.5

355.52

539.64

ng/l

4.10

11035

39563

Influenza and pneumonia

17564

59466

2.11

307.65

5.1

3.3

405.56

506.91

ng/l

1.34

13872

42220

Follow-up examination after treatment for conditions other than malignant neoplasms

6099

23392

1.94

307.65

4.0

3.3

329.49

548.20

ng/l

2.89

4428

17758

Visual disturbances

7454

45459

1.88

307.65

4.9

3.8

371.27

438.04

ng/l

0.54

5558

35022

Persons encountering health services in other circumstances, wide

16568

58715

1.57

307.65

4.6

3.6

401.43

501.33

ng/l

1.61

12241

44742

Persons encountering health services for other counselling and medical advice, not elsewhere classified

16755

58331

1.68

307.65

4.5

3.6

428.62

501.37

ng/l

0.71

12268

44376

Other CVD (FINNGEN)

1979

3943

5.31

307.65

6.7

2.1

281.33

35.92

ng/l

2.22

1722

2724

Chronic lower respiratory diseases

17077

62488

1.56

307.65

4.5

3.6

330.39

529.30

ng/l

5.50

12665

46023

Other anaemias

6858

40154

1.84

307.65

5.7

4.1

398.00

448.59

ng/l

0.38

5953

33512

Bacterial infection, other or unspecified

9349

43658

2.16

307.65

5.8

3.8

279.47

522.83

ng/l

8.49

8019

34854

Presence of cardiac and vascular implants and grafts

8559

31783

2.53

307.65

7.4

3.8

1002.84

420.45

ng/l

5.57

7952

27039

Diseases of oesophagus, stomach and duodenum

16404

60568

1.78

307.65

4.7

3.6

325.13

524.78

ng/l

6.05

12271

45223

Speech therapy

4563

22600

2.60

307.65

4.3

4.1

222.67

441.81

ng/l

3.70

3538

17937

Cardiovascular diseases (excluding rheumatic etc)

9700

19200

3.46

307.65

4.2

1.9

614.28

51.70

ng/l

29.49

6671

9092

Mood disorders, excluding more controls

12906

51765

1.59

307.65

4.3

3.6

268.18

577.60

ng/l

12.73

9075

39046

Heart failure,strict

9746

33256

2.60

307.65

7.0

3.3

687.01

434.28

ng/l

1.71

9176

26999

Myocardial infarction

9233

28584

2.96

307.65

7.7

2.9

1625.04

68.85

ng/l

75.58

8698

22852

Asthma (only as main-diagnosis), excluding more controls

9928

29005

2.14

307.65

4.6

2.7

256.75

548.39

ng/l

9.59

7200

20390

Neurological diseases

11466

36285

1.73

307.65

4.0

3.4

426.46

620.96

ng/l

1.20

7929

26519

Asthma, excluding more controls

11047

29005

2.23

307.65

4.4

2.7

278.69

548.39

ng/l

8.91

8011

20390

Anxiety disorders, excluding more controls

11314

48029

1.64

307.65

4.5

3.5

249.65

564.21

ng/l

10.50

7709

35631

Endocrine, nutritional and metabolic diseases

10275

32464

1.73

307.65

4.2

2.9

414.97

544.12

ng/l

1.57

7373

21686

Dyspnoea

16445

61316

2.32

307.65

5.7

3.4

297.91

519.69

ng/l

5.52

12954

46124

Dorsopathies

13948

48676

1.56

307.65

4.2

3.5

338.46

586.39

ng/l

7.67

9860

36132

Intestinal infectious diseases

13594

69228

1.59

307.65

5.1

3.6

419.79

481.55

ng/l

0.34

10099

51591

Any gastric operation

10930

32520

1.85

307.65

4.1

3.1

412.78

598.69

ng/l

1.10

7640

22854

Other diseases of urinary system

13511

53005

1.55

307.65

4.5

3.6

308.31

551.69

ng/l

8.84

10097

39833

Atrial fibrillation and flutter with reimbursement

4943

7706

5.72

307.65

5.7

2.0

521.95

32.12

ng/l

5.62

4391

5021

Explicit Sepsis

6922

36790

1.98

307.65

6.0

3.6

346.32

518.63

ng/l

3.87

6015

29312

Covid-19 confirmed case

7238

34414

2.73

307.65

6.2

3.9

404.28

462.54

ng/l

0.30

6073

27263

Renal failure

7819

40623

1.92

307.65

6.5

4.1

674.22

456.96

ng/l

1.04

7269

34073

Complications of surgical and medical care, not elsewhere classified

15197

65448

1.72

307.65

4.9

3.7

462.57

471.19

ng/l

0.04

11988

48835

Cardiomyopathies, Primary/intrinsic

1987

7961

3.31

307.65

7.1

3.0

727.86

428.16

ng/l

0.68

1869

6298

Pneumonias (Asthma/COPD co-morbidities)

16970

60692

2.12

307.65

5.1

3.3

411.26

501.20

ng/l

1.10

13630

43317

Condition for Implicit Sepsis (Organ dysfunction codes)

15440

54199

2.37

307.65

5.4

3.4

467.06

507.30

ng/l

0.23

12583

40334

Bacterial Sepsis

8938

36981

2.49

307.65

6.7

3.7

286.96

525.33

ng/l

9.21

7958

30094

AV-block

3083

11408

2.93

307.65

7.0

3.0

552.42

439.72

ng/l

0.59

2858

9347

Other intervertebral disc disorders

12113

46023

1.74

307.65

4.4

3.5

320.77

584.82

ng/l

7.99

9097

35054

Cardiomyopathy, other and unspecified

1405

4864

4.22

307.65

8.0

2.9

832.75

509.36

ng/l

0.48

1326

3778

Certain infectious and parasitic diseases

13405

44573

1.63

307.65

4.4

3.3

432.33

555.21

ng/l

0.81

10034

32134

Other symptoms and signs involving cognitive functions and awareness

7844

39149

2.10

307.65

4.9

3.8

212.53

535.49

ng/l

12.79

6506

31950

Asthma-related infections

9377

53869

1.94

307.65

5.4

3.8

225.92

482.95

ng/l

11.40

7181

40589

Other acute lower respiratory infections

7717

48403

1.68

307.28

5.7

3.8

424.05

472.83

ng/l

0.24

5942

37159

Other external causes of accidental injury

10542

36002

1.58

307.03

4.1

3.4

361.49

621.94

ng/l

4.83

7784

25980

Personality disorders, excluding more controls

3229

16645

2.21

305.56

4.3

3.1

274.65

577.97

ng/l

2.31

2002

10843

Anxiety disorders

12001

58426

1.52

305.52

4.4

3.6

250.96

485.87

ng/l

7.39

7974

42961

Neurotic, stress-related and somatoform disorders

11864

57923

1.52

304.36

4.4

3.6

248.84

488.75

ng/l

7.53

7860

42492

Functional dyspepsia

4008

22604

2.08

301.81

5.4

3.6

159.01

429.55

ng/l

5.42

2877

17109

Asthma/COPD (KELA code 203)

12975

62434

1.49

301.15

4.5

3.6

269.66

529.32

ng/l

11.15

9795

45987

Asthma, hospital admissions , main diagnosis only

11166

68776

1.53

299.59

4.7

3.7

252.32

489.60

ng/l

9.07

8264

50934

Accidents

10496

36002

1.57

298.95

4.1

3.4

351.50

621.94

ng/l

5.22

7743

25980

Cardiac arrest

976

2384

4.52

298.05

7.4

2.1

1702.48

51.21

ng/l

8.84

914

1717

Cholelithiasis

11623

56496

1.52

293.81

4.4

3.8

328.56

491.23

ng/l

3.00

8738

43464

Depression or dysthymia

8871

32402

1.62

292.42

4.4

3.6

241.96

688.95

ng/l

18.25

6623

25302

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8185

55329

1.64

290.79

5.0

3.9

449.58

443.43

ng/l

0.02

6534

42869

Benzodiazepine use

13816

68348

1.46

290.34

4.5

3.7

245.31

512.80

ng/l

12.47

10055

51361

2114

9648

2.69

287.99

5.1

3.4

313.14

482.77

ng/l

0.64

1583

6672

Acute renal failure

3632

20391

2.17

287.94

6.9

4.1

832.24

439.51

ng/l

0.88

3372

17205

Other medical care

6847

37394

1.71

284.95

4.9

3.7

314.11

492.08

ng/l

3.03

5826

30020

Myalgia

3387

18360

2.14

284.51

5.1

3.4

195.39

457.40

ng/l

3.81

2313

13346

Early onset COPD, excluding more controls

2873

14770

2.31

284.47

5.8

3.2

403.43

772.15

ng/l

3.34

2352

11760

Hernia

12749

61631

1.48

281.00

4.5

3.7

345.18

497.99

ng/l

4.20

10084

46293

Mood [affective] disorders

13742

64692

1.46

280.83

4.2

3.7

266.92

507.71

ng/l

9.98

9403

48598

Mood disorders

13769

64739

1.45

280.38

4.2

3.7

266.36

507.51

ng/l

10.04

9424

48642

Depression

12726

61986

1.47

276.49

4.2

3.7

275.88

504.11

ng/l

8.12

8578

46143

Factors influencing health status and contact with health services

3843

10353

2.05

274.55

4.1

2.8

384.07

682.85

ng/l

4.71

2981

7999

Dialysis, with operation codes

2082

9885

2.77

271.17

7.2

3.9

1342.65

478.70

ng/l

1.40

1960

7933

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

3394

18295

2.06

270.17

4.2

3.2

255.93

549.00

ng/l

2.76

2074

12021

Gout

4349

22191

1.97

270.02

5.9

4.1

481.90

626.12

ng/l

0.67

3965

18965

Obesity related asthma

4878

29944

1.86

269.10

5.1

3.7

270.39

510.98

ng/l

3.24

3671

22605

Diaphragmatic hernia

5352

33809

1.82

268.85

5.0

4.0

224.44

457.16

ng/l

6.09

4409

27480

Amiodarone users

1811

8283

3.12

268.60

8.2

4.3

720.96

522.64

ng/l

0.34

1730

7163

Acute upper respiratory infections of multiple and unspecified sites

10349

53557

1.52

266.19

4.7

3.6

374.43

494.13

ng/l

1.99

7004

39740

Superficial injury of head

3660

20987

2.03

259.68

5.3

3.9

176.09

471.41

ng/l

6.53

2935

16291

Acute bronchitis

5870

37279

1.72

255.25

5.8

3.9

341.09

447.74

ng/l

0.86

4552

29136

Cholecystectomy

9749

59041

1.53

255.05

4.3

3.9

259.04

455.95

ng/l

4.78

7189

45822

Unspecified haematuria

6166

32881

1.72

252.35

5.2

4.0

474.92

538.71

ng/l

0.17

5219

27241

Transplanted organ and tissue status

1574

6822

3.07

251.61

7.1

3.4

1326.66

402.01

ng/l

2.33

1397

5152

Dysphagia

3662

21292

1.99

247.79

5.3

3.6

262.78

552.74

ng/l

2.84

2885

17707

Selective serotonin reuptake inhibitors

13195

50742

1.44

246.75

4.1

3.7

300.67

579.65

ng/l

9.64

9655

38787

Diseases of the musculoskeletal system and connective tissue

6577

21304

1.66

241.47

3.8

3.2

333.98

740.57

ng/l

7.57

4484

15104

Hyperlipidaemia, other/unspecified

5401

31226

1.75

241.39

5.3

3.7

429.83

518.95

ng/l

0.61

4680

25644

Urinary track infection

6966

22928

1.64

241.31

3.9

3.0

199.49

313.94

ng/l

3.18

4470

14685

Nonorganic sleeping disorders, excluding more controls

2677

14215

2.16

236.07

4.3

3.3

248.37

528.23

ng/l

2.14

1759

9787

Disorders of eyelid, lacrimal system and orbit

11801

64126

1.45

235.18

4.5

3.8

287.50

489.73

ng/l

5.10

9096

48723

Injuries to the knee and lower leg

15824

65589

1.38

234.97

4.2

3.8

304.29

510.30

ng/l

8.22

11769

48706

Calcific aortic valvular stenosis

4631

28179

1.85

234.97

6.3

4.4

978.25

393.81

ng/l

2.71

4394

24767

Calcific aortic valvular stenosis, operated

4631

28179

1.85

234.97

6.3

4.4

978.25

393.81

ng/l

2.71

4394

24767

Finngen Rheumatological endpoints

12390

52042

1.44

234.54

4.1

3.6

332.56

546.49

ng/l

5.77

9181

37342

Sleep disorders (combined)

14709

58304

1.40

233.82

4.3

3.7

377.69

504.87

ng/l

0.97

10791

44185

Secondary hypertension

967

3227

3.62

233.29

5.5

2.0

664.29

60.15

ng/l

1.87

864

2068

Injuries to the thorax

6621

44948

1.63

233.06

5.2

4.0

301.80

525.71

ng/l

5.76

5319

36021

Other diseases of intestine

2439

12857

2.32

232.65

5.3

3.8

336.48

527.46

ng/l

1.30

1989

10552

Calcific aortic valvular stenosis, diagnosis (helper)

4617

28150

1.84

232.22

6.2

4.4

976.55

393.64

ng/l

2.69

4380

24746

Operations 2 for CAVS

4617

28150

1.84

232.22

6.2

4.4

976.55

393.64

ng/l

2.69

4380

24746

Chronic kidney disease

4839

29726

1.80

231.12

6.7

4.2

727.96

434.77

ng/l

0.97

4520

25345

Type 2 diabetes

12970

56201

1.42

231.08

4.7

3.5

488.73

456.48

ng/l

0.29

10098

41147

Calcific aortic valvular stenosis, including rheumatic fever

4628

28249

1.84

230.48

6.2

4.4

974.51

395.36

ng/l

2.67

4390

24835

Undetermined asthma, excluding more controls

1819

8493

2.56

230.42

4.7

2.8

217.01

469.15

ng/l

3.56

1388

6263

Diabetes, varying definitions

13285

57875

1.41

229.78

4.7

3.5

481.65

461.49

ng/l

0.17

10251

41848

Other disorders of skin and subcutaneous tissue

10010

61606

1.48

228.93

4.9

3.9

310.19

473.22

ng/l

5.35

8069

47695

Any operation in hilmo

444

305

8.41

228.35

3.2

1.3

499.78

103.95

ng/l

0.96

298

142

Diseases of the skin and subcutaneous tissue

13050

48864

1.42

228.33

4.3

3.6

336.70

552.38

ng/l

6.48

9784

36329

Spinal stenosis

7136

36061

1.61

228.14

5.0

3.8

265.01

573.31

ng/l

8.99

6053

29884

Diabetes mellitus

13323

57892

1.41

228.03

4.7

3.5

483.52

461.55

ng/l

0.19

10266

41845

Nephropathy related operations

1939

9599

2.62

226.88

7.2

4.0

1351.72

472.11

ng/l

1.30

1824

7754

Non-allergic asthma (mode), excluding more controls

2440

12606

2.20

226.37

4.4

2.8

263.80

483.19

ng/l

3.51

1925

9397

COPD

6440

35427

1.65

226.28

5.9

4.0

374.63

546.90

ng/l

1.85

5644

29802

Substance abuse

7651

49831

1.55

220.59

4.7

3.8

301.28

598.92

ng/l

10.28

5789

37939

Mental and behavioural disorders due to psychoactive substance use

7847

50694

1.54

218.11

4.7

3.8

299.27

593.71

ng/l

10.42

5933

38522

Mouth breathing

5230

34253

1.71

217.98

4.5

3.9

324.14

562.32

ng/l

4.12

3784

26563

External causes of morbidity and mortality

8136

28227

1.54

217.51

3.9

3.3

464.58

604.87

ng/l

0.52

5946

20135

Chronic gastritis

3984

24662

1.87

217.18

5.3

3.9

319.61

456.78

ng/l

1.31

3346

20577

Gout, idiopatic and unspecified

3806

23431

1.92

216.90

5.9

4.3

524.61

517.38

ng/l

0.02

3480

20243

Need for other prophylactic measures

1034

4028

3.75

212.49

4.7

3.9

179.59

507.79

ng/l

5.37

822

3081

Ulcer of lower limb, not elsewhere classified

2368

12859

2.30

211.55

6.2

4.3

410.31

512.81

ng/l

0.57

2193

10945

Other chronic obstructive pulmonary disease

6159

34315

1.64

211.38

5.9

4.0

373.96

547.83

ng/l

1.80

5397

28951

Other joint disorders

11117

42724

1.44

210.97

3.9

3.5

301.70

596.30

ng/l

9.89

7755

30482

Type 2 diabetes, definitions combined

12488

54859

1.41

210.58

4.7

3.5

470.21

457.55

ng/l

0.10

9771

40609

Nutritional anaemias

6976

46463

1.57

209.87

5.6

4.0

325.82

437.23

ng/l

1.86

5736

37157

Rotator cuff syndrome

8292

40682

1.52

209.58

4.4

3.7

254.78

583.43

ng/l

13.20

6477

32181

Panic disorder

1860

9044

2.39

209.58

4.3

3.0

341.64

440.95

ng/l

0.23

1016

5493

Type 2 diabetes, strict (exclude DM1)

12527

55114

1.41

209.11

4.7

3.5

469.51

457.04

ng/l

0.10

9808

40816

Poisoning by drugs, medicaments and biological substances

2997

17162

1.99

208.96

4.8

3.5

282.82

485.64

ng/l

1.41

1979

11467

Migraine with aura and triptan purchases

1954

9701

2.33

208.09

4.0

3.1

249.69

408.11

ng/l

0.77

996

5515

Allergic asthma (mode), excluding more controls

2604

13787

2.04

207.25

3.7

2.6

370.40

460.83

ng/l

0.34

1706

8831

Benign neoplasm of colon, rectum, anus and anal canal

8932

55122

1.49

207.16

4.8

4.1

486.62

461.82

ng/l

0.09

7508

44990

Unspecified fall

7075

48728

1.56

206.91

4.9

4.0

245.73

479.93

ng/l

6.11

5687

37792

Injuries to the abdomen, lower back, lumbar spine and pelvis

5724

38063

1.64

206.85

4.9

4.0

278.92

455.14

ng/l

2.87

4578

29837

Other CVD

3189

18974

2.01

206.69

6.9

4.3

330.11

462.14

ng/l

0.92

2831

16364

Disorders of vestibular function (Vertigo)

6553

44338

1.60

206.48

4.8

4.0

388.40

391.39

ng/l

0.01

5038

35351

Spondylosis

7304

40076

1.55

205.20

4.6

3.7

218.27

587.05

ng/l

15.21

5763

32027

Type 2 diabetes, definitions combined, including avohilmo

12460

54564

1.40

205.04

4.6

3.5

478.20

456.52

ng/l

0.17

9671

40261

Chronic rhinitis, nasopharyngitis and pharyngitis

4293

27205

1.76

204.54

4.1

3.6

208.99

451.82

ng/l

4.59

3080

20005

Infections of the skin and subcutaneous tissue

7674

53751

1.52

204.06

4.9

3.7

413.57

531.00

ng/l

1.09

5765

39782

Poisoning by medicine

2726

15310

2.04

203.25

4.9

3.4

291.37

503.80

ng/l

1.29

1794

10161

Abnormal findings on diagnostic imaging of lung

6875

45782

1.57

202.91

5.2

4.1

320.51

497.02

ng/l

4.05

5738

38000

Migraine without aura

2259

11826

2.14

202.90

3.8

2.8

190.92

402.11

ng/l

3.39

1131

6849

Iron deficiency anaemia

6024

40590

1.61

199.67

5.8

4.0

314.98

424.84

ng/l

1.64

4933

32352

Acute upper respiratory infections

13780

63696

1.37

199.57

4.5

3.7

332.11

491.01

ng/l

4.10

9792

48664

Other symptoms and signs involving the circulatory and respiratory systems

996

3814

3.36

199.36

6.9

2.8

168.23

888.33

ng/l

2.17

719

2905

Unspecified privation

1675

8189

2.60

199.36

5.2

3.9

355.63

554.58

ng/l

0.84

1378

6292

Other symptoms and signs involving the nervous and musculoskeletal systems

5528

37299

1.64

198.88

4.9

3.8

277.50

448.90

ng/l

2.45

3607

28328

Undetermined asthma

1819

9006

2.39

198.61

4.7

3.1

217.01

629.38

ng/l

2.83

1388

6798

Abnormal findings on examination of blood, without diagnosis

6491

40936

1.59

198.28

4.8

4.1

487.33

544.44

ng/l

0.16

5464

33301

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

12743

61680

1.39

198.07

4.3

3.8

294.64

529.07

ng/l

8.56

9995

46853

Diseases of pulp and periapical tissues, including avohilmo

13617

54071

1.38

198.04

4.0

3.8

369.57

488.69

ng/l

2.47

10137

40645

7565

48173

1.52

197.59

4.6

3.9

299.30

607.51

ng/l

10.41

5876

37145

Hernia of abdominal wall, postoperative

2592

14388

2.06

197.57

5.1

3.3

292.08

664.55

ng/l

6.60

2057

11262

Other diseases of hard tissues of teeth

7673

27921

1.54

197.26

4.2

3.9

336.89

576.30

ng/l

4.81

6093

22421

Diseases of oral cavity, salivary glands and jaws

7810

28332

1.53

196.72

4.3

3.9

371.56

576.43

ng/l

3.39

6307

22798

Personality disorders

3229

19157

1.89

196.66

4.3

3.3

274.65

489.08

ng/l

1.46

2002

12333

Osteopathies and chondropathies

7645

50125

1.52

195.92

5.1

3.9

301.71

438.48

ng/l

2.80

6083

38827

ILD medications: immunosuppressive drugs

8159

53375

1.49

195.48

4.9

3.4

481.33

534.19

ng/l

0.42

6274

39096

Chronic apical periodontitis

14569

63573

1.36

195.23

4.1

3.8

386.98

486.77

ng/l

1.79

11007

47038

GI-bleeding

4670

30717

1.72

194.46

5.9

4.2

377.97

480.84

ng/l

0.73

3922

25797

Hypokalaemia

1818

9183

2.43

194.40

5.7

3.6

169.26

479.81

ng/l

2.16

1547

7289

Gout, FINNGEN

4349

28096

1.76

193.86

5.9

4.3

481.90

531.30

ng/l

0.18

3965

24270

Diseases of inner ear

7438

51086

1.52

193.20

4.7

4.0

389.42

416.11

ng/l

0.07

5736

40667

Irritable bowel syndrome

3521

21517

1.83

192.94

4.3

3.4

182.06

423.10

ng/l

3.37

2304

15526

Alcohol use disorder, Swedish definition

7155

46210

1.53

191.80

4.7

3.9

307.57

611.72

ng/l

9.44

5597

35914

Other diseases of the digestive system

4656

30709

1.71

191.79

5.8

4.2

363.34

480.81

ng/l

0.88

3903

25749

7859

49269

1.50

191.72

4.6

3.9

305.99

605.10

ng/l

9.89

6075

37837

Hypotension

2800

16445

2.05

191.10

6.8

4.4

243.15

454.12

ng/l

1.82

2493

14349

Memory loss

1534

7482

2.76

190.84

4.7

4.4

181.26

489.02

ng/l

1.79

1363

6390

Transport accidents

5784

32670

1.59

189.49

4.0

3.4

282.85

648.14

ng/l

7.74

4088

23337

Chronic sinusitis

5496

37301

1.61

188.73

4.2

3.7

333.73

480.09

ng/l

1.85

3971

27734

Injury, poisoning and certain other consequences of external causes

6532

22309

1.57

188.67

3.9

3.2

507.02

615.32

ng/l

0.29

4723

16006

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2152

11196

2.20

188.21

4.8

3.7

1119.62

487.86

ng/l

5.06

1753

7978

Genitourinary diseases

7038

24448

1.54

188.13

4.1

3.4

543.01

690.81

ng/l

0.49

5293

18276

Other nutritional deficiencies

8437

56364

1.47

188.04

4.4

3.7

311.67

487.88

ng/l

3.38

6066

40436

Disorders of adult personality and behaviour

3345

20255

1.84

187.92

4.2

3.3

254.90

486.11

ng/l

1.80

2053

12947

Non-allergic asthma (mode)

2440

13427

2.05

187.05

4.4

3.1

263.80

592.79

ng/l

3.29

1925

10249

Diseases of the eye and adnexa

9464

34670

1.44

185.31

3.9

3.3

440.59

605.33

ng/l

2.25

6585

23794

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

2277

12148

2.13

184.95

4.8

3.7

1082.23

485.14

ng/l

5.13

1854

8687

Other degenerative diseases of the nervous system

3776

17101

1.79

184.74

4.3

3.5

224.73

618.92

ng/l

13.72

3190

13928

Diseases of the digestive system

6308

44034

1.56

184.14

5.4

4.1

380.10

471.31

ng/l

0.79

5121

35697

Viral hepatitis, IBD co-morbidity

710

2312

3.78

183.87

4.1

2.7

236.93

920.92

ng/l

5.56

472

1573

Other diseases of pleura

6354

38897

1.57

183.68

5.9

4.1

365.92

516.82

ng/l

2.45

5582

32755

Open wound of head

7371

49867

1.50

183.04

4.6

3.9

304.76

562.15

ng/l

7.37

6061

39270

Soft tissue disorders related to use, overuse and pressure

3763

23834

1.78

181.97

4.7

3.6

431.85

520.43

ng/l

0.44

2943

18830

Sequelae of cerebrovascular disease

5161

29900

1.65

181.70

5.6

4.1

332.15

493.04

ng/l

1.87

4564

25429

Sequelae of external causes of morbidity and mortality

3618

22825

1.82

181.66

5.3

4.0

378.48

451.81

ng/l

0.22

2978

18032

Viral pneumonia (unknown virus, not influenza)

1118

4826

3.09

180.97

5.6

3.7

325.48

454.24

ng/l

0.68

916

3639

Allergic asthma (mode)

2604

14402

1.94

180.23

3.7

2.8

370.40

565.62

ng/l

0.75

1706

9469

Other and unspecified effects of external causes

3432

21212

1.81

180.19

4.4

3.6

370.39

453.71

ng/l

0.19

2232

14709

Other bacterial intestinal infections, including avohilmo

3265

20065

1.85

179.60

5.4

3.8

304.12

399.01

ng/l

1.17

2585

15723

Benign neoplasms

12434

52021

1.37

179.16

4.1

3.7

441.83

542.10

ng/l

0.57

9189

37909

Other chronic obstructive pulmonary disease, including avohilmo

7446

44389

1.51

179.10

5.6

4.1

357.09

518.35

ng/l

2.08

6456

36953

Neoplasms

9025

34592

1.44

179.08

3.8

3.4

450.75

656.13

ng/l

0.96

6192

23437

L04AD Calcineurin inhibitors

1550

7642

2.53

178.55

7.4

3.6

1023.98

624.04

ng/l

1.16

1384

5565

Mental and behavioural disorders due to alcohol

6587

44586

1.52

176.98

4.6

3.8

279.52

618.90

ng/l

11.89

5069

34387

Other and unspecified iron deficiency

4750

31875

1.66

176.39

5.8

4.0

282.68

423.60

ng/l

2.19

3870

25271

Gout, unspecified

3068

18868

1.92

175.97

6.1

4.3

460.98

512.65

ng/l

0.17

2822

16338

Recurrent or chronic depression

4681

21258

1.65

175.96

3.9

3.3

285.63

644.32

ng/l

5.76

2980

15388

General examination and investigation of persons without complaint and reported diagnosis

7473

27532

1.49

175.75

4.8

3.3

348.32

603.90

ng/l

6.08

5023

20982

Periodontitis

13035

64867

1.36

175.71

4.2

3.8

397.47

479.69

ng/l

1.42

10253

48816

Other arthrosis

7107

34073

1.51

175.13

4.3

3.7

257.00

606.66

ng/l

12.36

5663

26601

Other reaction to severe stress, and adjustment disorders

4206

27293

1.68

174.89

4.4

3.3

270.21

465.90

ng/l

2.47

2707

18029

Nonischemic cardiomyopathy

1444

6973

2.58

174.34

5.6

3.0

673.37

135.06

ng/l

1.04

1323

5585

Pain in thoracic spine

2091

11388

2.14

174.32

5.3

3.5

146.56

538.96

ng/l

3.88

1470

8406

Later onset COPD, excluding more controls

3022

13900

1.92

174.23

6.1

3.5

316.95

639.85

ng/l

2.17

2803

12075

Chronic periodontitis, including avohilmo

12998

64864

1.35

172.97

4.2

3.8

396.42

479.68

ng/l

1.45

10227

48834

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

3394

21080

1.78

172.32

4.2

3.4

255.93

454.55

ng/l

1.66

2074

13531

Caries of dentine, including avohilmo

10365

39948

1.41

172.04

4.2

3.9

363.34

509.63

ng/l

2.76

8137

31277

Mental and behavioural disorders due to alcohol, excluding acute intoxication

5734

39738

1.56

171.04

4.7

3.9

276.49

636.67

ng/l

12.17

4480

30973

Congenital malformations of the circulatory system

1877

9664

2.23

170.75

5.0

3.6

1238.46

530.35

ng/l

4.85

1537

6894

Epilepsy

3936

25415

1.70

169.16

4.7

3.7

221.28

530.23

ng/l

14.48

3030

19958

Specific personality disorders

2743

16228

1.89

168.66

4.2

3.3

276.12

501.68

ng/l

1.26

1651

10362

Diseases of pulp and periapical tissues and dental caries

8778

33211

1.45

168.21

4.2

3.9

355.96

517.27

ng/l

2.89

7016

26368

Congenital malformations of heart and great arteries

1682

8392

2.33

167.54

5.1

3.6

1301.25

564.64

ng/l

4.33

1400

5942

Alcohol abuse, main dg, excluding more controls

1951

10523

2.16

167.09

5.3

3.6

284.01

689.15

ng/l

2.85

1426

7952

Hypo-osmolality and hyponatraemia

2493

14459

1.99

166.99

6.1

3.7

247.56

444.69

ng/l

1.42

2163

11944

Obesity and other hyperalimentation

7875

54639

1.45

166.42

4.3

3.6

300.03

488.54

ng/l

3.69

5691

39033

Dental caries, including avohilmo

9715

37345

1.42

166.30

4.2

3.9

358.64

517.00

ng/l

3.10

7728

29534

Fracture of rib(s), sternum and thoracic spine

4347

29139

1.67

165.83

5.5

4.1

264.13

503.88

ng/l

4.61

3636

23895

Obesity

7833

54418

1.45

165.74

4.3

3.6

301.39

489.64

ng/l

3.65

5663

38855

Obesity, other/unspecified

4142

27279

1.67

164.91

4.1

3.5

241.81

426.40

ng/l

2.30

2926

18688

Benign paroxysmal vertigo

4085

27106

1.70

164.71

5.0

4.0

492.73

351.92

ng/l

0.25

3108

21685

Other diseases of anus and rectum

4124

27157

1.68

164.39

5.1

3.8

381.04

482.11

ng/l

0.81

3289

21917

Retention of urine

4738

25991

1.64

163.29

5.4

4.1

411.45

563.65

ng/l

1.19

4100

21989

Paralytic ileus and intestinal obstruction

3575

22967

1.75

162.68

4.8

3.8

296.13

473.32

ng/l

1.27

2899

18998

Unspecified kidney failure

1689

8970

2.35

160.97

6.5

4.1

563.98

420.17

ng/l

0.45

1594

7740

Symptoms and signs involving speech and voice

4463

30240

1.64

160.34

4.8

3.9

232.20

417.74

ng/l

3.29

3426

23589

Arthropathies

11054

42787

1.37

160.03

3.9

3.5

332.31

597.52

ng/l

6.37

7793

30525

Schizophrenia or delusion, excluding more controls

3526

22286

1.71

157.07

4.3

3.5

193.96

570.64

ng/l

8.13

2439

16218

Injuries to the shoulder and upper arm

11230

67614

1.36

156.15

4.3

3.9

377.06

491.29

ng/l

1.55

8836

51518

Implicit fungal Sepsis, including avohilmo

1162

5448

2.79

155.87

6.9

3.6

286.61

424.43

ng/l

0.94

971

4327

Alcohol use disorder, ICD-based

5277

36990

1.56

155.79

4.8

3.9

268.25

636.78

ng/l

11.89

4100

28757

COPD, hospital admissions

6162

37435

1.53

155.69

6.0

4.1

368.54

521.95

ng/l

1.52

5401

31724

COPD related to multimorbidity

5487

32822

1.57

155.41

6.4

4.2

405.42

521.73

ng/l

0.87

4904

28172

Nonorganic sleeping disorders

2677

16150

1.86

154.83

4.3

3.6

248.37

469.59

ng/l

1.65

1759

11000

Gingivitis and periodontal diseases

12879

52408

1.34

154.14

4.2

3.8

401.11

495.42

ng/l

1.50

9923

39809

Myocardial infarction, with ST-elevation

2550

15425

1.94

154.13

7.1

4.4

3119.58

421.61

ng/l

27.67

2406

13434

COPD, early/later onset

6213

37738

1.52

153.66

5.9

4.1

370.72

520.58

ng/l

1.48

5449

31978

Other and unspecified visual disturbances

1572

8231

2.35

153.62

5.5

3.8

766.13

375.57

ng/l

1.01

1166

6290

COPD, hospital admission 2, with asthma infections

4520

26623

1.64

153.51

6.6

4.2

343.28

513.25

ng/l

1.38

4019

22817

Dental operations

8170

31125

1.44

153.23

4.3

3.9

350.44

552.53

ng/l

3.88

6596

24965

Other disorders of eye and adnexa

1933

10756

2.11

152.68

5.2

3.7

297.05

479.79

ng/l

0.82

1384

7763

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

11916

55389

1.34

152.61

4.6

3.5

515.84

463.19

ng/l

0.48

9342

41084

Thoracic aortic aneurysm

2122

12312

2.09

151.74

5.1

4.0

977.42

540.27

ng/l

2.96

1934

10397

Progressive vascular leukoencephalopathy

803

3337

3.78

151.56

4.8

4.5

220.50

276.13

ng/l

0.36

780

3000

Emotionally unstable personality disorder

1429

7116

2.32

151.30

4.0

3.0

257.32

455.45

ng/l

0.90

774

3962

Polyuria

3132

19967

1.80

151.14

5.2

4.0

233.60

482.63

ng/l

6.49

2596

16500

Disorders of synovium and tendon

6569

40484

1.47

149.91

4.2

3.5

310.58

562.27

ng/l

5.89

4812

30355

Dilated cardiomyopathy

1762

9760

2.25

148.69

6.9

4.2

732.14

568.94

ng/l

0.25

1655

8284

Peripheral artery disease

5992

34186

1.52

148.30

6.3

4.1

620.45

456.37

ng/l

1.21

5470

29319

Other or ill-defined heart diseases

788

3115

3.22

147.95

9.0

2.8

584.67

515.84

ng/l

0.25

707

2279

Post-traumatic stress disorder

1004

4368

2.68

147.51

3.6

2.8

215.78

536.02

ng/l

2.05

495

2283

Other diseases of upper respiratory tract

14117

58890

1.31

147.05

4.2

3.8

346.08

524.43

ng/l

5.11

10522

45104

Benign neoplasm: Colon

7390

52047

1.45

146.20

4.9

4.1

519.82

458.94

ng/l

0.20

6241

42914

Diabetes medication

13161

61274

1.32

145.40

4.5

3.6

459.48

473.27

ng/l

0.11

10146

44966

Any death

8526

45509

1.42

145.27

5.1

4.0

620.77

442.59

ng/l

0.83

7539

36997

Malignant neoplasm, wide definition

10776

48842

1.35

144.64

4.1

3.8

355.64

556.46

ng/l

1.46

8358

35643

Malignant neoplasm, including Hilmo

10759

48790

1.35

144.47

4.1

3.8

354.81

557.33

ng/l

1.47

8338

35577

Gout, strict definition

2662

16622

1.88

144.00

6.1

4.4

593.86

519.31

ng/l

0.18

2458

14471

Liquid cancers, including Hilmo

4822

29790

1.57

142.69

4.7

4.2

346.65

540.37

ng/l

1.89

3999

24294

Somatoform disorder

2075

11987

1.99

142.33

4.9

3.5

141.18

482.29

ng/l

3.40

1373

8624

Exposure to other specified factors

10064

67359

1.35

141.97

4.1

3.7

443.76

492.30

ng/l

0.40

7306

49321

Arthrosis

9013

37600

1.39

141.22

4.1

3.7

301.81

599.87

ng/l

9.70

7047

28555

Sleep apnoea

12110

60670

1.33

141.07

4.4

3.8

409.63

499.15

ng/l

0.48

9007

46314

Injuries to the hip and thigh

6626

43986

1.46

139.92

4.9

4.1

363.01

453.10

ng/l

0.77

5511

35672

ILD, hospital admission 2, with pulmonary infections

1460

7704

2.32

139.53

6.1

3.7

417.05

632.48

ng/l

0.87

1317

6516

Care involving dialysis

1155

5614

2.60

139.21

7.2

3.6

927.74

559.45

ng/l

0.84

1089

4545

Enlarged lymph nodes

1943

11036

2.00

139.11

4.9

3.2

244.35

652.10

ng/l

3.19

1471

8401

Malignant neoplasm

10534

48171

1.35

138.87

4.1

3.8

348.67

559.57

ng/l

1.53

8203

35337

Behavioural syndromes associated with physiological disturbances and physical factors

11791

63328

1.32

138.70

4.1

3.8

272.23

488.51

ng/l

6.11

8139

47185

Atherosclerosis, excluding cerebral and coronary sclerosis

5658

32170

1.52

138.54

6.5

4.2

630.14

452.58

ng/l

1.29

5245

27844

Malignant neoplasm

10519

48124

1.35

138.11

4.1

3.8

347.56

557.36

ng/l

1.52

8190

35301

Autoimmune diseases excluding thyroid diseases

13282

57708

1.30

137.36

4.4

3.7

472.87

503.17

ng/l

0.25

10017

42765

Left ventricular outflow tract obstruction (LVOTO), broad definition

1383

7199

2.35

136.94

5.7

3.8

2088.95

522.35

ng/l

1.93

1230

5384

Traumatic subdural haemorrhage

1898

10113

2.04

136.74

4.9

3.8

262.76

696.87

ng/l

6.97

1668

8736

Other and unspecified nerve root and plexus disorders, also in other diseases

2723

17123

1.80

136.52

4.5

3.7

257.41

497.85

ng/l

2.47

2016

12964

Fibromyalgia

1190

5802

2.43

135.97

4.6

3.1

228.36

364.70

ng/l

0.65

714

3845

Disorders of choroid and retina

10564

58267

1.34

135.65

4.7

3.9

437.38

481.05

ng/l

0.43

8854

46066

Explicit bacterial Sepsis, including avohilmo

1546

8355

2.21

134.93

5.6

3.6

326.83

509.49

ng/l

1.87

1340

6714

Sequelae with surgical and medical care as external cause

2793

17854

1.79

133.97

5.4

4.0

442.44

448.20

ng/l

0.01

2330

14307

Any event in cancer register

11111

51197

1.33

133.60

4.0

3.7

343.52

545.94

ng/l

1.51

8475

36856

Other bacterial intestinal infections

2479

15347

1.85

133.54

5.9

3.9

312.26

410.69

ng/l

0.95

2017

12368

Superficial injury of lower leg

3311

21783

1.68

133.53

4.7

3.7

328.00

437.53

ng/l

0.83

2423

15949

Other gastritis (incl. Duodenitis)

2980

19275

1.75

133.38

5.4

3.8

272.99

491.26

ng/l

2.46

2444

15723

Diseases of liver

4480

31442

1.57

133.37

4.9

4.0

309.21

483.32

ng/l

2.73

3594

24695

Abnormal blood-pressure reading, without diagnosis

654

2481

3.38

133.20

4.4

2.7

105.94

667.30

ng/l

6.87

515

1824

Congenital malformations, deformations and chromosomal abnormalities

6742

47583

1.42

133.02

4.0

3.6

551.41

425.21

ng/l

1.62

4772

32480

Unknown and unspecified causes of morbidity

958

4336

2.70

133.01

4.7

3.2

282.32

582.83

ng/l

2.93

487

3297

Aortic aneurysm

3213

20772

1.72

132.82

5.1

4.1

799.48

554.39

ng/l

2.03

2941

17974

Other (not insulin) diabetes medications

12457

58568

1.31

132.80

4.5

3.7

440.68

471.72

ng/l

0.27

9700

43867

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

7529

51895

1.40

132.60

4.0

3.6

519.28

431.19

ng/l

1.07

5314

35940

Other diseases of pericardium

685

2702

3.39

132.55

8.0

2.9

581.58

532.85

ng/l

0.12

608

2080

Autoimmune diseases excluding thyroid diseases, strict definition

12844

56059

1.30

131.61

4.3

3.7

487.27

513.21

ng/l

0.20

9668

41500

Sleep disorders

11316

61973

1.32

131.48

4.0

3.8

270.76

479.78

ng/l

5.47

7757

46020

Status post-ami

3191

15754

1.71

131.21

7.4

3.0

1106.63

59.32

ng/l

13.61

2980

13269

Substance use, excluding alcohol

2389

14618

1.83

130.90

4.8

3.5

291.52

533.86

ng/l

1.99

1635

10313

Abnormal serum enzyme levels

4043

27037

1.61

130.70

4.4

4.3

628.05

620.53

ng/l

0.01

3489

22796

Acute sinusitis

6186

41403

1.44

130.54

4.3

3.5

339.63

500.34

ng/l

1.80

4208

29413

Viral and other specified intestinal infections, including avohilmo

3156

19694

1.67

130.42

4.9

3.3

738.43

410.48

ng/l

0.43

2069

12865

Dipeptidyl peptidase 4 (DPP-4) inhibitors

7412

44218

1.42

129.97

5.3

4.0

390.55

486.69

ng/l

1.14

6312

36526

Disorders of lens

8411

40047

1.39

129.44

4.7

3.7

540.08

547.59

ng/l

0.03

7050

31342

COPD, hospital admissions 3, with asthma pneumonia sepsis

3798

22283

1.64

128.75

6.8

4.3

334.56

521.31

ng/l

1.31

3437

19346

Sleep apnoea, including avohilmo

12594

61373

1.30

128.36

4.4

3.7

421.53

491.83

ng/l

0.36

9237

46513

Cutaneous abscess, furuncle and carbuncle

3262

21602

1.67

128.11

4.8

3.7

513.50

491.63

ng/l

0.07

2420

15857

Acute pancreatitis

2610

16534

1.79

128.08

5.0

4.0

195.78

528.34

ng/l

5.65

2078

13414

Endocarditis

571

2100

3.76

127.30

6.9

3.0

2565.96

541.28

ng/l

0.82

533

1654

Injuries to the ankle and foot

8670

57384

1.36

127.30

4.1

3.6

352.83

488.24

ng/l

2.35

5888

40736

Early onset COPD

2873

18671

1.75

127.20

5.8

3.9

403.43

546.43

ng/l

0.96

2352

15081

COPD-related respiratory insufficiency

1728

9953

2.10

126.28

7.5

4.2

466.19

521.26

ng/l

0.13

1588

8639

Gonarthrosis

8173

35302

1.39

126.05

4.2

3.7

354.03

601.58

ng/l

4.59

6498

27503

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

6403

46146

1.43

125.58

4.2

3.8

335.38

563.01

ng/l

4.67

4678

35011

Adverse effects, not elsewhere classified

2352

14505

1.82

125.39

4.6

3.6

428.94

466.78

ng/l

0.05

1566

10040

Voice disturbances

3426

23144

1.65

124.96

4.6

3.8

212.95

435.71

ng/l

3.22

2586

17721

Biguanides

12162

59116

1.30

124.86

4.5

3.7

435.19

482.79

ng/l

0.47

9545

44635

Explicit bacterial Sepsis

1488

8147

2.17

124.52

5.6

3.6

334.00

516.82

ng/l

1.78

1290

6558

Lung cancer and mesothelioma

2525

13432

1.80

124.40

5.0

3.4

308.81

692.98

ng/l

3.79

2230

11335

Paracetamol or NSAID medication

1896

5259

1.96

124.28

3.8

3.2

374.07

902.66

ng/l

3.62

1385

3949

Cervicalgia

2644

16844

1.75

123.91

5.0

3.6

229.70

503.88

ng/l

3.12

1942

13051

Fracture of lumbar spine and pelvis

3161

21053

1.69

123.85

5.3

4.2

285.23

426.27

ng/l

1.11

2744

17584

Sequelae of injuries, of poisoning and of other consequences of external causes

2951

19311

1.70

123.72

4.3

3.8

354.11

507.87

ng/l

0.76

2183

14465

Unspecified acute lower respiratory infection

2060

12390

1.91

123.60

6.1

3.8

593.36

570.92

ng/l

0.03

1626

9623

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1882

10958

1.94

123.49

4.5

3.4

315.59

450.32

ng/l

0.70

1195

7015

Diabetes, insulin treatment (Kela reimbursement)

12758

61521

1.29

123.00

4.7

3.7

496.32

471.74

ng/l

0.20

10075

46446

Insomnia

11011

61218

1.31

122.74

4.0

3.7

270.45

472.47

ng/l

4.94

7474

45101

Abnormalities of gait and mobility

1756

10247

2.06

122.66

5.3

4.1

373.16

519.31

ng/l

0.68

1529

8658

Diseases of the ear and mastoid process

14171

57967

1.27

121.89

4.1

3.7

419.11

527.94

ng/l

0.74

10157

42646

Alzheimer disease, excluding more controls

2437

9737

1.83

121.68

4.4

3.7

191.50

716.98

ng/l

12.69

2200

8464

Disorder of lipoprotein metabolism, unspecified

1755

10180

2.02

121.61

5.5

3.8

607.92

539.02

ng/l

0.15

1519

8527

Left bundle-branch block

1002

4811

2.54

121.54

5.5

3.0

427.23

385.60

ng/l

0.10

904

3804

Cervicobrachial syndrome

2684

17206

1.73

121.35

4.5

3.4

323.16

503.70

ng/l

1.03

1833

12860

Gonarthrosis [arthrosis of knee](FG)

9670

43744

1.34

121.32

4.2

3.7

347.04

557.51

ng/l

4.51

7700

34004

Suicide or other Intentional self-harm

2802

18123

1.70

121.21

4.6

3.5

273.05

480.15

ng/l

1.52

1852

12450

Autoimmune diseases related-to ILD

10533

70246

1.31

121.16

4.2

3.8

370.97

487.83

ng/l

2.11

7655

52431

Special screening examination for infectious and parasitic diseases

2551

11493

1.74

121.06

3.2

2.9

385.75

543.63

ng/l

1.19

1563

7309

Intestinal stricture

4125

29091

1.57

120.99

4.7

4.2

303.56

459.95

ng/l

1.27

3356

23969

Pericarditis

546

2007

3.68

120.76

7.9

2.9

438.55

603.49

ng/l

0.48

468

1516

Chronic periodontitis, complicated

7216

54012

1.40

120.13

4.2

4.0

412.75

501.70

ng/l

1.24

5876

42572

Solid cancers, including Hilmo

10435

48268

1.32

119.89

4.0

3.8

358.86

558.91

ng/l

1.39

8126

35352

Hyperkinetic disorders, excluding more controls

1148

5254

2.23

119.44

2.8

2.5

246.31

651.31

ng/l

3.69

468

2424

Senile cataract

7803

36495

1.39

118.62

4.7

3.8

461.56

539.04

ng/l

0.70

6641

29132

Bipolar affective disorders

2079

12538

1.84

118.45

4.1

3.3

218.15

558.81

ng/l

2.37

1314

8281

Other cataract

5669

31118

1.46

118.21

4.8

3.8

541.75

536.98

ng/l

0.01

4837

24927

Liquid cancers

3902

25833

1.58

118.14

4.8

4.3

366.20

523.02

ng/l

1.09

3302

21315

Solid cancers

10201

47448

1.32

118.10

4.1

3.8

357.25

558.06

ng/l

1.36

7987

34956

Other and unspecified nonorganic psychotic disorders

2189

13428

1.81

117.53

4.2

3.4

191.26

447.77

ng/l

4.66

1438

8902

Aortic valve malfunction, age under 60 years

1270

6773

2.28

117.40

5.5

3.8

2123.68

535.17

ng/l

1.74

1136

5090

Delirium, not induced by alcohol and other psychoactive substances

1849

11027

1.98

117.30

6.0

4.5

171.39

521.58

ng/l

3.95

1668

9641

Asthma and allergy, excluding more controls

1288

6602

2.12

116.85

3.6

2.4

313.78

407.98

ng/l

0.32

765

3845

Other retinal disorders

8403

49973

1.36

116.13

4.8

4.0

439.98

462.59

ng/l

0.16

7185

40475

Streptococcal septicaemia, including avohilmo

1344

7333

2.22

116.10

5.8

3.8

359.20

619.44

ng/l

1.11

1186

5994

Obesity due to excess calories

5543

41048

1.44

115.88

4.4

3.6

299.66

469.78

ng/l

2.35

3989

28868

Cervical disc disorders

4422

31705

1.51

114.67

4.6

3.6

317.77

581.91

ng/l

4.08

3339

25197

Trochanteric bursitis

1934

11686

1.90

114.23

4.7

3.5

315.64

409.11

ng/l

0.38

1480

9084

Other viral diseases, including avohilmo

4204

29471

1.51

113.53

4.4

3.5

317.76

485.23

ng/l

2.22

2798

19524

Alcohol abuse, main dg

1951

11824

1.88

113.17

5.3

3.8

284.01

578.75

ng/l

1.91

1426

8829

Migraine without aura and triptan purchases

1717

9917

1.91

113.12

3.6

3.0

178.22

428.37

ng/l

3.01

809

5481

Deforming dorsopathies

3341

22835

1.59

111.25

4.4

3.5

285.55

480.12

ng/l

2.27

2534

17406

ILD, hospital admissions 3, with pneumonia sepsis

1248

6761

2.26

110.95

6.1

3.9

386.23

622.29

ng/l

0.87

1133

5761

Certain disorders involving the immune mechanism

2370

15198

1.77

110.43

6.2

3.8

326.69

482.52

ng/l

1.01

1832

11637

L04AA Selective immunosuppressants

2702

17800

1.69

110.22

5.9

3.7

644.60

450.32

ng/l

1.01

2242

13070

Meniscus derangement

6895

34971

1.39

110.16

4.2

3.7

381.74

605.91

ng/l

3.49

5408

27100

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

11225

70984

1.29

109.80

4.2

3.8

343.39

491.43

ng/l

3.05

8368

52621

Other and unspecified mood [affective] disorders

853

3948

2.53

109.62

3.8

3.1

290.14

502.63

ng/l

0.55

480

2411

Fall on same level involving ice and snow

7251

56280

1.37

109.49

4.2

3.9

342.44

444.78

ng/l

1.05

5474

42632

Acetic acid derivatives and related substances

3412

11816

1.61

109.36

4.1

3.9

222.65

679.17

ng/l

11.30

2626

9578

Asthma and allergy

1288

6752

2.07

109.29

3.6

2.5

313.78

430.64

ng/l

0.41

765

4030

Organic, including symptomatic, mental disorders

6907

37442

1.40

109.06

4.8

4.3

210.74

486.77

ng/l

12.59

6086

31941

Other and unspecified injuries of head

1096

5713

2.36

108.62

6.0

3.9

118.52

605.96

ng/l

2.34

932

4536

Other viral diseases, not elsewhere classified, including avohilmo

3020

20154

1.62

108.55

4.5

3.6

318.27

497.08

ng/l

1.61

2017

13597

Problems related to lifestyle

1300

7062

2.12

108.40

5.2

3.5

398.14

640.45

ng/l

0.69

948

5033

Acute pancreatitis (for exclusion)

2610

17191

1.71

108.40

5.0

4.1

195.78

500.93

ng/l

4.99

2078

13916

Left ventricular outflow tract obstruction, narrow definition

718

3197

2.93

107.86

5.9

3.8

1805.32

536.48

ng/l

9.05

639

2368

Fracture of lower leg, including ankle

6793

51393

1.38

107.84

4.3

3.8

371.90

483.89

ng/l

1.34

5212

39059

Streptococcal septicaemia

1292

7126

2.19

107.67

5.8

3.8

368.14

630.62

ng/l

1.08

1138

5836

Chondrocostal junction syndrome [Tietze]

618

2605

3.28

107.26

7.3

3.8

84.28

350.74

ng/l

4.85

434

1918

Other or unspecified ileus, impaction or obstruction

2438

15803

1.73

107.19

4.8

3.9

307.00

502.16

ng/l

0.90

1984

13211

Mycoses, including avohilmo

11383

70681

1.28

106.81

4.3

3.8

354.80

485.72

ng/l

3.13

8460

52361

Other respiratory diseases principally affecting the interstitium

2463

16148

1.74

106.46

5.7

4.3

420.23

487.78

ng/l

0.38

2194

13826

Ocular pain

1131

5978

2.26

105.42

5.6

3.6

269.89

434.63

ng/l

0.78

759

4193

Bacterial intestinal infections, IBD co-morbidities

2437

15903

1.73

105.36

5.9

4.1

315.63

465.79

ng/l

1.09

1983

12830

Injuries to the wrist and hand

12521

68310

1.27

105.35

4.1

3.8

332.74

501.93

ng/l

5.04

8934

50902

Artificial opening status

833

4010

2.70

104.97

5.4

3.6

370.91

385.62

ng/l

0.04

704

3245

Short Achilles tendon (acquired)

469

1736

3.84

104.79

4.5

3.3

76.93

440.03

ng/l

5.02

356

1258

Congenital malformations of aortic and mitral valves

626

2662

3.13

104.71

5.6

3.8

1829.29

554.29

ng/l

7.53

563

1975

Overexertion and strenuous or repetitive movements

1301

7245

2.13

103.67

4.1

3.8

445.36

596.61

ng/l

0.40

1014

5335

Artrosis, including avohilmo

10152

44659

1.30

103.56

4.0

3.8

284.37

595.01

ng/l

12.64

7748

33458

Used for control exclusion in common control thyroid runs

12989

53890

1.26

103.40

4.3

3.6

436.04

515.49

ng/l

0.91

9606

39904

Other disorders of lacrimal gland

4549

33379

1.47

103.39

4.9

3.8

263.63

406.16

ng/l

1.00

3394

25431

Abnormal involuntary movements

1772

10773

1.90

103.31

5.5

3.8

159.74

502.15

ng/l

3.26

1308

8484

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

850

4045

2.49

103.26

4.3

3.3

135.77

524.31

ng/l

5.88

523

2582

Generalized anxiety disorder

1690

9950

1.86

102.89

3.9

3.0

200.55

437.09

ng/l

2.28

946

5894

Coxibs

3358

11931

1.58

102.31

4.1

3.9

299.02

676.98

ng/l

6.41

2559

9635

Assault

1529

8857

1.94

102.16

4.2

3.4

228.15

503.17

ng/l

4.73

1002

5772

Cellulitis

2793

18846

1.64

101.50

5.3

3.9

445.53

515.03

ng/l

0.26

2195

14510

Benign neoplasm: Colon, unspecified

3337

23452

1.59

101.48

5.0

4.2

655.29

443.07

ng/l

0.36

2849

19688

Disorders of lacrimal system

5465

40634

1.42

101.19

4.8

3.8

263.63

395.87

ng/l

1.16

4121

31043

Inflammatory disease of uterus

1515

8769

1.94

101.10

3.6

3.2

113.71

298.11

ng/l

3.18

787

5270

Insulin medication

7481

48713

1.35

101.09

5.5

3.8

522.79

504.84

ng/l

0.12

6220

38122

Congenital malformations of cardiac septa

832

3852

2.54

101.05

4.8

3.5

1237.42

436.28

ng/l

4.24

669

2629

Other inflammation of eyelid, including avohilmo

5186

38793

1.42

100.72

3.9

3.5

311.36

443.46

ng/l

1.13

3630

26776

Candidiasis, including avohilmo

3616

25624

1.53

100.14

4.7

3.7

223.84

393.85

ng/l

2.39

2621

18585

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1212

6677

2.16

100.09

6.0

3.6

193.41

454.17

ng/l

3.57

931

5018

All influenza (not pneumonia)

1775

10807

1.84

99.48

5.8

3.4

328.68

626.08

ng/l

1.71

1412

8065

Fracture of skull and facial bones

2615

17450

1.65

99.06

4.3

3.7

313.39

536.33

ng/l

2.17

1990

13252

Insulin, intermediate and long-acting

6902

52116

1.36

98.72

5.5

4.0

533.40

499.90

ng/l

0.23

5745

41637

Missing teeth due to accident, extraction or parodontitis

7935

56424

1.33

98.35

4.7

4.0

315.33

470.90

ng/l

3.19

6479

45081

Systemic connective tissue disorders

4355

32088

1.47

97.15

4.9

4.0

200.62

373.84

ng/l

4.49

3393

25158

Other systemic involvement of connective tissue (FG)

3209

22011

1.56

96.50

4.7

3.7

174.14

452.80

ng/l

6.45

2465

17013

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4040

29414

1.49

96.14

4.5

3.8

393.65

393.33

ng/l

0.00

3013

21892

Cervicocranial syndrome

1361

7810

2.00

96.00

5.2

3.5

124.23

559.83

ng/l

2.91

948

5897

Conjunctivitis (acute, non atopic), including avohilmo

12477

62469

1.25

95.84

4.0

3.8

271.30

518.16

ng/l

10.32

8985

47025

Neuromuscular dysfunction of bladder

1224

6868

2.12

95.71

4.9

3.8

208.01

610.58

ng/l

2.23

956

5512

Other disorders of veins

5062

37585

1.42

95.37

4.3

3.8

252.68

429.22

ng/l

3.34

4127

28594

Cerebral palsy and other paralytic syndromes

1435

8412

1.98

95.30

5.4

3.9

169.83

550.49

ng/l

2.57

1062

6468

Familial hypercholesterolemia

1904

12017

1.80

95.08

5.9

3.8

355.67

502.65

ng/l

0.84

1611

10149

Diplopia

1709

10540

1.87

94.51

5.1

3.9

260.04

471.49

ng/l

1.26

1313

8323

Fall on and from stairs and steps

3272

23097

1.55

94.08

4.7

3.9

307.82

437.22

ng/l

1.25

2541

17799

Non-selective monoamine reuptake inhibitors

4446

31591

1.45

93.60

4.6

3.8

218.41

472.88

ng/l

5.08

3404

25055

Peripheral arterial reconstruction

2323

15480

1.71

93.57

7.0

4.5

668.42

471.76

ng/l

0.70

2161

13640

Disease of hard tissues of teeth, NOS

6632

26810

1.37

93.55

4.1

3.8

406.16

573.18

ng/l

1.80

5141

21400

Speech and linguistic disorders, excluding more controls

842

3821

2.33

93.53

4.9

3.2

336.08

570.81

ng/l

1.64

562

2391

Unspecified mental disorder

4505

33399

1.44

93.21

4.3

3.7

211.42

472.77

ng/l

6.52

3057

23944

Familial hypercholesterolemia, with ischemic heart disease

1208

6822

2.11

93.09

7.3

3.2

474.93

111.54

ng/l

4.61

1077

5840

Viral and other specified intestinal infections

2229

14109

1.66

92.16

5.2

3.3

947.81

389.50

ng/l

0.56

1482

9179

Phlebitis and thrombophlebitis (not including DVT)

2816

19496

1.59

90.53

4.8

3.9

353.69

462.97

ng/l

0.52

2203

15266

Other symptoms and signs involving the urinary system

1399

8297

1.97

90.38

5.2

4.0

1109.20

486.38

ng/l

0.38

978

6784

ILD, hospital admissions 1, main diag only

1856

11891

1.81

90.17

5.3

4.3

444.93

482.50

ng/l

0.15

1655

10188

Phobic anxiety disorders

1347

7719

1.91

90.03

4.1

3.0

224.60

477.60

ng/l

2.08

778

4495

Atrial septal defect

516

2121

3.14

90.01

4.4

3.7

1203.08

446.10

ng/l

2.01

414

1460

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

4107

29710

1.45

89.80

3.8

3.4

327.26

450.26

ng/l

1.14

2583

19417

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

847

4270

2.37

89.64

5.1

3.6

95.56

457.69

ng/l

8.40

543

2941

Other disorders of ear

11419

61162

1.26

89.59

4.3

3.9

325.78

518.67

ng/l

6.03

8892

46753

Other metabolic disorders

1511

9071

1.87

89.07

4.4

3.2

263.52

500.37

ng/l

1.06

1111

6226

Schizophrenia or delusion

3526

25358

1.49

88.69

4.3

3.7

193.96

463.16

ng/l

5.40

2439

18255

Coagulation defects, purpura and other haemorrhagic conditions

2374

15947

1.65

88.59

4.9

3.9

349.74

485.17

ng/l

0.80

1873

12254

Primary_lymphoid and hematopoietic malignant neoplasms

3063

21728

1.56

87.67

4.9

4.3

325.09

480.11

ng/l

1.09

2612

18173

Other disorders of the musculoskeletal system and connective tissue

1923

12447

1.76

87.57

5.1

4.0

239.56

464.08

ng/l

1.67

1550

9906

Idiopathic gout

1336

7968

2.01

87.21

5.8

4.3

565.26

578.99

ng/l

0.02

1213

6914

Alzheimer’s disease (Late onset), excluding more controls

1988

8244

1.75

87.04

4.4

3.7

183.99

680.00

ng/l

10.33

1808

7264

Injuries to the neck

2656

18227

1.59

87.03

4.4

3.7

324.66

469.12

ng/l

0.95

1818

13047

Procreative management

3568

21120

1.48

86.32

3.8

3.5

583.29

478.55

ng/l

0.24

2404

14169

Other specified/unspecified arthritis

3205

22813

1.52

86.27

4.7

3.7

348.95

565.38

ng/l

1.35

2460

17324

Pleural effusion

2065

13631

1.72

86.16

5.7

4.2

421.15

525.60

ng/l

0.46

1819

11713

Chronic pancreatitis

1603

9985

1.85

85.78

5.2

4.0

187.72

589.49

ng/l

3.81

1326

8209

Other shoulder lesions

1177

6688

2.02

85.65

5.0

3.5

156.32

644.53

ng/l

2.64

831

4955

Schizophrenia, schizotypal and delusional disorders

3525

25512

1.48

85.38

4.3

3.7

231.23

455.64

ng/l

2.71

2436

18395

Symptoms and signs concerning food and fluid intake

1287

7486

1.95

85.12

5.3

3.3

354.60

632.74

ng/l

0.90

968

5973

Disorders of conjunctiva

9928

63318

1.26

85.02

4.1

3.7

296.60

459.83

ng/l

3.35

6999

46135

Coxarthrosis

6311

31839

1.35

84.98

4.4

3.8

356.94

607.72

ng/l

4.58

5321

25638

Dislocation, sprain and strain of joints and ligaments of knee

6868

49190

1.32

84.98

3.9

3.5

250.05

539.86

ng/l

11.85

4812

34463

ILD, hospital admissions

2028

13413

1.73

84.92

5.4

4.3

419.72

481.19

ng/l

0.29

1812

11482

Other viral diseases

3115

21975

1.51

84.79

4.7

3.6

354.04

502.66

ng/l

1.28

2163

14918

Ovarian cyst

3670

15056

1.49

84.45

3.7

3.4

132.00

319.15

ng/l

5.16

2357

10360

Mental and behavioural disorders due to sedatives or hypnotics

857

4440

2.30

84.43

5.2

3.5

125.83

474.50

ng/l

6.86

581

3128

Diagnoses used for exclusion with ILD

3177

22771

1.53

84.38

6.1

4.1

351.02

485.55

ng/l

1.20

2588

18554

Dermatitis and eczema

13782

69024

1.22

84.31

4.3

3.8

327.59

502.35

ng/l

4.54

9984

51893

Striking against or struck by other objects

3808

27912

1.46

84.22

4.4

3.7

386.45

530.53

ng/l

0.97

2759

20115

Polyneuropathies and other disorders of the peripheral nervous system

2781

19540

1.58

84.20

5.6

4.2

283.00

508.31

ng/l

2.72

2380

16290

Injuries to unspecified part of trunk, limb or body region

1337

7978

1.95

83.90

5.6

3.9

249.64

520.78

ng/l

1.13

1079

6169

Other and unspecified drugs and medicaments

1122

6388

2.08

83.81

6.2

3.8

181.72

407.82

ng/l

2.92

872

4833

Congenital malformations of cardiac chambers and connections

131

226

12.14

83.76

8.2

3.3

2657.46

192.12

ng/l

2.06

117

116

Injuries to the elbow and forearm

8561

59711

1.28

83.63

4.2

3.8

365.00

446.14

ng/l

0.85

6546

43972

Other and unspecified coagulation defects

683

3290

2.58

83.48

4.7

3.6

250.14

440.05

ng/l

0.92

499

2244

Pain and other conditions associated with female genital organs and menstrual cycle

2057

11135

1.66

83.43

3.3

3.0

243.33

364.25

ng/l

0.85

955

6693

Abnormal findings on diagnostic imaging of other body structures

1870

12151

1.75

83.28

4.6

3.9

222.46

424.53

ng/l

1.58

1485

9525

Fungal Sepsis

635

3007

2.73

83.04

7.3

3.7

276.94

451.21

ng/l

1.32

548

2433

Open wound of lower leg

1904

12371

1.72

82.96

5.1

3.9

332.56

492.34

ng/l

0.61

1571

9613

Respiratory insufficiency

1049

5815

2.09

82.61

6.9

3.5

354.66

753.70

ng/l

1.41

956

4926

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1884

10424

1.68

82.40

3.4

2.8

273.76

507.38

ng/l

2.77

844

4998

Other interstitial pulmonary diseases

2048

13657

1.71

82.36

5.4

4.3

418.13

481.76

ng/l

0.31

1831

11707

Interstitial lung disease

2048

13664

1.71

82.16

5.4

4.3

418.13

482.23

ng/l

0.32

1831

11714

Interstitial lung disease endpoints

2048

13664

1.71

82.16

5.4

4.3

418.13

482.23

ng/l

0.32

1831

11714

Benign neoplasm of other and ill-defined parts of digestive system

2261

15365

1.65

81.91

4.8

4.1

356.39

427.33

ng/l

0.24

1819

12441

Hypertrophic cardiomyopathy

636

3062

2.76

81.48

7.8

4.2

649.21

433.02

ng/l

0.49

601

2509

Kidney transplant status

704

3479

2.53

81.41

5.8

3.8

642.52

562.69

ng/l

0.20

655

2627

Superficial injury of wrist and hand

2322

15704

1.60

81.06

4.2

3.6

271.16

526.10

ng/l

2.47

1490

10876

Other specified and unspecified personality disorders

1028

5696

2.08

81.02

4.8

3.4

151.35

464.70

ng/l

4.83

656

3779

Implicit fungal Sepsis

593

2763

2.80

80.99

7.5

3.7

291.35

420.35

ng/l

0.80

509

2229

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1381

8327

1.86

80.09

4.3

3.1

235.43

384.10

ng/l

1.30

1007

5693

Special screening examination for other diseases and disorders

1382

8306

1.84

79.94

4.6

3.3

453.33

504.52

ng/l

0.18

944

6407

Other diseases of the respiratory system

2610

18276

1.58

79.80

6.5

4.3

318.03

506.10

ng/l

1.96

2307

15498

Other respiratory disorders and diseases

2610

18276

1.58

79.80

6.5

4.3

318.03

506.10

ng/l

1.96

2307

15498

Zoster [herpes zoster], including avohilmo

6472

49784

1.33

79.77

4.6

4.0

376.83

422.96

ng/l

0.34

5177

39368

Hernia of abdominal wall

5545

43472

1.36

79.12

4.8

4.0

332.20

532.36

ng/l

4.06

4387

34576

Cardiac murmurs and other cardiac sounds

925

4868

2.09

79.10

4.1

2.8

576.86

847.15

ng/l

0.49

672

3411

Other and unspecified polyneuropathies, also in other diseases

2449

17023

1.61

78.97

5.6

4.2

298.91

503.36

ng/l

1.94

2108

14272

Other disorders of eyelid

5630

41730

1.36

78.96

4.6

4.1

265.41

445.63

ng/l

3.12

4646

34288

Autoimmune diseases

13491

57988

1.22

78.87

4.3

3.7

458.09

502.76

ng/l

0.42

10021

42942

Vascular dementia

1392

8226

1.88

78.82

5.5

4.9

146.05

524.62

ng/l

3.09

1281

7523

Intestinal adhesions without obstruction

1144

6669

2.01

78.56

5.1

3.8

440.74

554.09

ng/l

0.17

930

5521

Fracture at wrist and hand level

4001

29860

1.42

78.13

4.1

3.8

386.78

534.98

ng/l

1.34

2922

22212

Any dementia, excluding more controls

4776

25159

1.41

78.06

4.6

4.2

184.74

529.63

ng/l

11.55

4297

22084

Haemorrhage, not elsewhere classified

571

2641

2.75

78.03

6.9

3.6

461.86

879.75

ng/l

0.61

503

2230

Dronedarone medication

429

1766

3.34

77.98

6.8

3.0

135.56

497.78

ng/l

4.32

396

1449

Bicuspidal aortic valve syndrome

533

2406

2.89

77.98

5.1

3.8

1864.14

557.41

ng/l

6.49

482

1824

Acute alcohol intoxication, ICD10

2345

16091

1.60

77.86

5.1

3.8

251.46

594.88

ng/l

3.56

1742

12108

Volume depletion

1224

7248

1.93

77.69

6.9

3.8

242.01

589.89

ng/l

1.84

1067

6075

Other viral diseases, not elsewhere classified

2055

13660

1.64

77.62

5.0

3.7

352.84

539.74

ng/l

1.11

1469

9685

Other arthritis (FG)

3642

26953

1.45

77.47

4.6

3.7

347.51

519.99

ng/l

1.14

2792

20383

Invasive ventilation

985

5543

2.14

77.43

5.4

4.0

545.98

646.66

ng/l

0.19

845

4450

Lung transplantation

180

461

9.03

77.30

6.3

4.1

3621.55

451.37

ng/l

6.35

171

351

Vascular disorders of the intestines

967

5404

2.14

77.30

6.9

4.0

287.45

541.21

ng/l

0.83

874

4709

Coxarthrosis [arthrosis of hip](FG)

6932

38230

1.31

77.02

4.5

3.9

342.44

547.37

ng/l

4.13

5891

30811

Conotruncal defects

219

618

5.50

76.35

6.9

3.8

2420.85

757.67

ng/l

2.10

194

378

Preparatory care for dialysis

644

3203

2.64

75.77

5.9

4.1

1028.26

487.50

ng/l

0.73

610

2613

Degeneration of macula and posterior pole

6297

38804

1.33

75.71

4.7

4.2

344.87

437.21

ng/l

0.86

5479

33113

Lung transplant status

178

460

8.88

75.54

6.2

4.1

3622.75

451.37

ng/l

6.24

169

351

Alcohol dependence

3131

22762

1.49

75.46

5.1

3.9

234.17

611.32

ng/l

9.16

2487

18067

Persistent mood disorders

2197

14954

1.60

75.37

4.6

3.7

264.16

458.42

ng/l

1.17

1573

11159

Anosmia

236

635

4.28

75.19

4.8

1.6

160.81

33.66

ng/l

1.09

181

387

Rheumatism, unspecified

1556

9880

1.76

74.66

4.7

3.4

112.87

336.50

ng/l

8.81

1080

7479

Other enthesopathies

3343

24521

1.46

74.29

4.1

3.5

204.99

524.89

ng/l

6.86

2405

18427

COPD, hospital admissions 1, only main diagnosis

4349

28621

1.41

74.23

6.3

4.2

416.09

504.57

ng/l

0.46

3828

24597

Carpal tunnel syndrome

7329

51567

1.29

74.20

4.3

3.8

348.03

468.90

ng/l

1.51

5490

39493

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1272

7772

1.90

73.90

5.8

4.0

361.76

574.54

ng/l

0.79

1044

6132

Operations for atrial fibrillation

287

1026

4.96

73.71

5.4

4.2

2980.69

406.02

ng/l

6.59

277

875

Conjunctivitis

8745

58090

1.26

73.35

4.0

3.7

251.13

438.50

ng/l

4.61

6022

41521

Mental and behavioural disorders due to opioids

472

2039

2.84

73.13

4.8

3.2

146.08

526.37

ng/l

2.90

295

1279

Extracorporeal dialysis

825

4498

2.26

72.86

7.9

4.0

742.68

721.59

ng/l

0.03

780

3689

Mental disorders, not otherwise specified

920

5092

2.07

72.44

4.3

3.3

145.05

491.15

ng/l

5.16

591

3232

Other inflammation of eyelid

1771

11696

1.70

72.34

4.8

3.8

294.27

483.05

ng/l

0.58

1374

9011

Insulin, combination of fast acting with intermediate-acting or long-acting

7494

55526

1.28

72.25

5.5

3.9

522.07

494.11

ng/l

0.20

6231

44116

Dermatitis

7531

60269

1.28

71.62

4.5

3.8

299.96

481.73

ng/l

3.80

5606

45875

Inflammatory diseases of female pelvic organs

6686

36745

1.30

70.98

3.7

3.4

170.93

259.33

ng/l

1.89

4054

24774

Septal defects

722

3652

2.28

70.95

4.5

3.7

1058.22

523.01

ng/l

1.91

567

2509

Fracture of foot, except ankle

2750

19702

1.50

70.90

4.2

3.6

309.94

453.94

ng/l

0.99

1936

14082

Enterocolitis due to Clostridium difficile

1414

8949

1.81

70.79

6.9

4.2

256.78

487.37

ng/l

1.25

1211

7432

Gonarthrosis,primary

11169

56960

1.23

70.72

4.2

4.0

331.81

516.04

ng/l

4.44

9050

45480

Other coagulation defects

933

5274

2.07

70.55

4.9

3.8

269.74

406.30

ng/l

0.86

703

3801

Fracture of femur

3584

24245

1.44

70.36

5.0

4.4

458.01

423.90

ng/l

0.13

3188

20892

Mixed and other personality disorders

889

4920

2.07

70.28

4.7

3.3

118.21

488.18

ng/l

5.66

579

3161

Other disorders of bone

2211

15303

1.58

69.88

4.9

3.6

259.87

477.36

ng/l

1.68

1533

11054

Other complications of surgical and medical care, not elsewhere classified

1198

7274

1.88

69.63

5.3

3.5

278.94

432.13

ng/l

1.17

905

5426

Sarcoidosis

1591

10388

1.73

69.14

6.8

3.9

354.45

507.85

ng/l

0.64

1251

8032

Other disorders of kidney and ureter

1648

10885

1.72

68.83

5.2

4.1

331.07

508.17

ng/l

0.97

1421

8941

Polycystic ovarian syndrome, consortium definition

7678

35935

1.27

68.28

3.8

3.4

205.82

261.12

ng/l

0.97

4869

24189

Need for immunization against other single viral diseases

317

1212

3.85

68.18

6.5

4.0

182.24

476.18

ng/l

1.95

270

942

Sequelae of other external causes

755

4057

2.23

67.89

5.4

3.8

161.73

479.60

ng/l

5.41

605

3075

Other embolism and thrombosis

1589

10405

1.72

67.87

4.6

4.0

352.18

483.77

ng/l

0.49

1282

8352

Hyperkalaemia

785

4271

2.19

67.76

8.1

3.8

326.21

642.65

ng/l

0.78

724

3619

Cholecystitis

1761

11784

1.67

67.55

5.2

4.1

223.72

487.22

ng/l

2.44

1431

9818

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

1855

12544

1.64

67.52

4.2

3.9

273.55

505.82

ng/l

1.53

1510

9700

Other diseases of liver

2147

14952

1.58

66.85

4.7

3.8

311.11

478.52

ng/l

1.05

1637

11380

Ptosis of eyelid

1465

9515

1.77

66.64

4.8

4.1

249.44

477.68

ng/l

1.41

1208

7849

Other maltreatment syndromes

413

1769

2.96

66.60

3.8

3.4

160.16

665.80

ng/l

3.49

280

1195

Acute alcohol intoxication

2935

21537

1.46

66.24

5.1

3.9

281.47

598.44

ng/l

4.55

2247

16860

Spondylolisthesis/Spondylolysis

2112

14665

1.57

66.15

4.5

3.6

254.02

504.23

ng/l

2.06

1647

11504

Other diseases of lip and oral mucosa

4874

38415

1.34

66.03

4.3

3.8

310.09

433.14

ng/l

1.28

3626

29025

Noninfective enteritis and colitis

5269

41781

1.32

66.00

4.5

3.8

329.80

460.86

ng/l

1.45

3859

31134

Ventral hernia

2874

21101

1.48

65.88

4.9

3.9

261.68

492.70

ng/l

3.10

2288

16885

DVT of lower extremities

2317

16437

1.55

65.71

4.8

4.1

220.89

485.78

ng/l

3.16

1890

13388

Ascites

951

5530

2.01

65.61

4.8

3.6

278.16

654.12

ng/l

1.36

826

4641

Diabetic nephropathy, excluding more controls

1835

10141

1.66

65.21

6.4

4.4

683.80

478.63

ng/l

1.24

1647

8220

Diseases of male genital organs

5910

23691

1.32

65.10

4.3

4.0

679.77

751.51

ng/l

0.17

4717

19309

Kela-code for severe mental illness

3911

29951

1.38

65.10

4.3

3.7

221.54

486.91

ng/l

5.59

2674

21787

Disorders of skin appendages

5473

43463

1.31

64.75

4.2

3.6

345.41

443.19

ng/l

1.07

3798

30550

Superficial injury of thorax

1832

12447

1.63

64.70

5.2

3.9

274.33

512.85

ng/l

1.67

1423

9713

Other diseases of blood and blood-forming organs, wide

2581

18713

1.50

64.27

4.5

4.0

447.83

457.89

ng/l

0.03

2082

14686

Complications of internal orthopaedic prosthetic devices, implants and grafts

2840

20958

1.48

64.23

4.6

4.1

296.47

383.51

ng/l

0.80

2454

17565

Viral hepatitis, including avohilmo

863

4878

2.03

64.13

4.0

3.5

217.95

466.06

ng/l

2.66

580

3334

Urticaria and erythema

3942

30305

1.38

63.67

4.3

3.6

338.95

401.62

ng/l

0.40

2697

21425

Gastroduodenal ulcer

3164

23609

1.44

63.57

5.1

4.0

347.69

512.75

ng/l

1.55

2706

20101

Fenamates

1701

7632

1.65

63.52

4.1

3.9

454.84

544.52

ng/l

0.19

1292

6158

Stomatitis and related lesions

2260

16000

1.54

63.50

4.7

3.8

295.44

453.52

ng/l

0.90

1655

11784

Urticaria

3169

23636

1.43

63.22

4.3

3.6

325.57

423.98

ng/l

0.55

2088

16335

Disorders of vitreous body and globe

6266

48326

1.29

63.17

4.6

4.0

326.16

443.80

ng/l

1.75

4970

38843

Other general symptoms and signs

577

2818

2.34

63.05

5.1

3.0

312.83

611.56

ng/l

1.85

374

1965

Other noninfective gastroenteritis and colitis

2831

20815

1.46

62.86

5.0

3.9

270.65

459.25

ng/l

1.48

2128

15884

Persons with potential health hazards related to communicable diseases

3636

27348

1.38

62.80

4.0

3.3

327.02

459.42

ng/l

0.98

2274

17039

Viral infections characterized by skin and mucous membrane lesions

4883

38692

1.33

62.46

4.7

3.9

356.78

472.79

ng/l

1.04

3720

29341

Fibroblastic disorders

2723

19949

1.47

62.40

4.3

3.8

278.97

606.39

ng/l

5.45

2176

16367

ILD-related respiratory insufficiency

522

2599

2.69

62.31

7.5

4.4

365.77

363.44

ng/l

0.01

477

2269

Other systemic involvement of connective tissue

3265

24646

1.43

62.28

4.7

4.0

173.36

384.05

ng/l

4.84

2508

19324

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2605

18588

1.47

62.24

4.1

3.3

342.64

475.22

ng/l

0.76

1473

11236

Superficial injury of abdomen, lower back and pelvis

1811

12359

1.60

61.64

4.8

3.8

205.37

501.41

ng/l

2.61

1325

9137

Radiculopathy

1896

13082

1.59

61.63

5.2

3.8

519.43

525.70

ng/l

0.01

1489

10672

Other hearing loss

3708

27662

1.40

61.58

4.6

4.2

281.92

464.76

ng/l

2.76

3173

23521

Other and unspecified dermatitis

6195

50504

1.28

61.57

4.4

3.8

300.70

456.40

ng/l

2.27

4567

38314

Congenital malformations of great arteries

269

946

3.67

61.53

6.8

3.3

2383.68

403.70

ng/l

3.31

230

587

Malignant neoplasm of digestive organs, including Hilmo

5294

31140

1.32

61.39

4.0

4.2

387.23

546.35

ng/l

1.46

4485

25609

Injury of unspecified body region

973

5810

1.95

61.30

5.6

3.9

222.31

451.15

ng/l

1.43

794

4503

Other viral hepatitis, including avohilmo

748

4104

2.11

61.21

4.0

3.5

224.69

515.85

ng/l

2.61

488

2722

Agoraphobia

369

1535

2.87

61.05

3.7

2.8

239.10

649.38

ng/l

1.09

197

854

Viral hepatitis

821

4646

2.03

60.95

4.1

3.5

221.57

452.73

ng/l

2.33

560

3196

Oter anti-inflammatory and antirheumatic agents, non-steroids

2646

10446

1.49

60.90

4.5

4.1

334.86

691.06

ng/l

4.29

2255

8941

Extrapyramidal and movement disorders

4731

37610

1.34

60.90

4.5

4.1

215.54

433.91

ng/l

5.19

3726

30682

Superficial injury of hip and thigh

1898

13158

1.59

60.57

5.5

4.1

320.58

422.43

ng/l

0.35

1544

10687

Other viral hepatitis

711

3855

2.14

60.53

4.1

3.5

231.86

499.81

ng/l

2.24

472

2553

Excessive, frequent and irregular menstruation

3840

15559

1.38

60.51

3.7

3.4

157.30

329.42

ng/l

4.42

2328

10618

severe traumatic brain injury, does not include concussion

2777

20589

1.46

60.41

4.8

4.3

280.82

513.14

ng/l

2.84

2376

17394

Any dementia

5161

28578

1.33

60.31

4.7

4.5

188.09

451.13

ng/l

8.87

4653

25195

Disorders of vitreous body

6079

47253

1.29

60.29

4.6

4.0

333.28

440.63

ng/l

1.45

4815

37949

Other and unspecified tonsillitis

3220

19979

1.40

60.24

3.7

3.2

448.24

631.47

ng/l

1.53

1981

12794

Faecal incontinence

1117

6917

1.83

60.24

4.9

3.5

97.53

383.80

ng/l

9.11

897

5706

Conjunctivitis (acute, non atopic)

3081

22967

1.42

60.22

4.4

3.7

173.66

458.23

ng/l

5.71

2101

16481

Endometriosis

3412

14867

1.41

60.05

3.5

228.19

318.72

ng/l

1.04

2142

10322

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

2038

14369

1.56

59.46

4.2

4.0

323.13

504.20

ng/l

1.12

1656

11122

Dislocation, sprain and strain of joints and ligaments at neck level

1599

10689

1.63

59.34

4.2

3.4

334.78

537.52

ng/l

0.81

990

7034

807

4510

1.96

59.20

2.6

550.19

293.81

ng/l

0.60

321

1800

Disturbance of activity and attention

1103

6530

1.77

59.20

2.7

2.8

268.79

515.17

ng/l

1.84

440

2958

Chronic viral hepatitis

597

3078

2.28

59.11

4.0

3.4

253.37

523.37

ng/l

1.68

392

2005

Other extrapyramidal and movement disorders in other diseases

2966

22289

1.44

58.88

4.6

4.0

253.77

443.81

ng/l

1.94

2288

17783

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2428

10832

1.48

58.80

2.7

2.5

167.44

256.07

ng/l

0.75

908

4412

Fissure and fistula of anal and rectal regions

2665

19608

1.45

58.70

4.2

3.6

233.15

511.06

ng/l

3.50

1960

15086

Malignant neoplasm of skin, including Hilmo

6403

35108

1.28

58.62

4.5

4.1

324.82

528.19

ng/l

5.46

5437

28085

Alzheimer’s disease (Atypical or mixed), excluding more controls

1172

5452

1.81

58.51

4.8

3.9

168.51

696.55

ng/l

7.41

1081

4906

Deviated nasal septum

3733

28860

1.37

58.41

4.2

3.9

377.23

623.88

ng/l

3.06

2825

22890

Rheumatoid arthritis

3658

24920

1.38

58.40

4.4

3.7

361.12

532.37

ng/l

1.36

2978

19354

Hyperkinetic disorders

1158

6962

1.74

58.34

2.8

2.9

256.48

506.35

ng/l

2.12

477

3179

Disorders of psychological development

1104

6255

1.77

58.15

4.7

3.3

465.83

462.52

ng/l

0.01

697

3561

Fracture of shoulder and upper arm

4316

34018

1.34

58.00

4.5

4.0

450.16

428.18

ng/l

0.08

3548

26840

Other obstetric conditions, not elsewhere classified

2489

11214

1.46

57.66

2.7

2.5

163.34

254.38

ng/l

0.81

933

4644

Sequelae of injuries of lower limb

1088

6768

1.82

57.50

4.2

3.7

328.82

482.74

ng/l

1.18

806

4967

Disorders of muscles

1185

7499

1.76

57.45

5.0

3.6

957.41

598.89

ng/l

0.34

907

5743

Suppurative and necrotic conditions of lower respiratory tract

744

4226

2.12

57.14

5.4

4.2

483.71

687.08

ng/l

0.35

641

3513

Hallux valgus (acquired)

3788

20927

1.37

56.96

4.0

3.6

257.91

481.72

ng/l

3.21

2990

15934

Hemiplegia

642

3467

2.21

56.69

5.7

4.0

131.68

387.70

ng/l

3.50

483

2703

Neuralgia and neuritis, unspecified

645

3483

2.19

56.49

4.8

3.5

384.90

765.47

ng/l

0.51

467

2658

Other specified and unspecified disorders of eye and adnexa

512

2584

2.47

56.22

5.0

3.9

381.60

429.54

ng/l

0.11

415

1987

Enthesopathies of lower limb, excluding foot

2462

18002

1.46

56.09

4.3

3.5

188.06

523.87

ng/l

5.07

1775

13436

Assault by bodily force

833

4823

1.94

56.03

4.4

3.3

188.39

482.54

ng/l

4.42

530

3076

Dental pulpitis, including avohilmo

10248

56095

1.21

55.87

3.7

3.6

459.54

514.62

ng/l

0.30

6578

40290

Other infectious diseases, including avohilmo

1117

7076

1.80

55.56

5.5

4.0

254.32

560.08

ng/l

1.46

909

5656

Artificial joint operation, meniscal resection

11124

61366

1.20

55.45

4.2

4.0

335.28

507.00

ng/l

4.16

8998

48361

Speech and linguistic disorders

855

4758

1.90

55.42

4.9

3.5

373.89

515.46

ng/l

0.79

572

2895

Acute appendicitis, no complications

5989

48810

1.27

55.33

4.0

3.6

422.25

500.87

ng/l

0.56

4077

34784

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

5904

46264

1.27

55.14

3.7

3.5

244.00

374.61

ng/l

2.53

4060

31866

Other pulmonary heart/vessel disease

640

3526

2.24

55.00

7.5

4.3

2043.91

372.51

ng/l

0.72

595

3016

Nonalcoholic fatty liver disease

1161

7416

1.76

54.99

4.5

3.6

335.07

602.43

ng/l

0.83

845

5401

Other and unspecified local infections of skin and subcutaneous tissue

1174

7528

1.76

54.91

5.7

3.8

264.50

582.06

ng/l

1.38

922

5775

Recurrent aphthous stomatitis , including avohilmo

1644

11295

1.60

54.85

4.8

3.8

258.42

476.89

ng/l

1.02

1209

8485

Misadventures to patients during surgical and medical care

1696

11746

1.59

54.77

5.3

3.8

366.33

392.33

ng/l

0.15

1363

9180

Acute pharyngitis

1479

9743

1.61

54.77

4.1

3.2

588.62

586.14

ng/l

0.01

880

6394

Temporomandibular joint disorders, including avohilmo

4559

35151

1.31

54.57

3.8

3.4

204.54

393.24

ng/l

3.12

2719

22803

Emphysema

942

5758

1.89

54.47

6.2

4.0

630.54

665.62

ng/l

0.05

860

4952

Colectomy operation

2034

14640

1.53

54.00

4.3

4.2

482.74

479.10

ng/l

0.01

1701

12176

Focal epilepsy

2387

17542

1.47

53.81

4.7

4.0

223.08

481.72

ng/l

3.62

1847

13608

Zoster [herpes zoster]

2269

16610

1.49

53.78

5.2

4.1

386.60

419.41

ng/l

0.10

1852

13583

Disorders of the thyroid gland

11060

61922

1.19

53.59

4.2

3.8

367.74

481.94

ng/l

1.06

8106

46503

Peripheral artery operations in Hilmo

1562

10702

1.62

53.43

6.6

4.2

553.05

506.58

ng/l

0.11

1446

9274

Other symptoms and signs involving general sensations and perceptions

543

2832

2.31

53.41

5.3

3.7

495.81

460.90

ng/l

0.05

427

2227

Necrosis of pulp, including avohilmo

6419

52556

1.25

53.39

3.9

3.6

377.36

501.37

ng/l

1.63

4474

37469

Hyperplasia of prostate

4276

18994

1.34

53.34

4.4

4.2

506.14

763.03

ng/l

2.47

3663

16363

Childhood asthma (age<16), excluding more controls

954

4402

1.79

53.32

2.9

2.1

428.87

458.59

ng/l

0.07

430

2033

Gastric ulcer

2128

15411

1.50

53.23

5.2

4.0

341.28

523.49

ng/l

1.31

1819

13077

Complex cardiac defects

114

262

7.86

53.21

7.6

3.1

2212.76

440.85

ng/l

0.97

100

156

Allergic conjunctivitis

6144

48740

1.26

53.19

3.8

3.6

238.63

371.21

ng/l

2.77

4226

33502

Iron deficiency anaemia secondary to blood loss (chronic)

1961

14042

1.53

52.92

6.0

4.1

422.01

444.45

ng/l

0.08

1622

11537

Abnormal spermatozoa

615

10808

0.51

52.89

4.1

4.5

294.25

650.58

ng/l

1.75

454

9560

Amputation

1279

8464

1.71

52.77

6.9

4.2

426.04

510.18

ng/l

0.31

1185

7335

Localized swelling, mass and lump of skin and subcutaneous tissue

3627

28358

1.36

52.56

4.4

3.8

341.07

472.82

ng/l

0.75

2648

21945

Any event in hilmo or specialist outpatient

32.16

52.39

2.2

1.1

13.03

7.00

ng/l

—

Personal history of malignant neoplasm

987

6139

1.82

52.22

3.3

315.64

264.28

ng/l

0.10

752

4415

5222

38417

1.30

52.10

4.8

4.3

313.54

438.49

ng/l

1.62

4543

33057

Other local infections of skin and subcutaneous tissue

1224

8015

1.71

52.05

5.7

3.8

264.28

577.24

ng/l

1.47

963

6164

Irregular menses

4627

27734

1.30

52.03

3.3

3.1

157.10

284.46

ng/l

4.44

2437

16965

Thyrotoxicosis, other and/or unspecified

2247

16443

1.47

51.93

4.8

3.7

445.47

412.73

ng/l

0.05

1723

12063

Disorders of other endocrine glands

4931

39321

1.29

51.73

4.6

3.9

361.91

407.76

ng/l

0.29

3723

29319

Thyrotoxicosis

2809

21303

1.41

51.42

4.8

3.8

390.44

377.77

ng/l

0.02

2164

15852

Other/unspecified disorders of vestibular function

567

3067

2.28

51.39

4.8

4.0

291.81

399.25

ng/l

0.39

460

2506

Secondary right heart disease

579

3164

2.26

51.21

7.6

4.3

2213.93

388.68

ng/l

0.72

544

2698

Symptoms and signs involving emotional state

373

1706

2.66

50.98

4.7

3.3

461.80

625.60

ng/l

0.22

231

1167

Follow-up examination after treatment for malignant neoplasms

1182

7698

1.70

50.79

4.2

3.6

291.12

429.10

ng/l

1.33

1001

6529

Parkinson's disease, strict definition, excluding more controls

1442

9106

1.62

50.77

4.6

3.6

152.75

743.70

ng/l

15.06

1248

7877

Presence of other devices

3021

22845

1.39

50.69

4.7

3.8

391.80

363.82

ng/l

0.14

2219

19196

Skin changes due to chronic exposure to nonionizing radiation

4971

36746

1.30

50.66

4.8

4.4

293.72

433.59

ng/l

2.12

4371

31852

Osteoporosis

3319

23776

1.38

50.39

5.4

4.1

304.74

357.96

ng/l

0.34

2884

19862

Parkinson's disease, excluding more controls

1525

9609

1.59

50.38

4.5

3.6

165.42

740.51

ng/l

14.63

1316

8279

Childhood asthma (age<16)

955

4480

1.75

50.29

2.9

2.1

427.88

499.51

ng/l

0.19

431

2112

Cardiomyopathy, Hypertrophic obstructive

258

1020

3.37

50.16

8.8

2.8

651.52

436.64

ng/l

0.42

253

787

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

3042

23318

1.38

50.01

3.9

3.6

279.46

522.82

ng/l

3.06

2015

16278

Non-Hodgkin lymphoma, all, including Hilmo

1587

11087

1.59

49.80

4.5

4.3

379.47

512.09

ng/l

0.49

1363

9283

Elevated blood glucose level

1009

6399

1.79

49.80

5.9

3.9

251.30

433.02

ng/l

1.46

808

4957

Other diseases of pancreas

1034

6641

1.78

49.13

4.8

3.9

171.56

572.51

ng/l

2.13

857

5480

Other pleural conditions

1289

8690

1.67

48.94

6.3

4.2

370.26

545.32

ng/l

0.63

1161

7519

KRA_PSY_EATING, excluding more controls

629

3405

1.97

48.53

3.7

2.5

329.64

517.89

ng/l

0.35

282

1528

Surgical ablation of atrial fibrillation

128

366

8.13

48.26

6.1

4.2

3830.09

513.50

ng/l

4.43

123

306

Viral pneumonia (known virus, not influenza)

402

1974

2.60

48.22

7.4

4.0

369.83

409.61

ng/l

0.06

367

1590

Actinic keratosis

4828

35952

1.30

48.12

4.8

4.4

292.39

431.40

ng/l

2.05

4260

31267

Superficial injury of ankle and foot

1279

8529

1.63

48.00

4.5

3.5

189.42

449.70

ng/l

4.84

835

5692

Embolic stroke with flimmer

360

1681

2.68

47.88

6.9

3.8

448.29

379.87

ng/l

0.09

339

1481

Exposure to other and unspecified inanimate mechanical forces

881

5449

1.83

47.58

4.8

3.7

298.61

493.68

ng/l

0.95

671

3937

Right ventricular outflow tract obstruction

131

361

5.61

47.30

8.1

3.2

2693.09

1136.06

ng/l

0.88

115

204

L04AX Other immunosuppressants

6232

52132

1.24

47.25

4.5

3.8

324.70

456.07

ng/l

1.71

4733

38706

Other and/or unspecified nontoxic goitre

983

6292

1.78

47.20

4.0

3.8

110.38

310.46

ng/l

4.50

702

4890

Insulin, fast-acting

4020

32211

1.31

47.16

5.8

3.9

532.53

479.53

ng/l

0.35

3312

24957

Pyothorax

577

3224

2.18

47.15

5.3

4.2

498.70

753.53

ng/l

0.33

496

2681

Tinnitus

2716

20796

1.40

47.06

4.1

3.9

255.53

466.38

ng/l

2.88

2030

16212

Carbimazole or st.post thyroidectomy, condition for graves disease

2239

16636

1.44

47.04

4.4

3.7

164.35

411.05

ng/l

3.10

1661

11999

Second line medication for Crohn's disease

6400

53653

1.24

47.04

4.5

3.8

326.13

458.10

ng/l

1.77

4835

39672

Triptan medication for migraine, single purchase ok

7953

45781

1.21

46.75

3.5

259.48

431.64

ng/l

3.59

4824

31875

Migraine, single triptan purchase ok & required. ICD-code if available is included

7953

45781

1.21

46.75

3.5

259.48

431.64

ng/l

3.59

4824

31875

Malignant neoplasm of skin

5997

33774

1.26

46.74

4.5

4.1

325.01

526.34

ng/l

4.88

5141

27234

Glomerular disorders in diseases classified elsewhere

1354

9286

1.62

46.69

6.3

4.1

605.58

533.63

ng/l

0.21

1241

7500

Traumatic subarachnoid haemorrhage

485

2546

2.28

46.65

4.6

3.7

435.55

738.47

ng/l

0.82

417

2152

Umbilical hernia

3032

23549

1.37

46.61

4.6

3.9

398.68

607.53

ng/l

2.05

2385

18443

Atrial septal defect, secundum type

342

1571

2.69

46.57

4.2

3.8

1256.28

519.91

ng/l

1.16

275

1064

Focal epilepsy, strict definition

2201

16364

1.45

46.32

4.7

4.0

220.66

491.16

ng/l

3.56

1723

12825

Vascular dementia (mixed)

335

1575

2.89

46.26

6.5

4.8

93.18

260.64

ng/l

3.17

314

1443

Acute appendicitis

7670

60629

1.21

46.24

4.0

3.7

409.57

515.24

ng/l

1.13

5365

44243

Inguinal hernia

6846

38294

1.23

45.99

4.4

3.9

522.69

610.53

ng/l

0.77

5571

30500

Cramp and spasm

574

3203

2.12

45.85

5.5

3.7

93.53

456.34

ng/l

6.95

403

2360

Appendectomy

7007

56441

1.22

45.79

4.0

3.7

316.69

463.49

ng/l

1.94

4764

40447

Adhesive capsulitis of shoulder

1828

13221

1.49

45.56

4.3

3.6

367.68

536.75

ng/l

0.87

1366

10466

Postprocedural musculoskeletal disorders, not elsewhere classified

903

5742

1.83

45.56

5.3

4.1

201.21

373.79

ng/l

1.11

742

4700

Alcohol-induced chronic pancreatitis

768

4679

1.91

45.51

5.5

4.0

208.23

740.24

ng/l

1.84

634

3796

Other and unspecified disorders of vitreous body

4936

39789

1.28

45.41

4.5

3.9

319.30

432.60

ng/l

1.30

3876

31983

Vascular dementia (subcortical)

528

2922

2.25

45.37

5.4

4.9

165.62

275.79

ng/l

1.29

484

2674

Other specified/unspecified hearing loss

1118

7433

1.70

45.22

4.3

4.1

405.75

511.61

ng/l

0.27

901

6165

Menorrhagia

3369

14617

1.35

45.22

3.9

3.5

183.67

324.31

ng/l

2.70

2183

10384

Other hammer toe(s) (acquired)

2019

13533

1.47

45.07

4.3

3.8

193.38

453.23

ng/l

2.82

1719

11055

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1816

13205

1.50

45.03

4.5

4.2

353.95

542.16

ng/l

0.85

1472

10859

Unspecified/other endometriosis

837

5001

1.78

44.97

3.3

3.0

149.83

366.32

ng/l

2.02

347

2845

Propionic acid derivatives

3161

12216

1.36

44.96

4.0

3.9

342.32

692.31

ng/l

5.39

2380

9804

Benign neoplasm of other and unspecified endocrine glands

1518

10707

1.56

44.95

4.3

3.9

226.46

473.31

ng/l

1.51

1157

8360

Fracture of forearm

6311

47653

1.23

44.86

4.2

3.8

394.03

391.68

ng/l

0.01

4903

35542

Other infectious diseases

920

5865

1.79

44.84

5.7

4.0

269.83

587.22

ng/l

1.20

758

4756

Other mental disorders due to brain damage and dysfunction and to physical disease

1485

10474

1.58

44.73

5.3

4.4

159.06

473.17

ng/l

2.92

1284

8980

Chondropathies

1608

11410

1.53

44.69

5.0

3.7

296.79

505.09

ng/l

1.03

1121

8238

Idiopathic pulmonary fibrosis

995

6504

1.76

44.65

5.3

4.4

581.57

542.11

ng/l

0.09

909

5740

Diseases of salivary glands

3577

28489

1.32

44.50

4.3

3.8

278.06

412.86

ng/l

1.54

2669

21237

Fitting and adjustment of other devices

4224

30131

1.30

44.43

4.5

3.8

411.76

478.19

ng/l

0.46

2902

25208

Biomechanical lesions, not elsewhere classified

647

3797

2.02

44.37

4.9

3.9

198.14

389.32

ng/l

2.14

518

3000

Congenital malformations of pulmonary and tricuspid valves

117

310

5.77

44.36

7.5

3.1

1814.81

521.56

ng/l

1.54

100

170

Impingement syndrome of shoulder

2539

19379

1.40

44.31

4.4

3.6

260.00

579.26

ng/l

4.77

1932

15381

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

5721

32155

1.26

44.28

4.4

4.1

365.05

517.37

ng/l

2.73

4927

26182

Glomerular diseases

2007

14844

1.46

44.28

5.9

4.1

605.37

508.37

ng/l

0.29

1770

11859

Appendicitis, broad definition

8177

63019

1.20

44.18

4.0

3.7

399.55

511.25

ng/l

1.33

5727

46228

Calculus of kidney and ureter

3391

26923

1.34

44.09

4.4

4.1

406.95

551.09

ng/l

1.11

2680

21891

Malignant neoplasm of digestive organs

4706

29500

1.28

44.04

3.9

4.2

401.79

548.65

ng/l

1.12

3978

24462

Basal cell carcinoma, including Hilmo

5570

31363

1.26

44.01

4.4

4.2

372.17

514.33

ng/l

2.35

4825

25633

Diseases of appendix

8245

63384

1.20

43.92

4.0

3.7

398.16

509.38

ng/l

1.34

5772

46536

Exclusions for E4_PCOS_CONSORTIUM

7640

40585

1.21

43.86

3.7

3.6

266.63

354.91

ng/l

1.06

5204

27739

Amputation of toe

901

5775

1.80

43.77

7.0

4.3

423.45

583.37

ng/l

0.48

837

5021

Disorders of breast

5086

36936

1.26

43.72

3.6

3.5

185.32

254.08

ng/l

1.68

3314

25292

Additional codes for the location of defect, injury or illness

703

4227

1.93

43.41

4.7

3.9

188.06

411.53

ng/l

1.93

466

3228

Disorders of sclera, cornea, iris and ciliary body

6208

52371

1.23

43.27

4.3

3.9

397.01

456.90

ng/l

0.52

4641

39560

Internal derangement of knee

4057

32488

1.29

42.96

4.0

3.6

347.99

616.46

ng/l

3.81

2971

24428

Sequelae of injuries of upper limb

1081

7180

1.67

42.88

4.2

3.7

315.62

472.50

ng/l

0.37

785

5307

Mental and behavioural disorders due to use of other stimulants, including caffeine

314

1431

2.60

42.66

3.9

3.0

307.96

586.16

ng/l

0.73

190

838

Degenerative diseases of the nervous system

4660

27577

1.28

42.54

4.6

217.02

423.22

ng/l

4.93

4233

24436

Other and unspecified injuries of lower leg

836

5226

1.78

42.54

4.5

3.5

397.87

495.14

ng/l

0.27

556

3631

Fibrosis and cirrhosis of liver

940

6112

1.76

42.53

4.9

4.1

405.07

565.67

ng/l

0.40

789

4997

Specific development disorders of speech and language

593

3244

1.97

42.35

5.2

3.7

320.69

483.43

ng/l

1.31

435

2177

Pneumothorax

840

5312

1.80

42.31

5.3

4.0

467.57

658.85

ng/l

0.43

693

4393

Speech disturbances, not elsewhere classified

1100

7400

1.67

42.11

5.8

4.1

282.22

535.70

ng/l

1.11

884

6148

Disorders of tooth development and eruption

1633

9440

1.49

42.09

4.3

3.4

263.06

557.03

ng/l

1.67

1154

6760

Other congenital malformations, including avohilmo

1254

8561

1.58

42.06

3.8

3.5

448.88

436.16

ng/l

0.04

835

5659

Maternal care for other conditions predominantly related to pregnancy

1680

11712

1.47

42.04

3.0

2.8

284.49

251.05

ng/l

0.17

763

5771

Haemorrhoids and perianal venous thrombosis

3830

30702

1.30

41.80

4.7

3.7

347.99

480.18

ng/l

1.26

2976

24641

Urolithiasis

3657

29471

1.31

41.72

4.4

4.2

397.83

543.30

ng/l

1.25

2895

24099

Heart failure and hypertrophic cardiomyopathy

286

1320

3.00

41.70

10.8

4.2

599.18

336.48

ng/l

0.51

281

1126

Hypertensive Renal Disease

441

2318

2.23

41.65

5.5

3.5

335.84

498.13

ng/l

0.71

409

1953

Polyarthrosis

2397

16477

1.40

41.63

4.6

3.8

217.10

486.74

ng/l

3.48

1936

13312

Disorders of continuity of bone

1104

7402

1.64

41.63

4.4

3.6

240.20

421.85

ng/l

1.54

805

5307

Event of undetermined intent

712

4311

1.87

41.62

5.1

3.6

115.30

516.53

ng/l

8.58

500

3024

Somnolence, stupor and coma

513

2841

2.11

41.49

6.2

3.7

403.23

495.81

ng/l

0.21

399

2250

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

2852

18336

1.37

41.47

4.9

4.4

294.40

546.34

ng/l

3.95

2511

15659

Cluster headache, strict

401

2036

2.30

41.36

5.0

3.3

326.70

579.18

ng/l

0.87

245

1409

Suggestive for eosinophilic asthma

1042

6943

1.68

41.23

4.3

3.8

330.56

607.58

ng/l

1.01

825

5470

Anti-inflammatory and antirheumatic products, non-steroids

3128

12216

1.34

41.14

4.0

3.9

349.70

692.31

ng/l

5.13

2357

9804

Other congenital malformations of heart

109

290

5.73

41.08

9.5

3.2

2375.60

162.31

ng/l

1.32

183

Noninfectious colitis NAS

1509

10770

1.52

40.86

5.1

3.8

161.97

476.13

ng/l

2.72

1116

8169

Shoulder region

234

992

3.29

40.80

5.7

4.1

374.28

372.25

ng/l

0.00

166

771

Cluster headache, wide

426

2220

2.22

40.75

5.0

3.3

432.75

559.39

ng/l

0.28

265

1559

Disorders resulting from impaired renal tubular function

468

2565

2.23

40.71

5.6

4.0

357.05

482.71

ng/l

0.45

436

2053

Osteoporosis with pathological fracture (FG)

936

6157

1.74

40.54

6.1

4.0

282.79

260.47

ng/l

0.09

823

5188

Benign neoplasm: Stomach

1150

7884

1.64

40.53

5.1

4.1

307.74

457.96

ng/l

0.47

949

6467

Other sleep disorders

1198

8193

1.59

40.37

4.6

3.6

225.54

521.31

ng/l

2.12

862

6333

Allergic urticaria

856

5451

1.74

40.36

4.5

3.6

162.81

424.45

ng/l

4.18

573

3754

Otalgia

918

5959

1.71

40.32

5.0

3.7

138.69

439.90

ng/l

5.30

639

4333

Primary gonarthrosis, bilateral

6259

44535

1.23

40.19

4.3

4.1

209.62

486.26

ng/l

12.35

5204

36676

Personal history of other diseases and conditions

988

6426

1.65

39.99

4.5

2.8

225.14

370.62

ng/l

1.73

643

3696

Toxic effects of substances chiefly nonmedicinal as to source

1203

8265

1.59

39.92

4.6

3.7

332.49

456.94

ng/l

0.54

801

5969

Car occupant injured in other and unspecified transport accidents

1889

13985

1.44

39.90

4.1

3.6

205.84

494.37

ng/l

2.44

1257

9723

Other diseases of arteries and capillaries

1055

7101

1.66

39.83

5.3

3.8

374.15

536.01

ng/l

0.48

870

5692

Fentanyl

1188

8137

1.59

39.63

5.6

3.8

114.85

588.76

ng/l

4.09

969

6851

Obsessive-compulsive disorder

598

3446

1.89

39.63

3.4

2.9

102.38

589.75

ng/l

6.98

313

1901

Other enthesopathy of foot (+metatarsalgia)

1100

7425

1.62

39.59

4.2

3.4

175.00

559.70

ng/l

2.03

785

5462

Intracerebral haemorrhage

1492

10719

1.52

39.46

4.8

4.2

279.68

532.78

ng/l

1.76

1326

9313

Other diseases of oesophagus

1107

7538

1.63

39.30

5.3

3.9

274.94

562.18

ng/l

1.45

918

6256

Schizoaffective disorder

777

4870

1.78

39.27

4.4

3.5

77.49

502.97

ng/l

10.08

525

3300

Open wound of ankle and foot

1137

7760

1.61

39.22

5.2

3.8

411.68

560.17

ng/l

0.45

900

5874

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

823

5261

1.77

39.15

5.1

4.1

212.16

643.96

ng/l

1.75

708

4505

Social phobias

740

4529

1.76

39.14

3.5

2.9

241.14

493.04

ng/l

1.14

419

2580

Follicular cysts of skin and subcutaneous tissue

2020

15219

1.42

39.06

4.4

3.9

381.98

473.77

ng/l

0.37

1539

11666

Trigger finger

1550

11181

1.49

39.04

4.4

3.5

423.55

526.80

ng/l

0.35

1166

8549

Pruritus

1279

8945

1.56

38.80

5.2

3.7

199.66

475.52

ng/l

1.34

918

6668

Shock, not elsewhere classified

159

565

4.07

38.76

8.6

3.5

1047.24

559.25

ng/l

0.47

147

464

Mycoses

3068

24417

1.33

38.69

5.1

3.9

277.72

469.89

ng/l

2.91

2328

18679

ILD medications: azathioprine

1473

10530

1.50

38.66

6.0

3.3

213.12

547.93

ng/l

2.64

1108

7531

Alzheimer disease

4191

24631

1.28

38.64

4.6

200.15

411.59

ng/l

4.59

3828

22055

Dialysis

478

2668

2.13

38.61

6.8

3.8

1133.47

513.31

ng/l

0.69

448

2086

Cyst of kidney

887

5837

1.74

38.56

4.8

4.2

308.29

577.59

ng/l

0.84

751

4905

Decubitus ulcer and pressure area

789

5041

1.79

38.52

5.9

4.3

402.35

604.14

ng/l

0.51

722

4345

Ganglion

2087

15748

1.40

38.45

3.7

3.3

316.31

502.74

ng/l

1.15

1433

11331

Diseases of the myoneural junction and muscle

1420

10196

1.53

38.13

5.2

4.1

260.81

483.51

ng/l

1.46

1201

8333

Disorders of speech understanding and production

464

2494

2.10

38.09

5.7

3.9

314.59

523.91

ng/l

1.60

358

1769

Dissociative [conversion] disorders

393

2031

2.21

38.05

4.6

3.1

75.30

484.73

ng/l

3.65

197

1257

Herpesviral [herpes simplex] infections, including avohilmo

2586

20148

1.35

37.90

4.1

3.5

204.80

407.87

ng/l

2.19

1759

13696

Rash and other nonspecific skin eruption

1054

7153

1.63

37.79

4.4

3.8

253.63

418.41

ng/l

1.99

816

5518

Sacrococcygeal disorders, not elsewhere classified

359

1818

2.33

37.76

3.7

3.3

52.38

395.36

ng/l

5.32

242

1247

Alzheimer disease, including avohilmo

4721

27238

1.26

37.59

4.5

4.6

195.07

425.98

ng/l

6.19

4290

24242

Otitis externa

2436

18904

1.37

37.53

4.4

3.8

352.07

452.52

ng/l

0.55

1731

14080

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1682

12454

1.47

37.52

5.1

4.2

311.39

560.02

ng/l

1.66

1456

10318

Lesion of ulnar nerve

1520

11031

1.49

37.48

4.9

3.8

274.28

539.87

ng/l

1.96

1159

8538

Plantar fascial fibromatosis

1041

7038

1.62

37.35

3.6

3.4

214.51

577.45

ng/l

1.70

738

5224

Alcohol-induced acute pancreatitis

451

2507

2.17

37.30

5.5

3.9

106.52

539.44

ng/l

6.33

363

2005

Insulin, fast-acting or short human

4041

33225

1.27

37.28

5.8

4.0

530.46

477.47

ng/l

0.35

3331

25836

Hypertension, Pulmonary Arterial

141

480

4.36

37.20

8.4

3.2

854.09

331.36

ng/l

0.36

129

363

Presbycusis

1861

13847

1.44

37.13

4.9

4.5

235.09

466.12

ng/l

2.41

1721

12468

Vascular diseases of the intestine

515

2985

2.06

37.04

6.9

4.1

245.38

361.25

ng/l

0.67

468

2562

Orchitis and epididymitis

1045

7113

1.62

36.87

4.8

4.1

515.10

581.06

ng/l

0.15

876

5992

Basal cell carcinoma

5308

30464

1.24

36.85

4.4

4.2

372.78

513.20

ng/l

2.15

4634

24999

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2822

21740

1.34

36.84

4.5

4.2

203.26

536.59

ng/l

9.50

2344

18047

Other skin changes

2284

17679

1.38

36.80

5.1

4.0

243.93

486.56

ng/l

2.64

1797

14346

Disorders of mineral metabolism

909

6007

1.67

36.74

5.1

3.5

278.99

590.59

ng/l

1.04

739

4645

Other malignant neoplasms of skin (=non-melanoma skin cancer)

5437

31132

1.24

36.70

4.4

4.2

356.97

514.90

ng/l

2.83

4722

25482

Nontraumatic intracranial haemmorrhage

2293

17750

1.38

36.61

4.6

4.1

330.60

504.22

ng/l

1.50

1989

15023

Chronic ulcer of skin, not elsewhere classified

840

5512

1.73

36.42

6.3

4.1

354.43

623.13

ng/l

0.85

718

4592

Carcinoma in situ of skin of other and unspecified parts of face

1115

7790

1.62

36.41

4.8

4.5

413.24

449.00

ng/l

0.08

1019

6974

Use of disulfiram, acamprosate or naltrexone

933

6226

1.66

36.31

4.5

3.7

261.25

561.48

ng/l

2.28

670

4588

Other specified/unspecified dorsopathies

413

2235

2.18

36.19

4.7

3.4

175.85

408.99

ng/l

1.50

292

1691

Benign thyroid growths and nodules

3709

28206

1.28

36.18

4.2

3.9

143.54

343.05

ng/l

5.06

2838

22088

Other congenital malformations

817

5263

1.70

36.16

3.8

3.5

522.25

489.52

ng/l

0.08

529

3381

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

412

2227

2.17

36.10

4.5

3.6

133.64

525.76

ng/l

3.85

291

1518

Metatarsalgia

1012

6849

1.61

36.06

4.3

3.4

158.38

571.15

ng/l

2.04

733

5060

Diabetic nephropathy

1851

13859

1.44

35.91

6.4

4.9

679.62

545.66

ng/l

0.65

1660

11582

In situ neoplasms

4581

38330

1.25

35.87

4.3

4.1

274.27

403.77

ng/l

1.91

3730

30345

Non-follicular lymphoma

1121

7835

1.60

35.81

4.5

4.3

319.83

517.09

ng/l

0.50

975

6656

Other diseases of stomach and duodenum

767

4941

1.76

35.77

5.6

3.8

152.32

620.27

ng/l

1.81

624

4037

Secondary and unspecified malignant neoplasm of lymph nodes

974

6605

1.64

35.69

4.8

4.2

423.00

453.71

ng/l

0.06

839

5414

Asthma and opportunity respiratory infection

581

3529

1.95

35.57

5.9

4.0

187.16

354.89

ng/l

2.33

482

2938

Triptan medication for migraine, min. 3 purchases

5359

33717

1.22

35.57

3.3

238.04

404.68

ng/l

2.28

2860

21231

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

625

3872

1.90

35.54

6.0

4.4

183.40

448.31

ng/l

3.14

556

3334

Azathioprine

1473

10689

1.47

35.48

6.0

3.4

213.12

553.54

ng/l

2.77

1108

7672

Bronchiectasis

931

6285

1.67

35.38

5.8

3.9

241.02

517.21

ng/l

0.99

793

5296

Non-small cell lung cancer, adenocarcinoma

776

5046

1.76

35.24

5.0

4.4

336.22

419.16

ng/l

0.32

690

4344

Non-small cell lung cancer, including Hilmo

1795

12673

1.43

35.22

5.1

4.4

324.24

524.10

ng/l

1.72

1595

10923

Unspecified lump in breast

1633

12114

1.45

35.12

3.7

222.20

276.02

ng/l

0.46

1094

8823

Dermatophytosis, including avohilmo

7414

63137

1.19

35.00

4.2

3.8

407.47

501.53

ng/l

1.27

5656

47210

Hypothyroidism, other/unspecified

9997

58043

1.16

34.98

4.2

3.8

334.14

472.88

ng/l

2.19

7259

43344

Alcohol withdrawal state with delirium

791

5170

1.74

34.92

5.6

4.0

266.39

681.01

ng/l

1.40

671

4214

Other inflammatory liver diseases

746

4800

1.76

34.92

4.6

3.8

329.31

423.19

ng/l

0.38

580

3714

Right bundle-branch block

413

2251

2.12

34.80

5.5

2.9

311.50

509.73

ng/l

0.95

343

1790

Atypical facial pain

590

3588

1.88

34.68

5.4

3.6

169.57

360.10

ng/l

1.72

403

2629

Excessive vomiting in pregnancy

705

4418

1.74

34.66

3.0

239.76

299.62

ng/l

0.18

345

2444

Mental and behavioural disorders due to cannabinoids

299

1448

2.37

34.51

3.6

3.1

165.33

618.74

ng/l

2.24

173

813

Arterial embolism and thrombosis

697

4427

1.79

34.47

6.6

4.1

465.18

597.00

ng/l

0.17

633

3809

Purpura and other haemorrhagic conditions

1467

10752

1.48

34.29

5.0

4.0

395.58

499.95

ng/l

0.37

1185

8460

Dissection of aorta

421

2360

2.16

34.15

5.7

4.1

1323.57

369.36

ng/l

1.22

386

2010

Pain associated with micturition

1316

9487

1.50

33.91

5.2

3.8

150.72

405.54

ng/l

6.78

966

7354

Myocardial infarction, unclassifiable

2628

18649

1.34

33.81

7.3

4.5

995.81

445.78

ng/l

4.21

2480

16534

Benign neoplasm: Adrenal gland

902

6112

1.66

33.78

4.7

4.0

228.61

537.43

ng/l

1.11

726

4902

Amyloidosis

292

1447

2.50

33.76

8.6

3.7

155.29

1028.52

ng/l

0.79

278

1194

Focal epilepsy, mode (most common among epilepsy diagnosis)

1999

15353

1.39

33.58

4.5

4.0

239.04

500.98

ng/l

2.98

1569

11969

Dementia

5364

31207

1.23

33.57

4.5

4.4

217.28

463.88

ng/l

8.28

4787

27286

Amyloidosis, other/unspecified

253

1195

2.71

33.56

9.3

3.7

160.10

400.25

ng/l

2.35

244

981

Monoamine oxidase A inhibitors

1222

8706

1.52

33.53

4.2

3.7

174.56

599.39

ng/l

3.25

928

6784

Embolic stroke

578

3534

1.88

33.49

6.2

4.3

591.91

748.66

ng/l

0.20

538

3110

Cytomegalovirus infection, IBD co-morbidity

293

1462

2.50

33.47

7.3

3.9

634.95

500.84

ng/l

0.26

259

1100

Other dialysis

376

2047

2.24

33.45

6.6

4.0

1394.00

558.35

ng/l

0.74

351

1616

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

3219

26160

1.29

33.40

4.0

3.9

325.66

501.79

ng/l

2.12

2413

19838

Non-small cell lung cancer

1249

8859

1.52

33.35

5.2

4.5

349.16

514.10

ng/l

0.89

1118

7728

Disorders of ocular muscles, binocular movement, accommodation and refraction

4988

41809

1.22

33.30

4.1

3.7

341.84

437.63

ng/l

0.91

3544

29517

Scoliosis

810

5302

1.66

33.26

4.0

3.4

290.22

409.45

ng/l

0.76

575

3724

Varicose veins

7015

45991

1.19

33.13

4.3

3.9

215.03

467.75

ng/l

11.01

5641

36396

Dementia, including avohilmo

5698

33286

1.22

32.89

4.5

4.4

208.13

469.10

ng/l

10.02

5081

29055

Oesophagitis

641

4042

1.81

32.86

5.1

3.8

304.30

713.65

ng/l

0.89

500

3296

Cholangitis (primary sclerosing, PSC)

724

4691

1.74

32.79

4.8

3.9

109.38

655.95

ng/l

2.18

585

3831

Schizophrenia

1572

11683

1.43

32.78

4.1

3.6

224.40

547.42

ng/l

2.39

1075

8434

Other aneurysm

652

4139

1.80

32.67

5.7

4.0

384.36

625.12

ng/l

0.54

562

3490

Any prescribed medicine buy

10.11

32.56

2.7

3.2

50.83

1263.71

ng/l

0.72

Ventricular septal defect, a heart condition

237

1078

2.62

32.50

5.7

3.5

1263.70

695.00

ng/l

1.78

197

666

Benign neoplasm: Small intestine

499

2993

1.99

32.36

5.0

4.2

89.38

348.91

ng/l

6.81

412

2502

Periapical abscess

5031

42777

1.22

32.21

3.9

3.8

418.46

510.03

ng/l

0.94

3767

32071

3766

26889

1.27

32.07

5.1

4.4

268.91

399.92

ng/l

1.33

3350

23760

Hypothyreosis and Thyroxine purchase for inclusion criteria

10381

60529

1.15

31.95

4.2

3.8

328.36

455.91

ng/l

2.03

7547

45202

Immunodeficiencies

518

3110

1.91

31.95

4.8

3.7

357.12

485.50

ng/l

0.35

368

2255

Erosion of teeth , including avohilmo

2600

20694

1.31

31.93

3.7

3.6

235.48

468.53

ng/l

2.89

1763

13915

Budesonide

1452

10706

1.45

31.86

4.0

3.4

478.89

531.74

ng/l

0.12

1009

7773

Other/unspecified cytomegaloviral diseases

253

1218

2.63

31.84

7.6

4.0

625.20

446.45

ng/l

0.33

224

918

Adenomyosis (Endometriosis of uterus)

1372

10030

1.47

31.80

3.7

3.6

212.07

318.94

ng/l

0.66

987

7532

Other bursopathies

1405

10338

1.46

31.79

5.0

3.7

225.10

551.43

ng/l

2.84

1126

8321

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

1006

6901

1.55

31.78

3.5

3.4

489.32

492.52

ng/l

0.01

639

4352

Crushed, pushed or stepped on by crowd or human stampede

724

4675

1.69

31.75

4.0

3.4

234.50

502.90

ng/l

1.43

502

3037

Reimbursement for rheumatic diseases

6238

53656

1.19

31.61

4.2

3.9

354.89

417.57

ng/l

0.58

4829

40582

Panniculitis affecting regions of neck and back

409

2297

2.06

31.60

4.5

3.4

184.98

444.29

ng/l

1.80

288

1718

Poisoning by narcotics and psychodysleptics [hallucinogens]

196

839

2.89

31.55

4.8

3.3

147.17

617.28

ng/l

1.35

127

521

Pneumonia due to other infectious organisms, not elsewhere classified

395

2210

2.11

31.48

6.4

3.6

147.00

473.16

ng/l

4.06

331

1721

Fall involving bed

452

2661

2.04

31.36

6.7

4.5

169.50

330.52

ng/l

1.57

396

2325

Candidiasis

1494

11120

1.44

31.32

5.2

3.7

197.08

460.69

ng/l

2.01

1106

8244

Cytomegaloviral disease, including avohilmo

299

1537

2.39

31.31

7.2

3.9

624.10

495.51

ng/l

0.25

264

1163

Other diseases of biliary tract

1017

7142

1.57

31.17

4.6

4.0

209.67

514.04

ng/l

1.37

858

5965

Maltreatment syndromes

491

2890

1.88

31.12

3.5

3.1

252.05

492.24

ng/l

1.17

252

1717

Postprocedural disorders of nervous system

659

4187

1.72

31.00

3.7

3.1

99.85

507.93

ng/l

5.25

339

2515

Coxarthrosis, primary

7178

52192

1.18

30.93

4.5

4.2

312.48

474.66

ng/l

3.95

6150

43269

Cytomegaloviral disease

296

1524

2.39

30.91

7.2

3.9

627.78

497.91

ng/l

0.25

262

1157

Colorectal cancer, including Hilmo

3108

23708

1.29

30.73

3.8

4.3

506.23

523.93

ng/l

0.06

2645

19986

Female genital prolapse

2956

13224

1.30

30.72

3.8

3.7

252.24

329.35

ng/l

0.64

2080

9984

Behavioural disorders, excluding more controls

198

843

2.71

30.72

3.9

2.8

106.77

974.48

ng/l

3.34

111

508

Infections with a predominantly sexual mode of transmission

2690

21500

1.30

30.68

3.5

3.2

339.09

408.89

ng/l

0.29

1588

13022

Pregnancy examination and test

1164

5050

1.50

30.58

2.5

2.7

158.90

287.75

ng/l

0.97

446

2234

Inflammatory diseases of the central nervous system

885

6063

1.61

30.41

4.0

3.8

195.89

444.89

ng/l

3.76

644

4562

Alzheimer’s disease (Late onset)

2984

20041

1.30

30.28

4.5

4.7

199.49

423.79

ng/l

3.99

2735

18128

Reactive arthropathies

899

6164

1.59

30.25

4.0

3.7

352.99

640.11

ng/l

0.85

669

4606

Other disorders of glucose regulation and pancreatic internal secretion

899

6182

1.59

30.14

5.4

3.9

237.01

459.27

ng/l

2.55

725

4776

Special screening examination for neoplasms

689

4467

1.69

30.08

3.9

3.4

884.60

636.72

ng/l

0.26

531

3629

Diffuse large B-cell lymphoma, including Hilmo

596

3797

1.82

30.04

4.8

4.3

530.30

425.97

ng/l

0.13

525

3222

Diffuse large B-cell lymphoma, helper endpoint

596

3797

1.82

30.04

4.8

4.3

530.30

425.97

ng/l

0.13

525

3222

Diffuse large B-cell lymphoma

596

3797

1.82

30.04

4.8

4.3

530.30

425.97

ng/l

0.13

525

3222

Personal history of risk-factors, not elsewhere classified

176

736

3.00

29.99

5.5

2.8

147.70

328.67

ng/l

0.69

115

468

Other fall from one level to another

2291

18140

1.33

29.80

4.3

3.9

549.52

527.16

ng/l

0.06

1673

13530

Osteomyelitis

748

4998

1.68

29.78

6.4

4.1

407.12

664.65

ng/l

0.72

651

4119

Other disorders of binocular vision

166

679

3.10

29.74

4.1

3.0

37.89

269.97

ng/l

2.14

410

Other disorders affecting eyelid function

152

615

3.56

29.61

5.3

4.0

242.88

380.64

ng/l

0.42

121

493

Oxicams

2469

11077

1.32

29.57

4.4

4.0

331.06

688.46

ng/l

4.15

1940

9261

Cirrhosis of liver, NAS

653

4264

1.76

29.50

5.0

4.2

472.58

668.54

ng/l

0.34

568

3557

Other/unspecified enthesopathies of lower limb, excluding foot

720

4731

1.66

29.47

4.8

3.3

290.71

449.93

ng/l

0.69

504

3415

Keratitis

3844

32185

1.24

29.46

4.3

3.8

449.74

447.46

ng/l

0.01

2868

24245

Mixed disorders of conduct and emotions, excluding more controls

176

718

2.75

29.46

3.2

2.4

189.77

998.14

ng/l

1.85

316

Visual field defects

942

6590

1.58

29.45

5.1

4.0

298.31

561.26

ng/l

0.92

746

5357

Disorders of calcium metabolism

686

4487

1.70

29.39

5.3

3.5

180.06

607.38

ng/l

1.30

579

3515

Other and unspecified diseases of blood and blood-forming organs

333

1820

2.23

29.34

5.2

4.1

177.32

527.70

ng/l

2.48

279

1439

Superficial injury of shoulder and upper arm

1271

9317

1.47

29.33

4.5

3.8

220.61

529.37

ng/l

1.73

973

7044

Abnormal results of function studies

949

6633

1.56

29.25

5.2

3.7

627.94

419.50

ng/l

0.40

739

4980

Bronchitis, not specified as acute or chronic

916

6351

1.57

29.24

5.3

3.7

464.99

613.30

ng/l

0.23

710

4970

Other necrotizing vasculopathies (FG)

685

4512

1.71

29.09

5.6

3.9

119.32

574.08

ng/l

1.57

584

3702

Other peripheral vertigo

1021

7269

1.55

29.03

5.1

3.9

150.79

366.87

ng/l

4.59

785

5840

Papulosquamous disorders

4281

36274

1.23

28.94

4.1

3.9

425.22

459.60

ng/l

0.18

3169

28084

Open wound of forearm

1040

7403

1.52

28.83

4.8

3.8

272.72

569.04

ng/l

1.18

818

5680

Other and unspecified urticaria

1891

14681

1.36

28.80

4.3

3.6

341.20

445.50

ng/l

0.38

1258

10230

Seropositive rheumatoid arthritis

2687

21671

1.30

28.77

4.5

3.8

349.05

459.85

ng/l

0.62

2239

17058

Barrett oesophagus

598

3847

1.78

28.70

5.8

3.8

406.26

691.15

ng/l

0.56

497

3214

False labour

2278

11082

1.32

28.63

2.6

2.8

209.77

295.91

ng/l

0.63

932

5347

Open wound of wrist and hand

4702

38720

1.21

28.62

4.2

3.8

338.95

592.82

ng/l

4.79

3404

28755

Abnormal findings on antenatal screening of mother

604

3798

1.69

28.51

2.3

2.5

198.63

206.63

ng/l

0.03

220

1403

Benign neoplasm: Rectum, anus and anal canal

2268

18142

1.33

28.47

4.7

4.2

330.64

477.42

ng/l

0.94

1906

15154

Dislocation, sprain and strain of joints and ligaments of thorax

408

2371

1.99

28.44

5.3

3.8

585.05

450.39

ng/l

0.20

288

1781

Macular pucker

1846

14449

1.38

28.40

4.5

4.2

438.48

464.37

ng/l

0.09

1600

12358

Other disorders of white blood cells

605

3901

1.76

28.30

4.9

4.0

394.32

447.30

ng/l

0.19

488

3072

Sleep disorders, other/unspecified

368

2059

2.02

28.19

4.0

3.5

371.42

525.32

ng/l

0.34

224

1330

Retinal vascular occlusion

1397

10524

1.44

28.16

5.4

4.3

415.49

468.18

ng/l

0.19

1208

9112

Hypothyroidism, strict autoimmune

8162

47352

1.16

28.15

4.1

3.7

376.58

462.44

ng/l

0.80

5922

35219

Unspecified visual impairment (binocular)

215

1023

2.69

28.14

6.3

3.9

933.13

369.08

ng/l

0.33

167

801

Focal brain injury

663

4324

1.68

28.08

4.6

3.6

201.76

697.95

ng/l

6.40

530

3547

Intentional self-harm by unspecified means

163

679

2.99

27.93

4.7

3.0

65.63

426.76

ng/l

1.20

383

Melanocytic naevi

3151

26024

1.26

27.83

4.0

3.7

358.75

433.59

ng/l

0.47

2275

18776

Failure and rejection of transplanted organs and tissues

181

803

2.91

27.83

8.1

3.8

1845.54

593.95

ng/l

0.66

152

599

Nasal polyp

2028

16006

1.34

27.77

4.1

4.0

262.95

595.21

ng/l

4.01

1592

12827

Flat foot [pes planus] (acquired)

1011

7205

1.52

27.76

4.1

3.6

287.69

583.99

ng/l

1.00

721

5399

Other disorders of patella

1614

12314

1.38

27.74

3.8

3.5

220.50

606.61

ng/l

3.05

1060

8509

Other and unspecified glaucoma

854

5963

1.60

27.67

4.9

4.4

318.93

476.15

ng/l

0.41

762

5176

Malignant neoplasm of bronchus and lung, including Hilmo

2464

16577

1.31

27.65

5.0

4.4

312.87

534.90

ng/l

2.63

2178

14250

Weight loss

1132

8265

1.49

27.64

5.3

4.1

358.78

523.09

ng/l

0.44

866

6674

Other noninflammatory disorders of vulva and perineum

929

6499

1.54

27.63

4.2

3.4

311.68

318.64

ng/l

0.02

605

4514

Retinal detachments and breaks

4070

34533

1.23

27.61

4.5

4.1

372.62

471.37

ng/l

0.91

3379

28479

Osteonecrosis

727

4916

1.66

27.57

4.9

3.8

187.72

469.14

ng/l

4.27

617

3919

Non-small cell lung cancer, adenocarcinoma, helper endpoint

776

5331

1.64

27.44

5.0

4.3

336.22

558.11

ng/l

0.58

690

4615

Causalgia

204

953

2.67

27.40

5.0

3.3

48.94

316.94

ng/l

3.50

141

667

Other disorders of penis

1047

7531

1.51

27.30

4.9

4.1

477.00

615.45

ng/l

0.48

862

6261

Diseases of external ear

3867

32646

1.23

27.30

4.4

4.0

378.56

460.82

ng/l

0.61

2910

25394

Malignant neoplasm of respiratory system and intrathoracic organs

2464

16508

1.31

27.27

4.9

4.4

315.62

548.06

ng/l

2.84

2174

14177

Pneumocystosis, including avohilmo

260

1356

2.46

27.22

6.5

4.2

180.84

327.48

ng/l

1.07

238

1130

Pneumocystosis

260

1356

2.46

27.22

6.5

4.2

180.84

327.48

ng/l

1.07

238

1130

Superficial injury of forearm

1013

7230

1.50

27.17

4.4

3.6

274.68

453.72

ng/l

1.13

705

5075

Acute and transient psychotic disorders

1125

8181

1.47

27.14

3.9

3.6

286.73

468.48

ng/l

0.64

775

5796

Other surgical follow-up care

372

2124

2.00

27.09

5.2

3.3

268.69

511.20

ng/l

1.36

284

1531

Blepharochalasis

3285

27421

1.26

27.05

4.6

4.0

207.15

416.65

ng/l

4.55

2683

22472

Acute gastritis

815

5633

1.59

26.94

5.8

3.8

156.73

594.66

ng/l

2.01

643

4594

Autoimmune hepatitis, wide definition

508

3169

1.81

26.92

4.6

3.5

383.94

418.67

ng/l

0.08

375

2346

Retinal vascular disorders

1409

10704

1.42

26.73

5.4

4.3

412.11

469.00

ng/l

0.21

1219

9273

Hydronephrosis

1231

9134

1.45

26.67

4.6

3.7

346.79

436.50

ng/l

0.29

1005

7341

Other necrotizing vasculopathies

816

5686

1.60

26.55

5.6

4.1

178.39

534.25

ng/l

1.50

687

4694

Use of other anti-dementia drugs

3475

23490

1.25

26.38

4.6

4.7

195.44

413.83

ng/l

4.85

3169

21170

Use of memantine

3475

23490

1.25

26.38

4.6

4.7

195.44

413.83

ng/l

4.85

3169

21170

Other/unspecified synovitis and tenosynovitis

1145

8393

1.46

26.24

4.5

3.6

301.85

558.09

ng/l

1.06

865

6395

Colorectal cancer

2759

21765

1.28

26.23

3.8

4.4

533.73

515.84

ng/l

0.05

2343

18430

Later onset COPD

3384

22780

1.26

26.23

6.1

4.4

343.99

489.74

ng/l

0.78

3138

20331

Diabetic retinopathy, excluding more controls

2758

12600

1.29

26.04

5.6

4.3

661.58

460.33

ng/l

1.47

2365

9928

Chronic diseases of tonsils and adenoids

8206

45957

1.15

26.01

3.6

376.38

535.17

ng/l

2.06

5270

33297

Reactive arthropathies, FINNGEN

720

4875

1.62

26.00

4.0

3.5

349.52

700.02

ng/l

0.81

534

3514

Injury of eye and orbit

1394

10533

1.40

25.94

4.1

3.7

604.01

597.51

ng/l

0.01

1009

7710

Complications of other internal prosthetic devices, implants and grafts

502

3172

1.82

25.90

5.0

3.7

285.49

354.45

ng/l

0.34

416

2573

Hypermobility syndrome

472

2890

1.79

25.86

3.0

153.80

318.12

ng/l

0.94

204

1566

Cluster headache, strict, including avohilmo

498

3109

1.78

25.86

4.7

3.5

355.82

500.23

ng/l

0.50

297

2065

Abscess of anal and rectal regions

852

5954

1.55

25.84

4.2

3.5

1110.83

689.59

ng/l

0.47

640

4459

Previous suicide attempt

141

573

3.15

25.81

5.4

3.1

165.44

612.53

ng/l

1.05

355

Protozoal diseases, including avohilmo

369

2162

2.02

25.75

5.7

4.1

219.42

379.60

ng/l

1.21

318

1724

Amenorrhoea

524

3274

1.71

25.61

3.7

2.9

443.59

411.08

ng/l

0.03

273

1704

Congenital malformations and deformations of the musculoskeletal system

762

5174

1.57

25.51

3.6

3.4

608.29

460.32

ng/l

0.41

487

3196

Colonic or urogenital fistula

2797

23078

1.27

25.43

4.2

3.9

232.24

468.44

ng/l

3.07

2070

17752

Specific development disorders of scholastic skills

355

1965

1.93

25.42

4.0

3.1

493.18

731.55

ng/l

0.50

194

987

Protozoal diseases

357

2083

2.04

25.37

5.8

4.1

224.82

388.40

ng/l

1.19

310

1660

Type 1 diabetes

2417

19562

1.28

25.35

5.2

3.5

864.95

470.89

ng/l

1.93

1884

14206

Toxic effect of other and unspecified substances

160

694

2.88

25.31

5.5

3.5

80.48

312.55

ng/l

2.13

438

Covid-19 suspected case

1973

15633

1.32

25.21

4.7

3.4

213.79

491.79

ng/l

2.96

1420

10447

Alzheimer’s disease, strict definition

3153

21256

1.26

25.12

4.4

4.6

204.95

435.26

ng/l

4.37

2867

19077

Exposure to other and unspecified animate mechanical forces

334

1889

2.02

25.10

4.0

3.5

95.64

473.62

ng/l

3.31

215

1220

Other noninflammatory disorders of uterus, except cervix

2248

12047

1.31

25.09

4.4

3.8

144.09

316.46

ng/l

4.92

1760

9481

Unspecific neurodegenerative disorder

5136

30529

1.20

25.02

4.5

218.07

450.78

ng/l

6.69

4630

26979

Restless leg syndrome

1522

11763

1.38

24.96

4.7

3.9

192.65

460.75

ng/l

1.82

1131

9052

Trigeminal neuralgia

634

4234

1.66

24.88

4.8

3.7

506.76

350.43

ng/l

0.25

432

3184

Effects of other external causes

304

1674

2.08

24.83

3.8

3.5

103.35

651.83

ng/l

3.82

165

1097

Cluster headache, wide,, including avohilmo

523

3337

1.74

24.82

4.8

3.6

442.64

480.16

ng/l

0.08

317

2252

Cauda equina syndrome

182

854

2.75

24.81

6.3

3.9

62.01

324.87

ng/l

2.23

121

651

Pure hyperglyceridaemia

268

1432

2.23

24.78

6.1

3.6

167.25

438.28

ng/l

2.53

221

1114

Type 1 diabetes, wide definition, subgroup 1

1953

15481

1.32

24.75

5.2

3.4

796.90

499.30

ng/l

1.47

1510

10943

Benign neoplasm: Rectum

2005

16089

1.33

24.69

4.8

4.2

352.39

478.75

ng/l

0.66

1687

13451

Abnormal weight loss

1041

7649

1.48

24.63

5.4

4.1

356.46

542.73

ng/l

0.48

804

6225

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

832

5884

1.55

24.58

5.5

3.9

466.05

397.95

ng/l

0.26

653

4572

Palmar fascial fibromatosis [Dupuytren]

1628

12715

1.36

24.45

4.6

4.0

305.67

639.08

ng/l

3.14

1388

11031

Other bursitis of hip

264

1417

2.25

24.41

5.0

3.5

605.00

440.28

ng/l

0.13

207

1124

Gangrene, not elsewhere classified

112

422

3.65

24.41

7.0

3.2

213.67

501.32

ng/l

1.38

105

368

Hypoglycaemia, other or unspecified

704

4814

1.60

24.40

5.6

3.9

246.69

450.46

ng/l

1.61

561

3679

Malignant neoplasm of urinary organs, including Hilmo

1275

9675

1.42

24.24

5.3

4.4

917.02

510.05

ng/l

0.27

1133

8293

Sequelae of injuries of head

560

3663

1.70

24.22

4.7

3.8

403.46

516.06

ng/l

0.14

415

2765

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2082

16796

1.31

24.19

4.0

4.2

408.66

521.49

ng/l

0.37

1674

13956

Olecranon bursitis

677

4615

1.62

24.19

5.1

3.9

624.61

783.09

ng/l

0.17

549

3865

Glucagon-like peptide-1 (GLP-1) analogues

3207

26924

1.24

24.18

4.7

3.7

368.24

552.77

ng/l

1.88

2355

20399

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

3207

26924

1.24

24.18

4.7

3.7

368.24

552.77

ng/l

1.88

2355

20399

Lesion of lateral popliteal nerve

541

3522

1.73

24.17

5.2

3.8

273.27

464.99

ng/l

1.17

442

2766

SLE (Finngen)

375

2227

1.92

24.10

5.4

3.4

462.67

283.13

ng/l

0.48

300

1564

Convergence insufficiency and excess

161

715

2.77

24.05

4.2

3.0

41.77

241.27

ng/l

2.92

439

Early lumbar disc prolapse, operated

808

5627

1.52

24.03

3.4

3.1

293.82

589.80

ng/l

1.16

455

3421

Pediculosis, acariasis and other infestations, including avohilmo

1597

12406

1.35

24.02

3.9

3.5

392.30

548.06

ng/l

0.46

1031

8262

Salpingitis and oophoritis

1644

12865

1.35

24.00

4.0

3.5

115.64

308.19

ng/l

5.49

1156

9136

Emotional disorders starting during childhood or adolecense, excluding more controls

291

1510

2.00

23.98

4.3

2.5

276.06

812.54

ng/l

1.77

127

667

Paralytic ileus

434

2690

1.84

23.95

5.3

4.0

162.96

803.07

ng/l

1.27

370

2283

Injury of muscle and tendon at shoulder and upper arm level

3947

33800

1.21

23.93

4.3

4.0

331.36

578.16

ng/l

3.91

3116

27449

Collagenous colitis

987

7214

1.49

23.89

5.0

3.9

428.18

393.81

ng/l

0.06

741

5544

Cerebral cysts

571

3750

1.67

23.82

4.7

3.6

1468.84

453.08

ng/l

1.51

386

2678

Hordeolum and other deep inflammation of eyelid

618

4137

1.64

23.73

4.2

3.6

196.90

482.37

ng/l

3.78

434

2980

Benign neoplasm of meninges

1114

8327

1.45

23.62

4.3

4.0

181.43

421.23

ng/l

1.27

871

6666

Other female pelvic inflammatory diseases

1505

11680

1.36

23.46

4.4

3.5

259.77

285.75

ng/l

0.09

957

8294

Medical abortion

6204

29474

1.17

23.43

3.5

3.6

264.01

242.64

ng/l

0.20

4035

20241

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1482

11412

1.38

23.41

4.8

4.7

311.06

451.69

ng/l

1.40

1342

10135

Infections with a predominantly sexual mode of transmission, including avohilmo

3470

26756

1.22

23.39

3.3

3.2

305.47

423.68

ng/l

0.75

1958

15963

Other and unspecified paralytic syndromes

187

905

2.61

23.39

5.4

3.6

140.08

360.43

ng/l

1.88

138

688

Impotence

638

4343

1.64

23.32

5.8

4.2

453.08

575.09

ng/l

0.52

545

3728

Thyroiditis, ILD-related definition

1103

8194

1.44

23.30

4.3

3.5

280.18

364.13

ng/l

0.39

736

5711

Polymyalgia rheumatica

1552

12180

1.37

23.29

5.4

4.3

154.39

421.66

ng/l

3.11

1363

10579

Other infective otitis externa

646

4396

1.62

23.24

4.3

3.9

345.52

671.41

ng/l

0.61

476

3294

Pedal cyclist injured in transport accident

2227

18094

1.29

23.24

3.8

262.47

480.38

ng/l

2.39

1617

13153

Inflammatory diseases of prostate (prostatitis)

1360

10460

1.39

23.18

5.4

4.1

1029.22

664.40

ng/l

0.23

1111

8936

Diseases of tongue

637

4311

1.62

23.14

4.4

3.7

240.85

631.06

ng/l

1.03

483

3457

Use of pramipexole

2398

19727

1.28

23.12

4.9

4.1

149.63

436.90

ng/l

5.78

1916

16014

Melanocytic naevi of trunk

1223

9252

1.41

23.12

4.4

3.7

295.44

545.45

ng/l

1.17

911

6797

Ulcerative colitis

2417

19826

1.27

22.97

4.0

3.7

420.38

487.99

ng/l

0.29

1729

14538

Charcot foot

188

905

2.47

22.86

6.7

2.6

311.84

100.30

ng/l

1.05

166

655

Anogenital herpesviral [herpes simplex] infection, including avohilmo

910

6536

1.47

22.86

3.2

3.1

240.89

446.23

ng/l

1.25

501

3649

Other specified/unspecified bacterial intestinal infections

719

5021

1.58

22.84

4.8

3.9

391.96

428.11

ng/l

0.11

552

3953

Encephalitis

330

1927

1.98

22.82

3.9

141.53

412.26

ng/l

2.95

250

1436

Exclusions for E4_PCOS_BROAD

1673

13184

1.33

22.78

4.9

3.8

409.11

497.03

ng/l

0.28

1198

9581

Other disorders starting during childhood or adolecense, excluding more controls

321

1721

1.90

22.76

4.5

2.7

353.09

755.76

ng/l

1.73

169

875

Muscle strain

355

2105

1.90

22.67

5.1

3.5

777.64

544.76

ng/l

0.29

239

1531

Other encephalitis

314

1814

2.02

22.62

4.0

3.9

103.78

416.93

ng/l

4.42

240

1348

Tetralogy of Fallot, a congenital heart defect.

197

5.44

22.61

4.0

3.8

2768.85

742.28

ng/l

2.92

121

Other other unspecified disorders of the circulatory system

418

2619

1.84

22.47

7.3

4.0

905.59

409.06

ng/l

1.16

363

2122

Other eating disorders

373

2209

1.81

22.45

4.0

2.7

592.50

409.70

ng/l

0.18

156

1007

Benign neoplasm: Cerebral meninges

1013

7525

1.46

22.45

4.2

4.0

185.49

445.78

ng/l

1.24

789

6037

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

335

1996

2.01

22.43

3.6

4.1

153.15

224.77

ng/l

0.35

271

1606

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

369

2222

1.88

22.39

3.6

140.98

525.22

ng/l

3.40

255

1540

Otitis externa, unspecified

1123

8425

1.42

22.37

4.9

3.7

362.38

543.71

ng/l

0.58

759

6096

Other disorders of bladder

1263

9667

1.40

22.36

4.9

4.0

242.60

630.02

ng/l

3.20

1053

8117

Postprocedural disorders of digestive system, not elsewhere classified

378

2309

1.89

22.33

5.3

4.0

118.80

362.19

ng/l

3.64

299

1825

Congenital malformations of the urinary system, including avohilmo

600

4044

1.63

22.32

3.9

3.8

428.38

484.61

ng/l

0.20

472

2923

Tubulo-interstitial nephritis, not specified as acute or chronic

717

5005

1.56

22.30

5.2

3.7

182.47

350.21

ng/l

2.12

591

3910

Other arterial embolism and thrombosis

335

1983

1.97

22.30

6.2

4.1

142.48

314.90

ng/l

3.29

304

1689

Bell's palsy

1203

9139

1.41

22.20

4.1

3.8

470.93

526.91

ng/l

0.12

891

7076

Inflammatory bowel disease

3112

26223

1.23

22.16

4.0

3.8

360.15

483.43

ng/l

0.89

2190

19069

Persons encountering health services in other circumstances

4119

35084

1.19

22.14

4.6

3.6

354.64

481.74

ng/l

0.96

2743

26241

Postmenopausal osteoporosis with pathological fracture

785

5644

1.56

22.10

5.8

4.3

197.37

205.68

ng/l

0.06

694

4832

Contusion of toe(s) without damage to nail

273

1508

2.06

22.09

4.7

3.5

214.82

537.55

ng/l

1.21

187

997

Other and unspecified iridocyclitis

505

3301

1.71

22.03

4.8

3.8

228.05

514.47

ng/l

1.42

388

2445

Multiple myeloma, including Hilmo

531

3536

1.71

22.02

6.3

4.3

111.61

400.00

ng/l

6.81

472

3040

Pneumonitis due to solids and liquids

924

6774

1.48

21.99

5.3

4.3

280.90

567.12

ng/l

1.20

781

5846

Intentional self-harm by sharp object

238

1253

2.15

21.97

4.8

3.1

74.34

686.91

ng/l

3.20

128

712

Other specified/unspecified systemic involvement of connective tissue

585

3951

1.64

21.87

4.9

3.7

256.83

344.81

ng/l

0.63

453

2885

Anogenital herpesviral [herpes simplex] infection

550

3629

1.63

21.87

3.5

3.2

342.37

424.80

ng/l

0.22

309

2064

Status epilepticus

391

2408

1.83

21.86

6.0

3.7

172.16

546.01

ng/l

3.56

313

1945

Sulfasalazine

2859

23943

1.24

21.86

3.8

3.5

369.75

501.51

ng/l

0.94

2170

17817

Immunodeficiency with predominantly antibody defects

286

1623

2.06

21.84

4.9

3.6

378.89

403.43

ng/l

0.03

205

1150

Spondyloarthritis

1778

14189

1.31

21.82

4.2

3.9

445.69

499.10

ng/l

0.17

1293

10743

Polyp of the female genital tract

2906

13697

1.25

21.80

3.6

147.34

320.02

ng/l

4.71

2048

10099

Mental retardation, excluding more controls

337

1906

1.89

21.77

3.9

3.3

309.45

751.17

ng/l

2.83

229

1331

Acidosis

239

1284

2.20

21.77

6.1

3.6

359.20

374.29

ng/l

0.04

205

1037

Other/unspecified soft tissue disorders related to use, overuse and pressure

323

1894

1.95

21.72

4.0

3.3

199.18

541.46

ng/l

3.06

237

1378

Infection of intervertebral disc (pyogenic)

187

938

2.54

21.65

5.4

3.9

590.57

499.52

ng/l

0.14

159

788

Noninflammatory disorders of female genital tract

3669

15593

1.21

21.63

3.5

3.4

217.91

331.19

ng/l

2.04

2306

10634

Otitis media, unspecified

938

6284

1.45

21.61

4.4

3.4

268.48

475.27

ng/l

2.47

559

3898

Ill-defined and unknown causes of mortality

606

8737

0.65

21.61

4.5

518.29

514.17

ng/l

0.01

516

7660

Other and unspecified myopathies

975

7244

1.46

21.58

5.2

4.2

260.57

539.30

ng/l

1.39

832

6073

Osteonecrosis due to drugs

207

1086

2.46

21.56

5.4

4.2

196.40

322.24

ng/l

0.66

171

897

Contusion of other and unspecified parts of foot

495

3211

1.68

21.51

4.2

3.4

172.41

469.38

ng/l

3.03

305

2102

Senility

144

635

2.72

21.45

6.2

3.7

98.51

328.67

ng/l

1.66

138

571

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

719

5036

1.53

21.32

3.5

3.4

571.09

572.09

ng/l

0.00

475

3379

Psychotic depression

537

3544

1.63

21.31

4.6

3.5

275.72

582.35

ng/l

1.02

377

2635

Hydrocele

1228

9409

1.39

21.30

4.6

4.2

465.93

599.87

ng/l

0.72

1065

8153

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

317

1866

1.96

21.27

5.2

3.7

163.05

622.51

ng/l

3.98

257

1374

Eating disorders

810

5760

1.48

21.24

3.9

3.1

323.10

427.85

ng/l

0.26

416

3066

Injury of other and unspecified intrathoracic organs

695

4888

1.56

21.23

5.0

4.0

337.71

673.43

ng/l

0.89

570

3958

Personal history of medical treatment

148

679

2.80

21.22

5.8

3.2

388.91

348.89

ng/l

0.09

130

504

Carcinoma in situ of skin

985

7378

1.46

21.19

4.7

4.4

286.21

461.54

ng/l

0.60

869

6375

Other benign neoplasms of skin

4063

35177

1.20

21.19

4.1

237.12

422.68

ng/l

3.37

3168

27927

Congenital malformations of the urinary system

559

3755

1.63

21.17

3.9

3.8

411.61

500.48

ng/l

0.34

437

2714

Squamous cell neoplasms and carcinomas of the skin

1179

9024

1.41

21.15

4.9

4.7

296.48

472.75

ng/l

1.82

1068

8055

Family history of certain disabilities and chronic diseases leading to disablement

445

2823

1.71

21.15

3.3

2.8

1713.23

427.28

ng/l

0.43

270

1642

Other/unspecified reactive arthropathies

652

4528

1.58

21.03

4.0

3.7

379.83

478.25

ng/l

0.31

481

3300

Vasomotor and allergic rhinitis

3550

29617

1.20

21.01

3.7

3.5

258.97

473.56

ng/l

3.08

2332

20381

Eating disorder

632

4298

1.55

20.87

3.7

2.8

336.65

332.85

ng/l

0.01

285

1902

Malignant melanoma, including Hilmo

1886

15296

1.30

20.83

5.0

4.2

204.14

500.92

ng/l

7.95

1585

12634

Other specified congenital malformation syndromes affecting multiple systems

173

836

2.45

20.82

4.6

3.8

1321.75

531.69

ng/l

0.84

134

506

Pedestrian injured in transport accident

723

5126

1.53

20.80

4.7

3.8

475.80

439.80

ng/l

0.05

560

3848

Ectopic pregnancy

1455

11387

1.34

20.79

3.3

184.84

299.39

ng/l

1.56

887

7267

Other and unspecified disorders of white blood cells

439

2830

1.76

20.79

4.2

4.0

374.86

435.89

ng/l

0.19

353

2231

Achilles tendinitis

1021

7638

1.43

20.76

4.3

3.5

184.77

625.09

ng/l

2.54

775

5885

Uterine polyps

2739

13324

1.25

20.74

3.6

165.09

323.00

ng/l

3.58

1932

9899

Other disorders involving the immune mechanism, not elsewhere classified

336

2024

1.90

20.71

5.4

3.7

157.01

601.90

ng/l

4.13

269

1497

Other orthopaedic follow-up care

579

3938

1.61

20.67

4.5

3.3

447.46

521.03

ng/l

0.10

469

3016

Malignant melanoma of skin, including Hilmo

1562

12421

1.34

20.60

5.2

4.2

192.66

498.50

ng/l

7.76

1311

10270

Conductive and sensorineural hearing loss

9104

54804

1.13

20.55

4.3

4.0

379.07

515.82

ng/l

2.51

7339

43510

Thyrotoxicosis with diffuse goitre

1353

10537

1.36

20.48

4.1

3.5

213.56

362.65

ng/l

1.65

961

7377

Redundant prepuce, phimosis and paraphimosis

2072

16659

1.28

20.47

4.6

3.9

577.36

674.55

ng/l

0.28

1664

13300

Viral infections of the central nervous system, including avohilmo

760

5449

1.51

20.37

4.0

3.7

256.79

434.89

ng/l

1.13

532

3944

Diseases of peritoneum

1047

7919

1.42

20.28

5.2

4.0

510.79

532.37

ng/l

0.04

859

6352

Malignant neoplasm of colon, including Hilmo

2075

16975

1.28

20.27

4.0

4.4

411.03

497.37

ng/l

0.27

1781

14476

Vascular syndromes of brain in cerebrovascular disorders

511

3434

1.68

20.25

5.1

4.5

213.97

396.41

ng/l

1.67

444

2991

Other specified/unspecified inflammatory spondylopathies

423

2683

1.72

20.23

3.3

3.2

447.00

548.77

ng/l

0.16

259

1782

Endometriosis of pelvic peritoneum

1341

9443

1.35

20.23

3.4

3.2

193.72

362.43

ng/l

1.95

700

6138

Ulcerative colitis, NAS

1327

10332

1.35

20.11

4.1

3.7

361.70

539.21

ng/l

0.63

939

7482

Lung diseases due to external agents

1502

11915

1.34

20.10

5.4

4.3

351.80

526.79

ng/l

0.96

1268

10199

Systemic lupus erythematosus

375

2341

1.81

20.08

5.4

3.6

462.67

332.09

ng/l

0.32

300

1663

Pneumonia derived septicemia

369

2294

1.82

20.07

6.1

3.9

363.79

485.51

ng/l

0.51

315

1786

Algoneurodystrophy

331

1996

1.87

20.01

4.4

3.3

47.62

367.44

ng/l

5.09

202

1317

Haemorrhage in early pregnancy

2270

18177

1.25

19.95

3.2

181.98

266.47

ng/l

0.57

1252

10978

Disorders of parathyroid gland

2279

18702

1.26

19.94

5.0

4.1

283.67

369.09

ng/l

0.53

1927

15365

Congenital malformations of the respiratory system, including avohilmo

224

1220

2.20

19.83

6.2

4.0

158.19

405.62

ng/l

1.81

169

921

Viral agents as the cause of diseases classified to other chapters, including avohilmo

275

1587

2.00

19.82

4.0

3.7

412.45

361.31

ng/l

0.12

198

1140

Personal history of allergy to drugs, medicaments and biological substances

143

659

2.67

19.81

5.1

2.9

1053.95

440.79

ng/l

0.26

438

Conduct disorder

201

1037

2.19

19.72

3.9

3.0

104.13

855.41

ng/l

3.36

114

599

Eosinophilic disease (BM)

167

816

2.44

19.69

6.4

3.2

434.05

473.87

ng/l

0.07

136

621

Lichen simplex chronicus and prurigo

676

4798

1.54

19.65

4.6

3.8

397.87

453.51

ng/l

0.15

524

3759

Exclusion endpoint for clefts

199

1031

2.23

19.61

4.7

3.6

1210.40

648.29

ng/l

0.58

147

638

Secondary parkinsonism, excluding more controls

268

1533

1.99

19.56

4.9

3.5

125.78

684.26

ng/l

6.38

219

1290

Malignant neoplasm of urinary organs

1065

8129

1.41

19.55

5.4

4.4

1088.70

502.92

ng/l

0.34

939

6949

Colorectal adenocarcinoma

2271

18644

1.26

19.52

3.8

4.4

551.25

511.77

ng/l

0.10

1944

15962

Acute laryngitis and tracheitis

953

6955

1.41

19.46

4.0

3.1

205.36

463.23

ng/l

4.06

574

4249

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

283

1633

1.93

19.41

4.4

3.6

959.88

681.63

ng/l

0.34

206

1008

Acute nasopharyngitis (common cold)

1120

8491

1.38

19.41

4.1

3.5

321.27

633.61

ng/l

3.99

847

6303

Pyogenic arthritis

694

4947

1.52

19.37

5.2

3.9

342.97

671.54

ng/l

0.82

569

3993

Rheumatoid arthritis, including avohilmo

4029

35094

1.19

19.36

4.4

4.0

369.26

387.88

ng/l

0.09

3235

27567

Benign neoplasm: Duodenum

312

1902

1.95

19.32

5.4

4.3

106.44

368.03

ng/l

3.92

263

1593

5-aminosalicylic acid

1982

16210

1.27

19.25

3.7

3.4

399.56

516.19

ng/l

0.47

1389

11581

Seborrhoeic keratosis

2782

23597

1.23

19.24

4.4

4.0

298.74

449.18

ng/l

1.42

2269

19308

Carcinoma in situ of skin of scalp and neck

358

2273

1.87

19.13

5.1

4.5

504.81

299.96

ng/l

0.37

336

2058

Postmenopausal bleeding

2749

12080

1.24

19.12

4.0

3.8

184.46

320.52

ng/l

3.06

2087

9586

Acute posthaemorrhagic anaemia

391

2500

1.77

19.06

7.0

4.2

501.78

389.32

ng/l

0.27

352

2097

Carcinoma in situ of skin of trunk

412

2698

1.78

19.05

4.7

4.5

112.39

308.15

ng/l

2.98

381

2404

2636

20803

1.24

19.04

5.1

4.5

210.92

406.96

ng/l

2.58

2348

18470

Secondary uncertain malignant neoplasm

1438

11428

1.33

19.04

4.6

4.3

330.15

528.40

ng/l

0.78

1209

9544

Pulmonary oedema

234

1315

2.14

19.02

8.9

4.5

315.83

273.45

ng/l

0.20

214

1151

Coarctation of the aorta

123

542

2.84

18.98

7.3

3.8

1850.93

703.75

ng/l

1.88

106

373

Asthma mixed form (mode), excluding more controls

446

2899

1.66

18.94

3.9

2.8

130.20

577.22

ng/l

3.36

276

2099

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1082

8317

1.40

18.89

5.2

4.4

1072.38

488.10

ng/l

0.34

954

7092

Benign neoplasm: Sigmoid colon

2051

16971

1.27

18.88

4.7

4.2

459.55

481.26

ng/l

0.08

1729

14150

Discitis, unspecified

212

1158

2.22

18.87

5.1

3.9

752.37

435.74

ng/l

0.48

183

965

Herpesviral [herpes simplex] infections

1144

8823

1.37

18.87

4.6

3.7

268.70

379.59

ng/l

0.62

842

6449

Vitreous haemorrhage

1067

8189

1.40

18.78

5.4

4.0

656.43

525.36

ng/l

0.28

894

6654

Family history of malignant neoplasm

1001

7560

1.40

18.77

3.5

3.1

166.60

308.81

ng/l

1.71

663

4883

Synovial cyst of popliteal space [Baker]

750

5448

1.49

18.76

4.8

3.7

178.25

600.01

ng/l

1.76

583

4399

Atrophic disorders of skin

1592

12801

1.31

18.75

4.4

3.7

157.49

345.72

ng/l

4.97

1128

9474

Supplementary factors related to causes of morbidity and mortality classified elsewhere

3225

27668

1.21

18.75

4.9

3.9

199.56

466.59

ng/l

7.07

2400

20867

Autoimmune hyperthyroidism

603

4206

1.55

18.74

4.3

3.3

207.27

337.95

ng/l

0.62

433

2873

Maternal care for known or suspected fetal abnormality and damage

1123

7240

1.36

18.71

2.7

359.40

304.40

ng/l

0.16

501

3261

Wet age-related macular degeneration

2107

16887

1.27

18.62

5.3

4.6

321.53

397.46

ng/l

0.34

1882

15138

Manic episode

297

1770

1.88

18.59

4.4

3.5

140.25

619.19

ng/l

3.83

205

1258

Allergic bronchopulmonary aspergillosis (ABPA)

152

4.90

18.58

4.4

2.2

488.94

125.04

ng/l

0.93

111

Kyphosis

167

845

2.43

18.51

5.7

3.8

333.51

429.63

ng/l

0.26

139

672

Biological medication for rheuma

1577

12644

1.30

18.49

3.6

3.5

352.84

441.16

ng/l

0.63

1037

8393

Presence of other functional implants

6573

40361

1.14

18.49

4.6

3.6

395.05

387.90

ng/l

0.05

5458

32795

Other diseases of gallbladder

489

3308

1.64

18.44

4.5

3.9

226.41

343.05

ng/l

0.67

387

2699

Vitamin B12 deficiency anaemia

1115

8622

1.38

18.42

4.9

4.2

346.11

472.33

ng/l

0.42

943

7299

Amputation of foot

318

1970

1.90

18.40

8.2

4.3

517.13

342.10

ng/l

0.67

298

1715

Burns and corrosions

1304

10249

1.34

18.40

4.2

3.8

238.77

589.47

ng/l

2.45

910

7476

Malignant melanoma

1669

13553

1.30

18.34

5.0

4.2

208.03

506.90

ng/l

7.02

1402

11209

Other superficial mycoses, including avohilmo

981

7417

1.40

18.30

4.3

3.5

299.58

472.85

ng/l

0.84

656

4930

Behavioural disorders

198

1044

2.14

18.29

3.9

3.0

106.77

801.00

ng/l

2.95

111

586

!Aliquae complicationes praecoces traumatis

472

3172

1.65

18.26

5.8

3.9

521.98

455.91

ng/l

0.15

363

2456

Early complications of trauma

472

3172

1.65

18.26

5.8

3.9

521.98

455.91

ng/l

0.15

363

2456

Other mycoses, not elsewhere classified/unspecified, including avohilmo

218

1211

2.14

18.24

4.5

4.0

207.47

397.98

ng/l

0.86

165

905

SLE, ICD10

349

2194

1.80

18.24

5.4

3.6

428.83

303.18

ng/l

0.29

277

1563

SLE, strict definition

349

2194

1.80

18.24

5.4

3.6

428.83

303.18

ng/l

0.29

277

1563

Other and unspecified injuries of wrist and hand

387

2478

1.72

18.22

4.3

3.5

139.52

517.33

ng/l

3.81

259

1750

Gonarthrosis, primary, with knee surgery

6701

46984

1.14

18.13

4.2

4.1

246.76

495.66

ng/l

8.51

5625

38897

Diseases of spleen

216

1201

2.15

18.13

5.5

4.0

306.66

426.64

ng/l

0.40

178

932

Other secondary gonarthrosis

569

3982

1.58

18.12

4.8

3.9

189.55

473.27

ng/l

3.49

471

3159

Nonsuppurative otitis media, including avohilmo

2842

20830

1.21

18.09

3.7

3.5

331.90

453.70

ng/l

0.75

1783

13527

Clear cell adenocarcinoma of kidney

537

3735

1.61

18.09

5.7

4.2

2020.95

492.78

ng/l

0.47

471

3152

Meralgia paraesthetica

366

2335

1.77

18.02

5.4

3.7

409.89

425.20

ng/l

0.02

268

1782

Psoriasis

2884

24621

1.21

18.01

4.1

3.9

443.15

476.47

ng/l

0.13

2141

18825

Ehlers-Danlos syndrome, including avohilmo

131

600

2.59

18.01

2.8

2.7

792.48

144.31

ng/l

0.84

285

Recurrent dislocation and subluxation of joint

608

4262

1.53

18.00

3.2

3.4

619.52

548.06

ng/l

0.06

388

2813

Small fibre neuropathy

345

2187

1.82

17.98

6.2

4.1

156.89

379.11

ng/l

2.87

299

1779

Total colectomy

421

2770

1.69

17.95

4.0

3.8

353.01

506.46

ng/l

0.33

322

2055

Total colectomy operation

421

2770

1.69

17.95

4.0

3.8

353.01

506.46

ng/l

0.33

322

2055

Malignant melanoma of skin

1282

10132

1.35

17.94

5.2

4.2

185.42

480.40

ng/l

5.85

1077

8375

Perineal laceration during delivery

685

7705

0.69

17.92

2.5

2.6

279.44

262.64

ng/l

0.05

246

3242

D07AA Corticosteroids, weak (group I)

1358

10720

1.32

17.90

4.2

3.6

503.20

539.10

ng/l

0.06

960

7227

Hepatic failure, not elsewhere classified

410

2696

1.72

17.89

6.0

4.1

229.07

449.55

ng/l

1.74

355

2169

Strabismus

2510

21107

1.23

17.87

4.2

3.8

293.72

460.13

ng/l

1.34

1842

15291

Marfan's syndrome

289

3.80

17.82

3.9

3.0

2016.66

311.66

ng/l

0.93

198

Other and unspecified abdominal hernia

446

2989

1.67

17.74

6.0

4.0

361.17

744.69

ng/l

0.54

359

2431

Agranulocytosis

1110

8622

1.37

17.73

4.0

3.9

428.43

513.73

ng/l

0.19

898

6662

Other disorders of binocular movement

234

1328

2.02

17.68

4.2

3.6

75.48

453.58

ng/l

3.35

152

872

Thrombocytopenia, unspecified

749

5508

1.48

17.67

4.7

4.1

427.75

630.57

ng/l

0.50

621

4435

Congenital malformations of the respiratory system

201

1099

2.19

17.66

6.5

4.1

168.88

442.56

ng/l

1.82

153

835

Malignant neoplasm of bladder, including Hilmo

1282

10016

1.34

17.60

4.9

4.6

248.27

586.22

ng/l

5.73

1126

8859

Other specified disorders of muscle

309

1901

1.84

17.50

4.9

3.7

1698.27

500.98

ng/l

0.37

258

1483

Crohn's disease NAS

601

4250

1.53

17.36

3.9

3.6

298.55

467.01

ng/l

0.39

392

2988

Post-traumatic wound infection, not elsewhere classified

303

1865

1.85

17.35

5.7

4.0

371.56

482.23

ng/l

0.31

226

1452

Systemic lupus erythematosus, unspecified

308

1904

1.84

17.33

5.1

3.6

458.70

310.23

ng/l

0.31

243

1348

Aneurysms, operations, SAH

1658

13525

1.29

17.26

4.5

3.9

373.83

486.58

ng/l

0.54

1342

10839

Malignant neoplasm of bronchus and lung

2098

14621

1.26

17.25

4.9

4.4

339.05

553.79

ng/l

1.99

1860

12627

Benign neoplasm: Other and unspecified parts of small intestine

205

1150

2.20

17.23

4.7

4.2

55.59

296.31

ng/l

3.61

166

939

Viral infections of the central nervous system

691

5021

1.48

17.21

4.0

3.7

262.44

448.35

ng/l

1.07

487

3648

Other and unspecified immunodeficiencies with predominantly antibody defects

146

722

2.49

17.20

5.3

3.5

68.83

265.55

ng/l

2.49

105

512

Other abnormal uterine and vaginal bleeding

2184

13059

1.25

17.18

4.4

3.7

134.39

320.02

ng/l

5.08

1567

9753

Other disorders of conjunctiva

1486

12005

1.31

17.18

5.2

4.0

503.48

475.49

ng/l

0.06

1200

9798

Other peripheral vascular diseases

799

5944

1.44

17.17

5.1

3.6

240.65

567.33

ng/l

1.17

632

4467

Vascular dementia (undefined)

485

3275

1.60

17.17

5.1

5.0

157.34

339.68

ng/l

1.42

448

3014

Hypotension due to drugs

197

1094

2.23

17.15

8.1

4.4

280.98

337.31

ng/l

0.14

172

946

ILD medications: pirfenidone

151

774

2.58

17.14

5.1

3.9

643.53

409.47

ng/l

0.61

143

664

Other blood glucose lowering drugs, excl. Insulins

1702

13962

1.29

17.12

5.2

4.1

405.18

434.71

ng/l

0.11

1451

11782

Other specified and unspecified retinal disorders

389

2553

1.72

17.12

4.8

4.1

564.10

405.67

ng/l

0.28

310

2061

Astigmatism

590

4164

1.52

17.06

4.1

3.7

363.61

459.32

ng/l

0.33

442

2945

Thyroiditis

676

4903

1.49

17.03

4.6

3.6

94.43

376.69

ng/l

5.71

454

3461

Other/unspecified enthesopathies, not elsewhere classified

830

6214

1.43

17.00

4.5

3.7

126.62

574.15

ng/l

2.34

637

4934

Benign neoplasm of mouth and pharynx

1094

8533

1.37

17.00

4.5

4.0

253.26

519.66

ng/l

1.43

859

6765

Lateral epicondylitis

1211

9518

1.33

16.98

3.9

3.4

292.11

602.30

ng/l

1.49

831

6972

Implicit parasitic Sepsis, including avohilmo

337

3.40

16.91

4.2

3.4

407.53

340.20

ng/l

0.10

256

Spondylopathies (FG)

1248

9848

1.33

16.91

3.8

3.6

413.70

614.55

ng/l

0.60

834

6934

Thyrotoxicosis with toxic multinodular goitre

646

4687

1.51

16.87

4.7

4.0

156.74

295.79

ng/l

1.88

531

3789

Malignant neoplasm of colon

1695

13912

1.28

16.87

4.0

4.4

382.28

504.06

ng/l

0.36

1458

11911

Other neurotic disorders

488

3355

1.60

16.86

4.7

3.8

119.54

498.73

ng/l

5.81

368

2657

Assault by sharp object

183

977

2.18

16.84

4.6

3.5

122.77

793.07

ng/l

3.00

130

677

Dementia in Alzheimer disease

1451

14993

0.78

16.83

4.6

4.7

122.52

465.64

ng/l

6.16

1282

13578

Injury of muscle and tendon at hip and thigh level

1011

7802

1.38

16.80

4.3

3.7

451.41

591.29

ng/l

0.23

756

5846

Radial styloid tenosynovitis [de Quervain]

510

3510

1.56

16.80

4.4

3.2

249.86

445.32

ng/l

0.85

343

2377

Unspecified event, undetermined intent

262

1561

1.91

16.77

4.9

3.8

53.72

523.60

ng/l

4.43

181

1105

Other diseases of blood and blood-forming organs

716

5278

1.47

16.74

5.0

4.0

557.00

607.27

ng/l

0.05

582

4207

Recurrent dislocation of patella

390

2524

1.65

16.73

3.5

3.0

252.36

524.22

ng/l

1.11

211

1312

Haemolytic anaemias

369

2404

1.73

16.70

5.5

4.1

221.60

385.80

ng/l

1.37

305

1889

Atopic dermatitis

5864

41833

1.14

16.64

3.6

3.5

338.52

454.02

ng/l

1.44

3783

28208

Molar incisor enamel hypoplasia, with caries

304

3.21

16.64

7.3

2.9

798.56

1313.70

ng/l

0.53

180

Entropion and trichiasis of eyelid

950

7316

1.40

16.57

5.0

4.4

115.45

496.43

ng/l

2.63

852

6416

Open wound of abdomen, lower back and pelvis

312

1946

1.79

16.57

4.8

3.7

455.08

588.01

ng/l

0.19

227

1394

Other ill-defined and unspecified causes of mortality

572

7943

0.67

16.57

4.6

4.5

534.33

537.58

ng/l

0.01

488

6976

Car occupant injured in noncollision transport accident

348

2226

1.73

16.57

4.4

3.6

136.52

512.32

ng/l

3.60

252

1539

Unspecified jaundice

502

3473

1.58

16.55

4.4

3.7

227.94

828.16

ng/l

1.56

416

2981

Hyperparathyroidism

1988

16415

1.26

16.54

5.0

4.2

298.45

369.59

ng/l

0.36

1685

13568

Benign neoplasm: Rectosigmoid junction

455

3120

1.64

16.54

4.8

4.2

383.41

344.55

ng/l

0.08

372

2616

Nontoxic goitre/thyroid nodule

3050

26371

1.20

16.53

4.1

4.0

133.55

335.58

ng/l

4.58

2304

20862

Viral agents as the cause of diseases classified to other chapters

235

1370

1.98

16.49

4.0

3.8

417.60

395.90

ng/l

0.04

176

998

Hypothyroidism, strict autoimmune, 3 medication purchases required

9084

55895

1.11

16.48

4.1

3.8

354.70

432.64

ng/l

0.81

6629

41424

Cardiomyopathy in other diseases

318

3.46

16.48

14.3

3.0

267.44

267.25

ng/l

0.00

263

L01XE Protein kinase inhibitors

559

3983

1.56

16.48

4.8

4.1

487.98

402.50

ng/l

0.26

468

3300

Inguinal or femoral hernia, bilateral

1128

8877

1.35

16.45

4.5

4.2

559.20

674.24

ng/l

0.30

972

7626

Ovarian dysfunction

553

3855

1.51

16.44

3.1

2.8

169.45

267.45

ng/l

0.58

272

1731

Explicit fungal Sepsis, including avohilmo

430

3.06

16.40

6.9

3.4

104.63

329.99

ng/l

1.50

346

Caught, crushed, jammed or pinched in or between objects

507

3517

1.57

16.39

4.8

3.7

215.50

500.05

ng/l

1.87

351

2506

Dislocation, sprain and strain of joint and ligaments of hip

417

2805

1.67

16.38

4.7

4.1

499.18

343.81

ng/l

0.34

340

2294

Artificial joint re-operation

765

5742

1.46

16.37

4.9

4.2

264.05

518.38

ng/l

0.72

669

4849

Use of rivastigmine

1867

15508

1.27

16.33

4.5

4.7

155.11

407.21

ng/l

3.95

1687

13966

Acquired haemolytic anaemia

275

1687

1.89

16.30

6.0

4.2

261.85

369.77

ng/l

0.57

237

1364

Pneumococcal septicemia

350

2265

1.74

16.26

6.1

4.0

334.22

465.65

ng/l

0.61

297

1757

Disorders of refraction and accommodation

2623

22273

1.21

16.25

3.9

3.6

402.52

462.56

ng/l

0.26

1793

15230

Poisoning by medicine, drug-induced

150

764

2.38

16.23

5.0

3.5

31.08

293.07

ng/l

3.45

106

529

Explicit fungal Sepsis

426

3.06

16.21

6.9

3.4

105.74

332.79

ng/l

1.50

343

Other and unspecified medical devices associated with adverse incidents

373

3.51

16.18

4.5

4.0

151.20

209.79

ng/l

0.23

312

Pedestrian injured in collision with pedal cycle

325

2069

1.77

16.17

4.7

3.9

426.16

421.60

ng/l

0.01

253

1563

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

927

7134

1.40

16.15

4.6

4.0

568.88

424.66

ng/l

0.27

758

5675

Multiple myeloma and malignant plasma cell neoplasms

536

3809

1.57

16.10

6.2

4.3

109.73

644.73

ng/l

1.67

474

3279

Malignant neoplasm of kidney, except renal pelvis

951

7352

1.39

16.01

5.3

4.4

1209.33

505.39

ng/l

0.37

838

6262

Inguinal hernia, bilateral

1105

8705

1.35

16.00

4.5

4.2

567.29

684.23

ng/l

0.30

954

7480

Background retinopathy and retinal vascular changes

241

1432

1.96

16.00

5.2

4.3

467.42

379.45

ng/l

0.23

205

1165

Carcinoma in situ of skin of ear and external auricular canal

205

1177

2.13

15.99

5.2

4.6

337.69

341.12

ng/l

0.01

197

1065

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

700

5183

1.47

15.97

3.9

4.1

142.42

418.74

ng/l

5.47

581

4271

Exposure to other and unspecified forces of nature

425

3.10

15.97

3.9

3.6

609.41

337.08

ng/l

0.37

312

Dependence on enabling machines and devices, not elsewhere classified

137

677

2.46

15.95

7.3

3.4

289.24

421.22

ng/l

0.44

119

529

Systemic sclerosis (FG)

253

1520

1.91

15.95

5.2

3.7

218.74

355.80

ng/l

0.82

202

1125

Other and unspecified vascular occlusions

1029

8054

1.37

15.90

5.3

4.3

315.26

491.51

ng/l

0.70

891

6979

Other disorders of nervous system

686

5067

1.47

15.83

5.0

3.8

252.85

620.04

ng/l

1.16

543

4069

Bursitis of shoulder

271

1658

1.86

15.82

4.6

3.5

365.77

555.85

ng/l

0.33

204

1269

Multiple myeloma

326

2103

1.78

15.78

6.4

4.5

105.93

430.31

ng/l

5.38

290

1824

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

326

2103

1.78

15.78

6.4

4.5

105.93

430.31

ng/l

5.38

290

1824

conjunctival haemorrhage

812

6164

1.42

15.75

5.9

4.0

476.77

547.51

ng/l

0.10

678

5077

Suppurative and unspecified otitis media

3169

24270

1.18

15.74

3.9

3.4

341.89

442.41

ng/l

0.60

1937

15586

Oligomenorrhoea

298

1846

1.76

15.73

3.4

3.2

95.72

452.13

ng/l

2.44

148

1108

Bicipital tendinitis

481

3341

1.57

15.67

4.6

3.6

156.49

521.34

ng/l

5.42

394

2620

Scar conditions and fibrosis of skin

403

2699

1.64

15.66

5.0

3.5

168.69

445.38

ng/l

2.53

285

1855

Portal vein thrombosis

189

1056

2.13

15.61

4.4

4.0

252.30

451.03

ng/l

0.57

147

839

Carcinoma in situ of skin of upper limb, including shoulder

323

2103

1.81

15.61

4.5

214.65

307.34

ng/l

0.51

293

1856

Iron deficiency

268

1619

1.81

15.61

3.7

3.0

1245.15

387.79

ng/l

0.54

135

873

Arterial embolism and thrombosis of lower extremity artery

388

2594

1.67

15.61

6.8

4.2

671.03

384.56

ng/l

0.30

355

2229

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

148

764

2.36

15.59

5.7

3.8

127.69

381.19

ng/l

1.04

105

558

Prurigo nodularis

281

1754

1.85

15.58

4.8

4.1

496.55

444.09

ng/l

0.07

234

1422

Oesophageal varices

443

3050

1.62

15.57

4.8

4.0

209.32

500.56

ng/l

2.63

378

2517

Persons encountering health services in circumstances related to reproduction

5508

33065

1.14

15.55

3.5

3.6

612.98

522.22

ng/l

0.31

3670

23271

Anankastic personality disorder

357

2326

1.68

15.55

4.1

3.2

553.85

456.82

ng/l

0.08

227

1472

Diffuse brain injury

331

2116

1.70

15.47

4.4

3.5

114.79

734.02

ng/l

8.88

248

1627

Gout due to impairment of renal function

148

777

2.42

15.41

8.0

4.2

74.43

435.84

ng/l

3.60

139

672

Chronic lymphocytic leukaemia, helper endpoint

343

2253

1.74

15.36

4.1

4.4

297.29

477.66

ng/l

0.73

302

1952

Chronic lymphocytic leukaemia

343

2253

1.74

15.36

4.1

4.4

297.29

477.66

ng/l

0.73

302

1952

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

343

2253

1.74

15.36

4.1

4.4

297.29

477.66

ng/l

0.73

302

1952

Hypoplasia of dental enamel

330

3.01

15.35

7.1

3.5

549.07

1366.09

ng/l

1.16

195

Polypectomy (DHB20)

671

4965

1.47

15.35

4.1

4.0

332.95

697.96

ng/l

1.08

537

4000

Complications of cardiac and vascular prosthetic devices, implants and grafts

245

1485

1.93

15.32

7.2

3.9

3647.53

327.86

ng/l

0.50

225

1255

Glucosamine medication

5277

37853

1.14

15.31

4.3

241.13

394.76

ng/l

2.91

4585

31903

Brachial plexus disorders

796

5998

1.40

15.29

3.9

3.3

290.22

462.59

ng/l

1.04

502

3905

Caries of enamel

10472

63309

1.10

15.28

3.8

422.41

492.20

ng/l

0.73

7272

46648

Effects of foreign body entering through natural orifice

2353

20024

1.22

15.27

4.6

3.9

403.05

558.04

ng/l

0.57

1695

15194

Benign neoplasm: Ascending colon

1516

12462

1.29

15.21

5.0

4.2

360.70

470.11

ng/l

0.51

1307

10485

Fracture of neck

651

4809

1.47

15.19

4.8

4.2

500.43

640.41

ng/l

0.23

545

4016

Primary Sclerosing Cholangitis, IBD and UDCA required

217

1260

1.96

15.18

4.6

3.6

54.69

505.34

ng/l

4.77

158

892

Bulimia nervosa (incl. atypical)

241

1417

1.83

15.18

3.4

2.6

25.93

184.87

ng/l

2.97

113

590

Outcome of delivery

1135

5433

1.33

15.14

2.4

2.7

157.22

314.97

ng/l

1.15

415

2538

Type 1 diabetes, wide definition

1998

16733

1.23

15.10

5.2

3.5

786.00

471.24

ng/l

1.70

1544

11965

Ulcer of oesophagus

713

5342

1.44

15.08

5.6

4.0

706.68

609.87

ng/l

0.09

619

4581

Campylobacter enteritis

289

1823

1.79

15.01

4.8

3.8

410.79

477.58

ng/l

0.10

210

1366

Alcoholic liver disease

1025

8072

1.35

14.91

5.0

4.1

240.46

615.63

ng/l

2.27

898

6666

Attention to artificial openings

426

2925

1.60

14.90

4.2

3.8

484.53

453.03

ng/l

0.04

363

2441

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

171

927

2.10

14.86

2.7

3.0

630.39

227.07

ng/l

0.78

521

Mixed hyperlipidaemia

395

2669

1.63

14.84

5.1

3.7

331.19

888.88

ng/l

0.91

332

2165

Other specified/unspecified soft tissue disorders

482

3380

1.55

14.83

5.8

3.6

236.13

367.85

ng/l

0.63

380

2703

Pedal cyclist injured in noncollision transport accidents

1073

8467

1.33

14.81

3.9

3.7

313.94

587.65

ng/l

1.16

792

6106

Sequelae of injuries of neck and trunk

304

1945

1.75

14.80

4.7

3.8

188.07

525.19

ng/l

2.16

236

1482

Non-Hodgkin lymphoma, all

493

3495

1.56

14.80

4.3

4.5

354.71

397.69

ng/l

0.11

442

3050

Lactose intolerance

283

1767

1.76

14.79

4.2

3.2

112.64

523.75

ng/l

3.63

196

1193

Corneal scars and opacities

305

1961

1.76

14.77

4.9

4.0

203.60

411.06

ng/l

1.84

240

1537

Ectropion of eyelid

468

3290

1.58

14.76

5.1

4.5

661.26

600.06

ng/l

0.05

426

2963

Laparoscopic left hemicolectomy

210

1240

2.03

14.75

3.7

4.1

670.92

404.49

ng/l

0.24

176

1033

Malignant neoplasm of other and unspecified female genital organs

198

1151

2.08

14.74

3.4

4.3

191.43

296.31

ng/l

0.29

155

926

Other congenital malformations of skin, including avohilmo

724

5423

1.42

14.71

3.7

3.6

294.62

454.52

ng/l

1.06

488

3726

Other and unspecified disorders of skin and subcutaneous tissue

306

4677

0.61

14.63

5.2

3.9

295.88

382.93

ng/l

0.33

214

3642

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

813

6236

1.40

14.56

5.9

4.2

184.55

331.74

ng/l

2.40

697

5217

Congenital stenosis of pulmonary valve

353

3.02

14.55

5.5

3.3

1436.03

461.76

ng/l

1.78

218

Injury of intra-abdominal organs

252

1546

1.83

14.45

5.3

3.7

435.23

571.86

ng/l

0.22

193

1124

Viral meningitis, including avohilmo

338

2214

1.67

14.45

3.7

3.5

153.90

472.87

ng/l

2.08

214

1463

Scabies, including avohilmo

1262

10145

1.29

14.44

3.9

3.4

448.40

466.70

ng/l

0.04

765

6477

Duodenal ulcer

1121

8942

1.32

14.43

5.0

4.0

446.33

542.76

ng/l

0.26

973

7747

Other prurigo

142

745

2.34

14.43

4.2

4.1

305.79

467.66

ng/l

0.40

115

601

Unspecified misadventure during surgical and medical care

595

4371

1.48

14.39

5.3

4.0

282.41

402.54

ng/l

0.63

490

3461

Iridocyclitis

2232

19024

1.22

14.37

4.4

3.9

357.25

447.23

ng/l

0.44

1698

14583

Lack of expected normal physiological development

126

526

2.26

14.32

5.2

2.3

893.40

1193.88

ng/l

0.38

244

Other strabismus

1953

16367

1.23

14.29

4.1

3.7

267.25

470.95

ng/l

1.62

1382

11413

Benign lipomatous neoplasm

2997

26149

1.18

14.27

4.2

4.0

231.12

461.15

ng/l

3.59

2281

20547

Alzheimer’s disease (Atypical or mixed)

1268

10163

1.31

14.27

4.9

180.90

460.63

ng/l

2.43

1172

9290

Other disorders of adrenal gland

439

3052

1.57

14.26

6.8

3.8

136.98

425.62

ng/l

3.90

327

2260

Lactose intolerance, other/unspecified

253

1553

1.80

14.20

4.3

3.3

102.55

546.35

ng/l

3.49

177

1053

Premature rupture of membranes

985

8960

0.76

14.09

3.0

2.8

118.00

273.18

ng/l

2.38

404

4374

Acute bronchiolitis

415

2539

1.56

14.09

5.0

3.4

964.50

586.52

ng/l

0.43

259

1469

Congenital malformations of trachea and bronchus

127

651

2.47

14.08

7.8

4.0

62.34

278.02

ng/l

2.94

103

519

Dissocial personality disorder

168

929

2.10

14.08

4.7

3.6

290.49

745.45

ng/l

1.15

666

Flatulence and related conditions

118

577

2.44

14.08

5.1

3.4

109.92

395.96

ng/l

2.00

458

Ménière disease

941

7388

1.36

14.08

4.4

4.0

218.24

380.65

ng/l

1.46

729

5982

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1497

12282

1.26

14.05

3.6

3.2

102.73

294.97

ng/l

5.33

812

7435

Benign neoplasm: Skin of eyelid, including canthus

1597

13280

1.26

14.04

4.2

4.1

217.81

431.96

ng/l

1.67

1269

10742

Mixed disorders of conduct and emotions

176

968

1.98

14.04

3.2

2.7

189.77

822.99

ng/l

1.66

410

Viral warts

902

7014

1.36

14.01

4.4

3.6

214.77

592.89

ng/l

1.73

649

4966

Other maternal disorders predominantly related to pregnancy

4826

26983

1.14

13.95

3.1

3.2

255.33

270.77

ng/l

0.11

2662

16895

Giant cell arteritis

469

3347

1.56

13.90

6.3

4.1

129.73

365.59

ng/l

4.23

405

2868

Autonomic disorders

254

1582

1.81

13.88

4.8

3.7

58.37

416.56

ng/l

5.12

190

1202

Blood alcohol or alcohol intoxication level

231

1398

1.85

13.88

5.1

3.5

72.48

599.99

ng/l

3.95

172

967

Polyarthritis, unspecified

365

2463

1.63

13.88

4.4

3.6

316.82

478.29

ng/l

0.52

289

1863

Abdominal aortic aneurysm (AAA)

1028

8090

1.33

13.76

5.6

4.4

431.97

602.02

ng/l

0.62

945

7307

Gestational [pregnancy-induced] hypertension

1945

16347

1.22

13.75

3.2

3.0

237.54

262.41

ng/l

0.16

1092

9010

Defect, injury or illness of neck

367

3.01

13.75

4.2

3.1

24.26

195.45

ng/l

2.80

249

Certain zoonotic bacterial diseases, including avohilmo

314

2063

1.70

13.75

4.7

3.9

273.85

454.85

ng/l

0.74

248

1578

Hyperaldosteronism

301

1966

1.73

13.73

4.7

4.1

139.07

346.46

ng/l

2.83

250

1562

Hypertrophy of breast in women and men

1715

14323

1.24

13.71

3.5

131.52

347.43

ng/l

4.51

1118

9693

Late syphilis, including avohilmo

186

1077

2.03

13.67

5.0

4.0

263.23

449.61

ng/l

0.59

151

846

Hypermetropia

662

4948

1.42

13.65

3.9

3.7

170.93

476.27

ng/l

4.64

460

3560

Asthma mixed form (mode)

446

3111

1.53

13.64

3.9

3.1

130.20

546.07

ng/l

3.40

276

2318

Corneal ulcer

1769

14840

1.24

13.64

4.4

3.8

674.85

457.41

ng/l

0.75

1286

10988

Sensorineural hearing loss

8585

52771

1.10

13.63

4.4

4.0

353.15

515.02

ng/l

3.57

6979

42398

Other and unspecified injuries of abdomen, lower back and pelvis

172

969

2.06

13.62

5.9

3.7

86.05

468.48

ng/l

2.15

120

709

Idiopathic urticaria

211

1252

1.89

13.61

4.0

3.4

759.56

361.07

ng/l

0.27

127

792

Burns and corrosions of external body surface, specified by site

998

7891

1.33

13.60

4.2

3.7

246.95

618.57

ng/l

1.83

696

5746

Oesophageal obstruction

381

2616

1.62

13.60

4.6

4.1

1153.70

784.27

ng/l

0.19

325

2215

Ehlers-Danlos syndrome

103

482

2.53

13.57

2.7

991.41

150.92

ng/l

0.89

230

Tobacco use

515

3717

1.50

13.55

4.9

3.6

749.56

493.14

ng/l

0.47

406

2695

Viral meningitis

321

2111

1.66

13.52

3.7

3.5

152.48

476.25

ng/l

2.01

206

1404

271

1740

1.79

13.49

7.5

4.3

137.33

336.99

ng/l

2.31

237

1514

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

387

2564

1.56

13.48

4.4

2.9

409.12

763.28

ng/l

1.27

212

1347

Abrasion of teeth

3599

31875

1.16

13.47

3.6

3.7

352.57

410.33

ng/l

0.29

2603

23514

Injuries involving multiple body regions

367

2491

1.61

13.45

4.7

3.8

159.56

477.81

ng/l

2.77

277

1808

Other retinal artery occlusion

266

1702

1.79

13.41

5.3

4.4

643.38

370.62

ng/l

0.61

227

1462

Hidradenitis suppurativa

328

2166

1.64

13.41

4.1

3.2

600.94

491.29

ng/l

0.12

184

1324

Hyperhidrosis

265

1660

1.73

13.40

4.0

2.8

180.23

589.18

ng/l

2.60

172

1126

Arthropathies in other diseases classified elsewhere

358

2426

1.63

13.38

6.0

3.7

675.88

535.07

ng/l

0.20

297

1861

Glaucoma

6427

49855

1.12

13.37

4.4

4.2

429.88

433.09

ng/l

0.02

5382

41234

Acute peritonitis

637

4776

1.44

13.37

5.6

4.2

651.24

443.91

ng/l

0.51

549

3925

Acute suppurative otitis media

2090

16522

1.21

13.34

3.8

3.2

405.20

500.97

ng/l

0.32

1180

9723

Contact with sharp object, undetermined intent

247

1540

1.80

13.34

5.5

3.7

211.45

646.18

ng/l

2.42

185

1084

Glomerulonephritis

932

7346

1.34

13.34

5.5

4.0

546.02

582.00

ng/l

0.05

784

5759

Abnormal findings in secretions and smears from cervix uteri vagina vulva

4310

28276

1.14

13.33

3.3

3.2

191.58

273.51

ng/l

1.11

2514

17359

Other problems related to primary support group, including family circumstances

859

6466

1.35

13.32

4.4

3.3

389.69

488.16

ng/l

0.54

516

3826

Crohn disease

1158

9329

1.30

13.32

4.0

3.6

226.29

441.17

ng/l

1.32

762

6571

Nail disorders

798

6160

1.37

13.30

4.9

3.7

511.27

445.65

ng/l

0.15

614

4546

Cerebral aneurysm, nonruptured

830

6451

1.37

13.30

4.5

3.8

361.03

545.65

ng/l

0.49

643

5002

Acquired absence of limb

126

654

2.37

13.26

8.3

3.7

212.24

318.37

ng/l

0.43

102

530

Injury of muscle and tendon at wrist and hand level

1287

10510

1.28

13.26

4.0

3.9

425.50

610.41

ng/l

0.53

955

8068

Disorders of orbit

420

2939

1.56

13.24

4.4

3.7

326.93

449.11

ng/l

0.43

325

2157

Contact with heat and hot substances

500

3600

1.49

13.23

4.0

3.8

381.59

497.10

ng/l

0.37

363

2622

Persistent delusional disorders

750

5760

1.39

13.21

4.7

4.0

215.98

405.56

ng/l

1.85

565

4516

Tumor necrosis factor alpha inhibitors

1365

11187

1.27

13.21

3.5

366.40

454.02

ng/l

0.52

882

7353

Malignant neoplasm of mesothelium and soft tissue

431

3047

1.56

13.20

4.1

4.2

157.31

448.83

ng/l

3.76

366

2561

Acute myeloid leukaemia and myelodysplastic syndromes

271

1747

1.77

13.15

4.6

66.55

441.23

ng/l

6.24

233

1504

Mental retardation

337

2231

1.63

13.10

3.9

3.8

309.45

660.19

ng/l

2.23

229

1525

Orthopaedic devices associated with adverse incidents

1352

0.35

13.08

3.9

4.4

28.80

381.44

ng/l

6.07

1153

Erectile dysfunction

822

6428

1.38

13.06

6.7

4.5

1200.25

637.58

ng/l

0.49

733

5721

Pneumonia due to Streptococcus pneumoniae

401

2785

1.56

13.03

5.7

3.5

660.16

504.04

ng/l

0.30

326

2149

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

3828

29473

1.15

12.99

3.3

3.2

284.63

261.48

ng/l

0.20

2336

18115

Atrioventricular septal defect

224

3.67

12.98

6.2

3.5

591.60

133.01

ng/l

0.94

147

Other disorders of pigmentation

462

3308

1.52

12.97

4.7

3.8

212.13

398.23

ng/l

1.48

367

2597

Type 1 diabetes, wide definition, subgroup 2

1021

0.27

12.93

7.9

4.2

387.03

333.52

ng/l

0.08

871

Postviral fatigue syndrome

380

2.68

12.92

3.3

2.8

106.72

249.86

ng/l

0.83

193

Mental retardation, wide definition

360

2426

1.59

12.90

3.9

3.8

288.68

660.37

ng/l

2.75

247

1687

Colon adenocarcinoma

1321

10884

1.28

12.86

4.0

4.5

437.12

464.06

ng/l

0.05

1146

9412

Abnormal findings in nipple discharge synovial fluid wound secretions

168

962

2.05

12.84

4.7

3.8

243.60

388.36

ng/l

0.49

139

705

Injury of muscle and tendon at lower leg level

1439

11931

1.26

12.75

4.2

3.9

353.22

578.20

ng/l

1.30

1127

9264

Adalimumab

846

6602

1.34

12.70

3.6

3.4

363.95

483.34

ng/l

0.51

552

4356

Monoplegia

173

1003

2.02

12.70

6.8

3.8

285.40

312.96

ng/l

0.05

137

770

Contusion of ankle

365

2494

1.58

12.69

4.8

3.5

118.63

513.92

ng/l

5.03

244

1720

Implicit parasitic Sepsis

293

3.20

12.64

4.4

3.5

470.26

392.39

ng/l

0.10

221

Patent foramen ovale

215

1315

1.84

12.60

4.1

3.8

884.96

605.80

ng/l

0.68

154

936

Assault by unspecified means

193

1141

1.89

12.58

4.9

3.4

188.95

747.86

ng/l

2.35

123

738

Atopic dermatitis, strict definition with reimbursement

2545

21182

1.18

12.57

3.6

3.2

324.39

470.20

ng/l

0.92

1583

12981

Viral warts, including avohilmo

1989

16954

1.21

12.57

3.9

3.6

237.09

466.38

ng/l

2.38

1391

11865

Type of accident

2924

25671

1.17

12.56

4.9

3.9

210.71

466.96

ng/l

5.84

2179

19435

Acute generalized exanthematous pustulosis

432

3073

1.53

12.50

4.9

3.9

116.42

404.86

ng/l

4.52

313

2319

Lymphoid leukaemia

567

4232

1.46

12.50

4.3

277.72

685.06

ng/l

1.12

486

3566

Gingival hyperplasia

357

2454

1.60

12.50

5.4

3.9

315.40

452.25

ng/l

0.69

293

1852

Medial epicondylitis

350

2386

1.59

12.47

4.0

3.4

120.61

527.88

ng/l

4.16

247

1738

Inflammatory disorders of breast

519

3781

1.45

12.46

3.2

194.23

333.25

ng/l

0.93

289

2219

Other (seronegative) rheumatoid arthritis, wide

1895

16160

1.22

12.44

4.7

4.0

374.44

398.41

ng/l

0.06

1530

12830

Other and specified injuries of hip and thigh

252

1616

1.76

12.42

4.9

4.2

57.21

309.87

ng/l

5.01

200

1305

545

7291

0.71

12.41

4.7

4.3

237.73

623.51

ng/l

1.99

482

6216

Systemic sclerosis

253

1625

1.76

12.41

5.2

3.8

218.74

309.04

ng/l

0.50

202

1207

Other follicular disorders

665

5047

1.39

12.40

4.2

3.5

405.82

452.28

ng/l

0.11

433

3431

Embedded teeth, including avohilmo

670

5064

1.38

12.36

3.5

3.1

459.09

432.85

ng/l

0.06

387

2778

Excessive attrition of teeth

6119

55347

1.11

12.35

3.8

3.6

350.35

491.27

ng/l

2.01

4197

39185

Disorders of optic nerve and visual pathways

850

6677

1.34

12.34

4.1

3.7

439.46

571.25

ng/l

0.29

586

4810

Emotional disorders and disorders of social functioning with onset specific to childhood

321

2079

1.59

12.33

4.5

2.6

266.11

845.43

ng/l

2.02

137

877

Other and unspecified intracranial injuries

313

2101

1.65

12.33

5.2

4.0

151.08

509.26

ng/l

3.56

237

1669

Malignant neoplasm of head and neck, including Hilmo

994

7974

1.32

12.32

4.5

4.3

381.01

517.08

ng/l

0.73

869

6741

Lower leg

418

2.72

12.30

3.7

3.8

101.75

195.39

ng/l

0.46

317

Transient global amnesia

940

7521

1.33

12.30

4.4

4.2

141.60

470.29

ng/l

1.81

771

6329

Congenital mitral valve regurgitation

6.38

12.25

9.1

3.9

2133.20

396.06

ng/l

1.23

Sequelae of intentional self-harm, assault and events of undetermined intent

369

2.76

12.25

4.6

2.8

154.22

206.43

ng/l

0.14

226

Left hemicolectomy

253

1638

1.77

12.24

5.0

4.4

298.35

334.53

ng/l

0.09

218

1391

Generalized epilepsy

360

2473

1.57

12.22

4.2

3.5

200.85

519.10

ng/l

2.39

239

1630

Nonspecific lymphadenitis

534

3938

1.45

12.19

3.9

3.5

402.03

446.55

ng/l

0.09

373

2721

Infarction of spleen

445

2.74

12.19

6.5

4.1

387.19

333.15

ng/l

0.12

365

Hypocalcemia

250

1611

1.76

12.16

6.4

4.0

200.79

382.22

ng/l

1.57

208

1235

Hypertrophy of breast

1447

12036

1.25

12.13

3.2

3.3

67.93

295.96

ng/l

10.05

892

7784

Ulcer of vagina/vulva

267

1733

1.70

12.12

3.8

3.6

69.23

366.22

ng/l

3.96

184

1171

Motor disorders, excluding more controls

103

462

2.31

12.12

5.6

2.9

778.92

1429.49

ng/l

0.85

257

Other disorders of male genital organs

382

2668

1.55

12.11

4.3

3.9

301.96

624.84

ng/l

2.04

287

2139

Other abnormal products of conception

2314

13035

1.19

12.10

2.6

2.8

209.69

296.60

ng/l

0.43

1071

6568

Extreme obesity with alveolar hypoventilation

414

2950

1.54

12.10

6.4

3.8

178.71

403.71

ng/l

2.13

355

2312

Myeloid leukaemia

288

1918

1.69

12.09

5.3

4.3

112.87

384.30

ng/l

3.83

243

1583

Other condition

1366

11327

1.26

12.09

4.7

3.8

221.06

508.54

ng/l

2.29

1002

8418

Malignant neoplasm of breast, including Hilmo

4085

23407

1.14

12.09

3.6

148.04

291.29

ng/l

5.94

3131

16323

Malignant neoplasm of breast, HER2-negative, including Hilmo

4085

23410

1.14

12.09

3.6

148.04

291.26

ng/l

5.94

3131

16325

Myositis

262

1703

1.72

12.04

5.6

3.7

219.32

486.93

ng/l

2.33

215

1379

Pregnancy with abortive outcome

6267

29793

1.11

11.99

3.5

3.6

222.18

242.56

ng/l

0.20

4158

20456

Other bursitis of elbow

113

587

2.39

11.98

6.1

3.9

260.58

516.68

ng/l

0.48

102

503

Other diseases of spinal cord

296

1977

1.66

11.96

4.5

3.7

124.88

471.97

ng/l

3.09

217

1531

Atopic dermatitis, strict definition

2399

20323

1.18

11.91

3.6

3.3

316.71

473.18

ng/l

0.95

1485

12200

Lesion of radial nerve

372

2601

1.56

11.91

4.6

3.8

141.37

509.28

ng/l

5.11

294

2029

Mucosal proctocolitis

1129

9187

1.28

11.90

3.6

566.19

554.31

ng/l

0.02

796

6461

Postzoster neuralgia

196

1205

1.91

11.86

7.0

4.3

669.27

320.94

ng/l

0.59

173

1022

Bacterial, viral and other infectious agents, including avohilmo

820

6446

1.34

11.85

4.4

3.7

376.80

462.96

ng/l

0.44

597

4642

Other disorders of the genitourinary system

1265

10470

1.27

11.83

4.4

4.0

316.18

272.85

ng/l

0.16

989

8382

Intussusception

226

1426

1.79

11.82

4.0

3.5

41.92

512.18

ng/l

6.30

157

1078

Other abnormal findings in urine

185

1118

1.93

11.82

4.8

4.2

414.93

346.59

ng/l

0.17

154

927

Malignant neoplasm of other connective and soft tissue, including Hilmo

427

3072

1.52

11.81

3.7

4.1

177.02

496.53

ng/l

3.53

357

2518

Adrenocortical insufficiency

352

2441

1.58

11.77

7.5

3.9

145.72

366.86

ng/l

2.40

265

1838

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

328

2233

1.59

11.76

5.4

3.4

1186.33

478.38

ng/l

1.28

261

1432

Pedal cyclist injured in other and unspecified transport accidents

1054

8539

1.29

11.75

3.8

3.7

231.60

558.82

ng/l

1.65

775

6288

Abnormal findings on examination of urine, without diagnosis

426

3060

1.51

11.75

5.2

4.0

366.45

433.71

ng/l

0.28

353

2393

Psoriatic arthropathies

926

7392

1.31

11.73

3.9

3.7

339.02

650.34

ng/l

1.20

666

5540

Primary biliary cholangitis, wide definition

242

1558

1.75

11.73

4.3

3.5

292.73

302.21

ng/l

0.03

191

1185

Non-allergic asthma

799

6272

1.35

11.73

4.1

3.9

467.11

448.84

ng/l

0.05

625

4865

Malignant neoplasm of bladder

706

5461

1.37

11.72

4.7

232.90

541.13

ng/l

2.87

627

4895

Benign neoplasm: Parathyroid gland

136

759

2.19

11.71

4.7

4.2

105.05

340.82

ng/l

1.54

611

Malignant neoplasm of head and neck

829

6559

1.34

11.66

4.4

4.3

387.92

518.31

ng/l

0.59

728

5559

Malignant neoplasm of oral cavity, including Hilmo

457

3333

1.49

11.64

4.4

4.2

362.93

462.37

ng/l

0.34

401

2767

Psoriatic and enteropathic arthropathies

1072

8706

1.29

11.62

4.0

3.6

301.59

602.34

ng/l

1.40

760

6425

Open wound of shoulder and upper arm

207

1281

1.82

11.62

5.2

3.8

84.18

444.62

ng/l

3.43

155

947

Isolated patent ductus arteriosus

452

2.42

11.61

6.1

3.6

1166.47

952.08

ng/l

0.23

264

Temporal arteritis

402

2888

1.55

11.58

6.2

4.1

83.52

362.66

ng/l

7.32

350

2478

Ulcerative proctitis

549

4099

1.42

11.56

3.7

3.6

540.95

466.60

ng/l

0.13

359

2854

Giant cell arteritis with polymyalgia rheumatica

402

2889

1.55

11.55

6.2

4.2

83.52

365.15

ng/l

7.49

350

2481

Seropositive rheumatoid arthritis, wide

2685

23615

1.17

11.55

4.5

4.0

349.36

387.11

ng/l

0.17

2237

18758

Benign neoplasm: Kidney

371

2621

1.57

11.54

4.7

4.0

143.15

364.80

ng/l

3.10

305

2114

Other salmonella infections, including avohilmo

400

2842

1.52

11.51

4.5

3.6

206.18

456.25

ng/l

2.32

297

2122

Vitamin deficiency, wide

469

3430

1.47

11.50

5.0

3.9

135.44

411.72

ng/l

5.33

363

2646

Vitamin deficiency

469

3430

1.47

11.50

5.0

3.9

135.44

411.72

ng/l

5.33

363

2646

Right hemicolectomy

601

4584

1.42

11.49

4.6

4.4

389.54

585.61

ng/l

0.39

510

3921

Contact with other sharp object(s)

580

4363

1.40

11.47

3.6

3.4

295.40

475.90

ng/l

1.08

381

2910

Systemic sclerosis, icd10

247

1609

1.73

11.43

5.2

3.9

225.17

312.20

ng/l

0.46

196

1196

Toxic liver disease

169

1004

1.95

11.38

5.7

3.9

258.75

445.17

ng/l

0.59

133

752

Cystic kidney disease, including avohilmo

333

2303

1.59

11.36

4.0

3.9

537.67

474.99

ng/l

0.15

282

1757

Acute myeloid leukaemia

155

904

2.03

11.32

4.5

4.4

65.92

359.66

ng/l

2.83

127

761

Acute myeloid leukaemia, helper endpoint

155

904

2.03

11.32

4.5

4.4

65.92

359.66

ng/l

2.83

127

761

Acute myeloid leukaemia, including Hilmo

155

904

2.03

11.32

4.5

4.4

65.92

359.66

ng/l

2.83

127

761

Pregnancy hypertension

3348

26588

1.15

11.31

3.2

307.61

270.24

ng/l

0.30

1993

15838

Other Crohn's disease

591

4470

1.40

11.31

3.8

3.5

326.26

442.90

ng/l

0.25

393

3042

Diabetic neuropathy

1157

9511

1.28

11.31

5.9

5.0

484.75

604.20

ng/l

0.58

996

8003

Ankylosing spondylitis

756

5911

1.34

11.29

4.0

3.5

428.37

696.11

ng/l

0.57

539

4463

Other congenital malformations of the digestive system, including avohilmo

443

3185

1.48

11.28

4.3

3.8

451.88

516.34

ng/l

0.22

318

2271

Other and unspecified injuries of shoulder and upper arm

321

2204

1.59

11.27

5.3

3.9

309.83

569.31

ng/l

1.11

237

1650

Other infestations, including avohilmo

202

1265

1.85

11.26

3.7

4.1

141.86

429.99

ng/l

1.96

156

1005

Urethritis and urethral syndrome

213

1336

1.77

11.23

5.3

3.7

424.28

512.63

ng/l

0.13

157

1014

Other and unspecified vaccines and biological substances

358

2.72

11.22

4.8

2.9

184.43

260.06

ng/l

0.21

232

Volvulus

290

1958

1.64

11.21

4.9

3.9

212.39

434.93

ng/l

1.22

233

1631

Hallux rigidus

1357

11345

1.25

11.20

3.9

3.8

490.75

527.96

ng/l

0.07

1082

9149

Marginal zone B-cell lymphoma, including Hilmo

186

1145

1.90

11.20

3.8

4.4

225.59

490.74

ng/l

0.85

151

946

Macular hole

620

4779

1.41

11.19

4.4

4.2

350.32

568.60

ng/l

0.53

542

4060

Nontoxic multinodular goitre

1976

17060

1.20

11.18

4.2

3.9

101.96

348.56

ng/l

4.17

1538

13656

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2608

22950

1.17

11.16

4.5

4.0

346.14

389.55

ng/l

0.19

2170

18202

Other and unspecified erythematous conditions

327

2265

1.59

11.16

5.1

3.9

193.34

360.87

ng/l

0.96

257

1753

Hypothyroidism due to medicaments and other exogenous substances

142

811

2.08

11.16

5.9

3.7

76.27

308.15

ng/l

1.83

117

623

Laparoscopic right hemicolectomy

613

4723

1.41

11.16

4.1

4.3

632.62

570.36

ng/l

0.05

529

4058

Assault by blunt object

148

845

2.00

11.15

5.0

3.5

232.30

737.90

ng/l

1.39

105

563

Benign neoplasm: Liver/bile ducts

255

1674

1.69

11.14

3.6

3.7

1135.64

300.43

ng/l

0.45

177

1177

Benign neoplasm: Tongue

286

1935

1.65

11.13

4.0

4.1

289.76

431.46

ng/l

0.43

221

1529

Nonpyogenic thrombosis of intracranial venous system

113

599

2.27

11.13

5.6

3.6

337.36

412.51

ng/l

0.11

434

Other noninfective disorders of lymphatic vessels and lymph nodes

363

2563

1.55

11.08

3.9

3.8

191.48

384.85

ng/l

1.50

269

1943

Benign neoplasm: Liver

228

1462

1.73

11.05

3.6

1261.88

295.56

ng/l

0.48

159

1012

Diabetic maculopathy, excluding more controls

1032

8405

1.29

11.05

5.3

3.8

902.06

519.61

ng/l

1.11

873

6610

Use of biperiden

487

3610

1.45

11.03

4.6

3.8

143.07

409.70

ng/l

2.93

367

2787

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

137

769

2.05

11.00

5.0

3.8

81.84

576.90

ng/l

2.18

518

Endometriosis ASRM stages 1,2

1377

11500

1.24

11.00

3.4

3.2

188.34

262.32

ng/l

0.67

727

6971

Other and unspecified psoriasis

661

5125

1.38

10.99

4.4

3.9

647.43

636.10

ng/l

0.01

527

4041

Magnesium deficiency

231

3.60

10.97

9.6

3.6

67.26

252.70

ng/l

0.93

192

Dermatitis due to substances taken internally

511

3814

1.43

10.94

4.9

3.7

220.40

456.81

ng/l

2.06

364

2857

Other keratitis

1038

8460

1.28

10.91

4.2

3.7

403.89

530.50

ng/l

0.34

734

6129

Other/unspecified seropositive rheumatoid arthritis

2646

23342

1.17

10.90

4.5

4.0

345.95

385.83

ng/l

0.18

2206

18542

Cystic kidney disease

306

2100

1.60

10.89

4.0

3.9

567.57

489.51

ng/l

0.17

259

1599

Carcinoma in situ of skin of lower limb, including hip

261

1759

1.71

10.85

4.9

4.5

179.36

312.80

ng/l

1.04

241

1551

L04AC Interleukin inhibitors

566

4286

1.40

10.84

3.6

3.5

268.17

497.53

ng/l

2.05

368

2901

Open wound of thorax

163

969

1.93

10.83

4.8

3.7

148.04

612.83

ng/l

2.42

117

739

Other disorders of cornea

955

7744

1.30

10.81

4.4

3.9

210.76

530.15

ng/l

1.74

766

6034

Macular cyst

339

2394

1.58

10.76

4.3

4.2

447.78

392.12

ng/l

0.13

302

2023

Postpartum haemorrhage due to anatomy

380

5328

0.69

10.76

2.6

2.5

143.09

231.31

ng/l

0.43

166

2040

Residual foreign body in soft tissue

461

3390

1.45

10.73

3.8

3.4

349.77

909.38

ng/l

1.03

328

2530

Diabetes mellitus in pregnancy

2208

12111

1.18

10.72

2.9

2.7

427.82

261.69

ng/l

0.82

966

5532

Malignant neoplasm of brain

337

2359

1.56

10.71

3.0

4.0

55.70

597.65

ng/l

8.44

249

1819

Toxic effect of ethanol

343

2399

1.54

10.71

5.1

3.6

618.45

575.52

ng/l

0.04

231

1653

Haemangioma, any site

792

6293

1.33

10.68

4.0

3.8

356.11

427.61

ng/l

0.20

561

4683

Polycystic kidney disease

252

1671

1.68

10.64

4.1

4.0

595.62

516.13

ng/l

0.15

220

1261

Tongue abnormality

601

4632

1.39

10.60

4.5

3.9

252.81

406.32

ng/l

1.00

457

3683

Other immunodeficiencies

118

642

2.16

10.60

3.8

3.5

365.34

534.58

ng/l

0.25

446

Abscess of lung

172

1048

1.89

10.58

5.0

4.1

244.70

466.81

ng/l

1.00

143

858

Complications of genitourinary prosthetic devices, implants and grafts

255

1697

1.66

10.55

5.1

3.6

155.22

421.91

ng/l

2.25

191

1276

Lichen planus

1293

10842

1.25

10.53

4.3

3.9

393.42

457.23

ng/l

0.18

960

8656

Primary biliary cholangitis (PBC)

226

1470

1.73

10.52

4.4

3.5

220.81

282.06

ng/l

0.32

177

1130

Malignant neoplasm of endocrine gland, including Hilmo

755

5973

1.33

10.52

4.2

3.8

130.55

421.81

ng/l

4.75

565

4450

Other benign neoplasms of connective and other soft tissue

913

7386

1.30

10.52

3.8

3.9

344.44

563.16

ng/l

0.71

653

5628

Malignant neoplasm of breast

3994

23201

1.13

10.50

3.6

151.23

288.84

ng/l

5.42

3079

16231

Other injuries of upper limb, level unspecified

137

784

2.03

10.49

6.1

3.8

222.54

414.04

ng/l

0.38

100

586

Congenital malformations of the musculoskeletal system, not elsewhere classified

140

799

1.98

10.48

2.7

3.0

742.78

228.35

ng/l

0.87

456

Sicca syndrome [Sjögren]

794

6333

1.33

10.47

4.5

3.8

162.26

309.07

ng/l

2.19

609

4776

Complications predominantly related to the puerperium

1975

17057

1.19

10.45

3.1

240.41

276.76

ng/l

0.27

1070

9970

Vestibular neuronitis

848

6821

1.31

10.42

4.2

3.9

377.04

419.41

ng/l

0.15

650

5401

Etanercept

565

4304

1.39

10.41

3.7

3.5

321.86

482.91

ng/l

0.85

395

2911

Vasculitis limited to skin, not elsewhere classified

269

1821

1.64

10.41

5.2

4.1

219.48

345.26

ng/l

0.58

217

1451

Benign neoplasm: Transverse colon

1123

9325

1.27

10.39

5.2

4.2

312.56

477.99

ng/l

0.70

962

7854

Malignant neoplasm of breast, HER2-negative

3988

23186

1.13

10.37

3.5

3.6

151.47

288.94

ng/l

5.40

3073

16225

Somnolence

133

755

2.03

10.36

5.4

3.7

135.17

272.21

ng/l

0.81

543

Lesion of plantar nerve

575

4415

1.39

10.35

4.2

3.7

228.92

324.63

ng/l

0.25

448

3429

Injury of blood vessels at neck level

272

3.09

10.34

3.3

3.2

934.16

406.59

ng/l

0.25

195

Burns and corrosions of multiple and unspecified body regions

218

1407

1.72

10.30

4.3

3.8

220.93

619.81

ng/l

2.28

168

1045

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1278

10718

1.24

10.27

4.3

3.9

142.00

496.72

ng/l

3.09

932

8201

Foreign body entering into or through eye or natural orifice

723

5706

1.34

10.26

5.0

3.8

510.88

520.80

ng/l

0.02

546

4282

Other/unspecified rheumatoid arthritis

1216

10166

1.25

10.25

5.1

4.1

506.64

407.98

ng/l

0.19

1018

8310

Early lumbar disc prolapse operation

830

6631

1.30

10.22

3.4

3.3

286.53

506.49

ng/l

0.80

467

3975

Scleritis and episcleritis

549

4182

1.39

10.22

3.9

3.5

169.99

415.38

ng/l

1.63

369

2907

Nummular dermatitis

830

6677

1.31

10.21

4.7

4.0

320.06

614.76

ng/l

1.12

658

5388

Benign neoplasm of urinary organs

476

3572

1.44

10.19

4.7

4.1

154.41

363.43

ng/l

3.51

397

2930

L01XX Other antineoplastic agents

597

4634

1.39

10.17

4.4

4.3

529.90

574.03

ng/l

0.04

510

3954

Chromosomal abnormalities, not elsewhere classified

171

1033

1.82

10.16

3.8

3.5

511.83

781.77

ng/l

0.63

118

618

Essential (haemorrhagic) thrombocythaemia

384

2790

1.51

10.16

4.2

848.41

466.65

ng/l

0.26

313

2271

Migraine, unspecified, drug-induced

417

2.50

10.08

3.9

3.5

32.07

143.81

ng/l

1.67

289

Other congenital malformations, not elsewhere classified

432

2.38

10.06

4.9

3.5

621.47

378.05

ng/l

0.41

273

Ingrowing nail

486

3653

1.42

9.95

5.2

3.7

515.49

507.06

ng/l

0.01

370

2688

Burn and corrosion of trunk

282

1937

1.59

9.95

4.8

4.0

241.79

482.65

ng/l

1.32

202

1464

Other injuries of lower limb, level unspecified

114

630

2.15

9.94

5.2

3.9

148.60

330.31

ng/l

0.94

470

Contracture of joint

135

780

1.99

9.94

4.4

3.9

161.90

444.15

ng/l

1.74

101

585

Urethral stricture

570

4397

1.39

9.93

4.7

4.2

273.78

760.42

ng/l

1.72

496

3837

Malignant neoplasm of oral cavity

352

2530

1.52

9.91

4.3

373.75

484.72

ng/l

0.31

315

2113

Meningitis

446

3315

1.44

9.90

3.9

3.8

169.36

464.98

ng/l

3.21

307

2472

Injury of nerves at wrist and hand level

346

2467

1.51

9.88

4.5

3.6

665.11

577.49

ng/l

0.13

258

1808

Mitochondrial myopathy

231

3.13

9.87

4.1

3.3

250.47

115.85

ng/l

0.35

156

Chronic hepatitis, not elsewhere classified

329

2334

1.54

9.85

3.7

170.98

425.68

ng/l

2.90

248

1741

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

321

2263

1.54

9.85

4.5

3.7

416.13

499.47

ng/l

0.12

202

1637

IgA nephropathy (IgA glomerulonephritis)

228

1506

1.68

9.84

5.4

3.8

139.69

661.33

ng/l

3.72

194

1129

Other disorders starting during childhood or adolescence

322

2216

1.51

9.83

4.5

3.0

352.91

739.12

ng/l

1.68

170

1089

Open wound of hip and thigh

299

2076

1.56

9.81

3.8

3.7

140.84

536.67

ng/l

4.00

209

1493

Bitten or struck by other mammals

975

7977

1.27

9.81

3.7

3.5

203.03

426.60

ng/l

3.33

653

5267

Intestinal helminthiases, other/unspecified, including avohilmo

188

3.74

9.80

3.7

3.5

1171.67

246.66

ng/l

0.62

151

Other epidermal thickening

439

3267

1.45

9.79

5.0

3.9

355.72

506.33

ng/l

0.52

329

2551

Dentofacial anomalies [including malocclusion]

6912

50114

1.09

9.76

3.7

3.5

331.85

428.91

ng/l

0.74

4296

34710

Other congenital malformations of skin

342

2436

1.51

9.75

3.8

3.7

262.90

514.20

ng/l

1.51

225

1688

Other erythematous conditions

351

2525

1.51

9.75

5.0

3.9

182.52

373.72

ng/l

1.25

273

1951

Haemangioma and lymphangioma, any site

833

6729

1.30

9.74

4.0

3.8

338.40

435.06

ng/l

0.31

593

5005

Disturbances of smell and taste

381

2771

1.48

9.73

5.1

3.5

183.16

459.79

ng/l

2.68

284

2098

Other acquired deformities of musculoskeletal system and connective tissue

426

3162

1.45

9.69

5.0

3.9

381.37

462.72

ng/l

0.23

327

2438

Other specified and unspecified disorders of eyelid

156

950

1.89

9.68

4.3

4.1

93.55

456.58

ng/l

2.75

124

759

Syphilis, including avohilmo

253

1715

1.63

9.66

4.5

3.9

641.92

623.39

ng/l

0.01

207

1330

Syphilis

253

1715

1.63

9.66

4.5

3.9

641.92

623.39

ng/l

0.01

207

1330

Other and unspecified mononeuropathies of upper limb

282

1949

1.58

9.64

4.4

3.7

270.30

507.53

ng/l

0.86

221

1474

Malignant neoplasm of thyroid gland, including Hilmo

669

5276

1.34

9.63

4.1

3.8

89.61

415.39

ng/l

7.66

496

3894

Pre-eclampsia or eclampsia

1663

14282

1.20

9.61

3.3

3.2

366.41

254.35

ng/l

0.73

1021

8696

Intracranial and intraspinal abscess and granuloma

133

780

2.01

9.58

4.3

4.1

457.86

357.86

ng/l

0.16

107

634

Anorexia (incl.atypical)

424

3114

1.43

9.58

3.7

3.2

173.78

485.85

ng/l

1.78

231

1825

Vulvovaginal ulceration/inflammation in other diseases

515

3904

1.38

9.56

3.5

3.1

73.11

323.00

ng/l

3.48

254

2268

Disorders of oesophagus in diseases classified elsewhere

223

1481

1.69

9.55

6.3

4.0

359.87

394.67

ng/l

0.11

189

1222

Other congenital malformations of the digestive system

371

2668

1.48

9.53

4.4

3.8

418.76

519.97

ng/l

0.35

266

1891

Carcinoma in situ of other and unspecified digestive organs

454

3428

1.44

9.53

4.3

4.1

505.63

655.51

ng/l

0.21

393

2850

Hypertrophic disorders of skin

479

3609

1.40

9.50

4.3

3.5

311.90

477.80

ng/l

0.96

317

2399

Other acute viral hepatitis

131

761

1.98

9.50

4.2

3.7

111.99

456.59

ng/l

1.93

532

Generalized skin eruption due to drugs and medicaments

364

2642

1.49

9.48

5.0

3.9

134.56

408.41

ng/l

3.29

261

1991

Fasciculation

127

733

2.01

9.47

4.1

3.8

64.15

378.67

ng/l

2.80

515

Evidence of alcohol involvement determined by blood alcohol level

148

889

1.89

9.46

4.7

3.8

28.35

551.75

ng/l

3.60

107

635

Allergic rhinitis

2577

22531

1.15

9.43

3.5

3.4

266.76

466.33

ng/l

1.64

1564

14369

Psoriasis vulgaris

1769

15331

1.19

9.43

4.1

3.9

418.52

506.63

ng/l

0.45

1313

11779

Malignant neoplasm of oesophagus, including Hilmo

369

2698

1.49

9.42

4.0

4.4

156.97

518.94

ng/l

5.02

332

2342

Dermatopolymyositis (FG)

148

894

1.90

9.40

6.5

4.1

209.84

373.21

ng/l

0.86

129

687

Other inflammation of vagina/vulva

292

2026

1.54

9.39

3.8

3.1

177.36

279.28

ng/l

0.40

167

1149

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

533

4070

1.37

9.38

3.0

2.9

339.31

266.96

ng/l

0.19

313

2052

Hypertrophic scar

440

3281

1.42

9.37

4.4

3.5

321.43

456.68

ng/l

0.70

294

2166

Other disorders of prostate

352

2551

1.50

9.36

4.1

4.3

501.99

563.26

ng/l

0.09

330

2276

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

657

5190

1.34

9.36

3.8

4.0

133.14

481.01

ng/l

6.04

522

4138

IBD patients in KELA-register

2025

17693

1.17

9.35

3.5

3.7

446.67

502.66

ng/l

0.19

1352

12471

Other intracranial haemorrhages

332

2388

1.52

9.35

4.9

4.3

142.63

408.40

ng/l

4.31

287

2094

Other predominantly sexually transmitted diseases, not elsewhere classified

1282

10794

1.22

9.32

3.3

3.2

381.07

361.06

ng/l

0.05

708

6285

Necrotizing fasciitis

321

2.67

9.32

6.0

3.8

168.92

429.18

ng/l

0.89

260

Melanocytic naevi of other and unspecified parts of face

532

4092

1.38

9.32

3.5

3.7

221.86

437.57

ng/l

1.03

373

2922

Golimumab

307

2163

1.53

9.31

3.4

104.28

497.65

ng/l

4.04

202

1398

Malignant neoplasm of brain, including Hilmo

466

3523

1.41

9.30

3.4

4.0

83.34

541.69

ng/l

10.88

358

2762

Contact with other hot fluids

272

1876

1.57

9.27

4.1

3.8

475.71

594.94

ng/l

0.21

188

1317

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

658

5217

1.34

9.27

4.4

414.30

445.22

ng/l

0.08

572

4504

Other salmonella infections

335

2406

1.50

9.26

4.9

3.7

220.10

401.81

ng/l

1.45

254

1859

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1526

13036

1.20

9.26

3.2

3.1

360.19

376.45

ng/l

0.05

817

7340

Other puerperal infections

497

3756

1.37

9.25

2.6

2.7

94.80

255.88

ng/l

1.62

196

1625

Injury of nerves and spinal cord at neck level

228

1532

1.66

9.24

5.6

4.0

470.88

520.37

ng/l

0.07

192

1201

Generalized epilepsy, mode (most common among epilepsy diagnosis)

259

1768

1.58

9.24

4.0

3.5

207.00

602.67

ng/l

2.21

174

1173

Seronegative rheumatoid arthritis

1092

9118

1.25

9.19

4.4

3.7

200.04

497.42

ng/l

1.93

864

7117

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

113

644

2.13

9.19

5.0

3.8

247.82

335.46

ng/l

0.22

536

Dystonia

495

3782

1.39

9.17

4.1

3.7

120.52

437.03

ng/l

5.43

331

2810

Prepatellar bursitis

425

3179

1.43

9.13

4.8

3.7

551.99

868.24

ng/l

0.42

346

2579

Other disorders of optic [2nd] nerve and visual pathways

581

4538

1.36

9.12

4.4

3.9

300.31

446.65

ng/l

0.74

433

3436

Exposure to smoke, fire and flames

242

1645

1.62

9.12

4.6

4.0

271.92

551.65

ng/l

1.13

166

1256

Hypothermia

194

1263

1.73

9.12

5.1

4.2

355.25

399.42

ng/l

0.12

165

1047

Sacroiliitis, not elsewhere classified

350

2517

1.46

9.11

3.5

3.0

279.47

500.19

ng/l

0.52

195

1545

Dermatographic urticaria

560

4339

1.36

9.10

3.9

3.4

230.48

365.39

ng/l

0.63

337

2864

Myelodysplastic syndrome, including Hilmo

320

2301

1.53

9.10

5.1

4.7

263.24

428.17

ng/l

1.04

282

2016

Spermatocele

742

5974

1.31

9.09

4.5

4.3

461.88

614.59

ng/l

0.63

624

5198

Follow-up care involving plastic surgery

148

2391

0.58

9.08

4.0

3.1

106.83

390.89

ng/l

2.91

105

1703

Nonsuppurative otitis media

1867

14054

1.18

9.08

3.9

3.4

322.23

486.17

ng/l

0.90

1142

8920

Kela reimbursement Agammaglobulinemia (D80-84)

517

2.21

9.06

6.1

3.2

141.50

265.40

ng/l

0.73

344

Benign neoplasm: Descending colon

719

5790

1.32

9.06

4.9

4.2

291.72

560.00

ng/l

0.83

596

4842

Glaucoma-related operations

593

4675

1.36

9.04

4.2

4.3

245.36

348.15

ng/l

0.56

525

4036

Pre-eclampsia or poor fetal growth

2257

19792

1.16

8.99

3.1

3.0

330.37

256.64

ng/l

0.52

1261

11020

Tularaemia, including avohilmo

194

1264

1.72

8.99

4.8

4.0

359.01

384.38

ng/l

0.05

150

950

Eosinophilia

168

1062

1.80

8.99

6.7

4.0

431.82

392.72

ng/l

0.07

137

817

Complications following infusion, transfusion and therapeutic injection

156

968

1.84

8.96

6.1

3.8

1587.86

381.80

ng/l

0.50

127

740

Other and unspecified injuries of ankle and foot

358

2605

1.46

8.90

3.8

3.5

554.27

476.25

ng/l

0.08

229

1740

Other disorders of Eustachian tube

288

2033

1.54

8.87

4.4

3.9

125.54

387.61

ng/l

2.97

214

1519

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1022

8533

1.25

8.82

3.5

4.4

685.26

521.72

ng/l

0.37

855

7263

Benign neoplasm of middle ear and respiratory system

751

6083

1.30

8.78

4.6

4.0

284.12

564.61

ng/l

1.05

593

4957

Complications of the puerperium, not elsewhere classified

291

2043

1.51

8.72

2.6

2.8

213.32

357.96

ng/l

0.37

133

929

Primary hyperparathyroidism

1088

9155

1.25

8.71

4.2

4.0

364.00

437.23

ng/l

0.19

874

7387

Malignant neoplasm of rectum, including Hilmo

1214

10300

1.23

8.71

3.6

4.4

679.00

533.87

ng/l

0.37

1019

8754

Otorrhagia

485

2.27

8.70

6.7

3.7

150.58

247.63

ng/l

0.50

404

Emotional disorders starting during childhood or adolescence

292

2022

1.49

8.69

4.5

2.8

273.96

908.30

ng/l

2.19

128

863

Malignant neoplasm of eye, brain and central nervous system

413

3101

1.43

8.69

3.4

4.0

148.81

552.37

ng/l

3.52

316

2436

Circumscribed brain atrophy

232

1589

1.63

8.68

4.1

4.4

337.17

323.94

ng/l

0.03

201

1358

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

142

859

1.84

8.68

4.2

3.5

184.59

554.21

ng/l

1.55

105

582

Other and unspecified disorders of adult personality and behaviour

287

2.60

8.65

6.0

2.8

38.63

162.34

ng/l

0.81

175

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

702

5635

1.30

8.63

3.4

144.96

291.17

ng/l

1.57

480

3738

ILD medications: nintedanib

409

2.52

8.60

4.9

3.8

1501.23

519.38

ng/l

1.12

356

Nephrotic syndrome

288

2047

1.53

8.59

5.5

4.1

167.30

437.83

ng/l

3.52

255

1592

Acne

717

5701

1.29

8.59

3.3

2.9

352.17

456.11

ng/l

0.37

354

2833

Other renal tubulo-interstitial diseases

217

1456

1.63

8.58

5.0

3.4

183.57

330.92

ng/l

0.94

171

1034

Other disorders of breast

1164

9824

1.23

8.57

3.7

3.5

140.33

293.30

ng/l

2.58

737

6687

Unspecified threat to breathing

102

568

2.08

8.56

5.6

4.0

479.46

304.72

ng/l

0.28

377

Bullous disorders

569

4484

1.35

8.56

5.3

4.2

179.18

385.67

ng/l

3.14

468

3718

Malignant neoplasm of small intestine, including Hilmo

310

2242

1.52

8.55

4.3

4.2

348.33

484.61

ng/l

0.36

263

1875

Episcleritis

459

3501

1.39

8.54

4.0

3.5

91.76

405.81

ng/l

6.38

307

2415

Anomalies of pupillary function

199

1315

1.67

8.53

4.6

3.7

216.05

421.64

ng/l

0.74

137

902

Assault by other specified means

101

559

2.07

8.52

5.2

3.1

513.68

693.11

ng/l

0.17

345

Bacterial, viral and other infectious agents

740

5987

1.29

8.51

4.5

3.8

380.57

478.84

ng/l

0.48

554

4337

Lichen ruber planus, wide definition including periferal and oral lichen planus

2241

19894

1.16

8.50

4.0

3.9

321.72

413.52

ng/l

0.53

1652

15588

Injury of nerves at lower leg level

106

599

2.05

8.50

4.8

3.6

78.87

396.60

ng/l

2.27

430

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

162

1025

1.77

8.48

3.1

3.8

100.00

673.10

ng/l

3.47

115

755

Benign neoplasm of major salivary glands

925

7682

1.26

8.48

4.5

4.0

613.02

492.23

ng/l

0.23

761

6219

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1381

11854

1.21

8.47

5.7

4.0

299.44

484.52

ng/l

1.19

1104

9450

Subacute thyroiditis

333

2428

1.48

8.46

4.2

3.5

101.71

365.27

ng/l

2.51

215

1716

Nonhereditary hypogammaglobulinemia

115

669

2.00

8.45

5.4

3.6

73.73

258.21

ng/l

1.81

477

Other and unspecified mental retardation

140

843

1.83

8.41

3.7

4.0

542.87

782.42

ng/l

0.50

573

Brain glioblastoma and astrocytoma

185

1213

1.71

8.41

2.9

4.0

51.97

637.43

ng/l

4.87

137

937

Cerebral palsy

138

834

1.83

8.40

4.6

3.2

208.64

562.65

ng/l

1.28

513

Abnormal findings on diagnostic imaging of central nervous system

451

3443

1.39

8.40

4.0

3.5

180.38

415.04

ng/l

2.65

304

2487

Hyperkinetic disorders (excl. ADHD)

146

877

1.78

8.39

3.5

2.9

339.37

1068.67

ng/l

1.71

471

Congenital malformations of gallbladder, bile ducts and liver

109

628

2.05

8.39

4.0

372.01

375.74

ng/l

0.01

475

Perforation of oesophagus

331

2.58

8.37

4.8

3.6

97.22

486.19

ng/l

1.62

271

Drug-induced osteoporosis with pathological fracture

179

1174

1.74

8.36

7.8

4.3

624.16

333.29

ng/l

0.30

155

950

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

179

1172

1.73

8.35

3.7

4.2

91.58

312.54

ng/l

2.50

142

944

Certain zoonotic bacterial diseases

186

1224

1.70

8.34

5.0

4.0

141.07

412.82

ng/l

1.78

148

956

Drug-induced osteoporosis

145

905

1.85

8.33

6.3

4.1

1001.13

420.98

ng/l

0.32

119

712

Superficial injury of neck

178

1149

1.69

8.33

4.9

3.6

176.99

713.74

ng/l

2.58

116

758

Chronic suppurative otitis media

587

4639

1.33

8.32

4.5

4.0

267.58

443.41

ng/l

0.90

452

3549

Other degenerative diseases of the basal ganglia

202

1364

1.69

8.31

4.4

72.43

345.32

ng/l

4.41

175

1187

Heterophoria

662

5297

1.31

8.30

4.4

3.5

268.43

443.16

ng/l

0.97

427

3585

Human immunodeficiency virus [HIV] disease, including avohilmo

177

1149

1.71

8.30

3.1

3.9

94.21

646.95

ng/l

3.88

126

856

Moderate visual impairment, binocular

147

2306

0.59

8.26

4.6

4.4

146.48

299.99

ng/l

1.53

119

2014

Hepatocellular carcinoma, including Hilmo

308

2239

1.51

8.26

4.8

4.4

356.06

463.90

ng/l

0.37

276

1978

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

229

1559

1.58

8.26

3.5

3.1

809.02

481.71

ng/l

0.24

122

976

Other and unspecified injuries of thorax

179

1166

1.70

8.25

5.7

3.8

320.80

526.79

ng/l

0.58

138

896

Malignant neoplasm of endocrine gland

643

5150

1.31

8.20

4.3

3.8

95.45

416.91

ng/l

7.14

480

3790

Adenocarcinoma and papilloma adenocarcinoma of rectum

975

8163

1.25

8.20

3.5

4.4

695.50

507.09

ng/l

0.43

821

6945

Other otitis externa (chronic)

620

4949

1.32

8.20

4.1

3.8

377.39

468.40

ng/l

0.27

449

3711

Diabetic retinopathy

3570

20168

1.13

8.18

5.8

4.8

638.24

474.39

ng/l

0.99

3108

16500

Combined immunodeficiencies

116

685

1.98

8.18

4.7

3.6

177.13

377.61

ng/l

0.69

535

Perforation of tympanic membrane

909

7554

1.26

8.13

4.4

3.9

273.38

545.05

ng/l

1.20

699

5828

Human immunodeficiency virus [HIV] disease resulting in other conditions

160

1020

1.75

8.13

3.1

3.8

100.84

676.63

ng/l

3.46

114

751

Inflammatory bowel disease, strict (require KELA)

2025

17874

1.16

8.11

3.5

3.7

446.67

492.92

ng/l

0.15

1352

12592

Unspecified abortion

387

2898

1.41

8.09

3.1

103.85

376.29

ng/l

2.01

222

1768

Convalescence

457

3511

1.38

8.07

5.6

3.3

278.81

410.29

ng/l

0.74

329

2593

Chronic conjunctivitis

273

1943

1.52

8.03

4.1

3.7

939.85

512.11

ng/l

0.23

203

1420

Malignant neoplasm of gum, including Hilmo

113

669

2.00

8.02

4.2

4.4

233.36

293.79

ng/l

0.18

101

566

Hyperosmolality and hypernatraemia

140

868

1.82

8.01

6.0

3.7

142.25

384.79

ng/l

1.70

117

724

Foreign body or object entering through skin

543

4273

1.34

8.00

4.6

3.7

264.25

512.96

ng/l

2.28

395

3127

Toxic effect of contact with venomous animals

373

2794

1.43

8.00

4.3

3.8

237.05

502.95

ng/l

1.86

248

2073

Lichen planus, including avohilmo

1884

16617

1.17

7.99

4.1

4.0

350.08

426.36

ng/l

0.34

1405

13111

Other lack of coordination

176

1157

1.71

7.99

4.5

4.0

258.46

433.23

ng/l

0.49

137

944

Hyposplenism

106

4.60

7.98

4.6

3.1

21.53

438.29

ng/l

0.79

Other/unspecified postprocedural disorders of ear and mastoid process

202

3.27

7.98

5.6

3.7

28.07

267.82

ng/l

2.18

173

Malignant neoplasm of heart, mediastinum and pleura

149

946

1.80

7.96

5.3

4.2

153.96

361.69

ng/l

1.49

128

799

Late syphilis

143

898

1.82

7.95

5.3

4.0

313.49

506.12

ng/l

0.48

122

712

Use of levodopa decarboxylase inhibitor

1441

12506

1.20

7.92

4.7

4.5

184.91

463.92

ng/l

2.81

1252

10995

Cholangitis (primary sclerosing, PSC), with reimbursement 202

176

1154

1.69

7.91

4.3

3.9

67.05

418.91

ng/l

4.06

133

826

Mild or no visual impairment, binocular

274

2.62

7.90

4.9

3.9

256.64

251.03

ng/l

0.01

198

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

195

1313

1.66

7.90

5.1

4.4

152.07

428.32

ng/l

2.51

172

1116

Spinal osteochondrosis

107

618

1.97

7.89

5.1

3.3

769.83

653.78

ng/l

0.07

454

Other specified and unspecified disorders of conjunctiva

114

677

1.96

7.88

5.7

3.8

905.38

271.07

ng/l

0.46

518

Seborrhoeic dermatitis

942

7884

1.25

7.86

4.7

3.9

466.65

572.84

ng/l

0.15

716

6217

Viral conjunctivitis, including avohilmo

334

2463

1.44

7.82

3.7

3.4

109.00

471.79

ng/l

4.14

224

1656

Other and unspecified acquired haemolytic anaemias

109

643

2.00

7.81

7.2

3.9

244.49

317.86

ng/l

0.21

508

Primary ovarian failure

158

1007

1.71

7.81

3.3

2.8

29.33

164.72

ng/l

3.01

103

532

Benign neoplasm: salivary glands, exclude unknown (D119)

820

6790

1.27

7.80

4.3

4.0

666.09

529.54

ng/l

0.23

668

5454

Cushing syndrome

119

715

1.91

7.80

4.6

3.6

351.75

261.76

ng/l

0.14

523

Spontaneous rupture of synovium and tendon

762

6251

1.28

7.80

5.0

3.7

341.97

579.44

ng/l

0.58

606

5038

Other diseases of peritoneum

413

3159

1.40

7.79

4.7

3.9

398.86

351.83

ng/l

0.10

313

2451

Other meningitis

153

975

1.75

7.77

4.0

3.8

69.82

340.65

ng/l

2.29

103

703

Progressive systemic sclerosis

323

2.59

7.75

5.0

3.8

358.19

134.22

ng/l

0.54

261

Other sexually transmitted chlamydial diseases, including avohilmo

639

5105

1.29

7.73

2.6

2.8

330.20

391.64

ng/l

0.18

291

2302

Tularaemia

138

865

1.82

7.73

5.4

3.9

159.22

316.12

ng/l

0.86

113

666

Injury of nerves at shoulder and upper arm level

118

710

1.91

7.72

4.0

3.9

288.89

412.64

ng/l

0.35

541

Benign neoplasm: Caecum

1090

9285

1.23

7.71

5.2

4.2

363.44

470.24

ng/l

0.30

928

7836

Disorders of magnesium metabolism

480

2.15

7.71

7.4

3.8

355.24

467.84

ng/l

0.19

375

Livedoid vasculitis

269

2.75

7.69

4.8

4.0

88.84

169.94

ng/l

0.32

219

Intercostal neuropathy

535

2.10

7.67

5.6

3.9

232.89

302.49

ng/l

0.13

435

Other or unspecified immunodeficiency

234

2.82

7.65

4.4

3.1

777.13

207.15

ng/l

0.49

162

Benign neoplasm: Oesophagus

131

816

1.86

7.64

4.7

4.0

565.88

299.79

ng/l

0.25

101

658

Habit and impulse disorders

143

896

1.75

7.63

4.2

3.3

233.78

717.06

ng/l

1.11

575

Colon adenocarcinoma, helper endpoint

1321

11426

1.20

7.62

4.0

4.4

437.12

451.43

ng/l

0.02

1146

9933

Antepartum haemorrhage, not elsewhere classified

554

4369

1.31

7.61

2.4

2.8

407.92

310.36

ng/l

0.19

242

2089

Other and unspecified types of non-Hodgkin lymphoma, hilmo

403

3090

1.40

7.60

4.8

4.2

679.27

362.12

ng/l

0.33

350

2619

Toxic effect of organic solvents

200

2.89

7.59

3.1

3.4

651.12

380.35

ng/l

0.18

146

Degenerative macular diseases

1232

10604

1.21

7.57

4.8

4.3

477.66

454.38

ng/l

0.04

1040

9110

Malignant neoplasm of thyroid gland

595

4770

1.31

7.57

4.2

3.8

93.28

428.33

ng/l

6.78

440

3495

Amputation of ankle bones

226

1581

1.58

7.57

7.9

4.2

679.21

357.28

ng/l

0.64

210

1346

Other specified disorders of kidney and ureter

304

2233

1.47

7.56

5.4

4.0

286.13

455.64

ng/l

0.98

248

1772

Inflammatory disorders of male genital organs, not elsewhere classified

136

850

1.80

7.55

4.8

4.2

214.31

605.34

ng/l

1.64

112

708

Melanocytic naevi of lower limb, including hip

397

3027

1.40

7.55

4.4

3.7

477.89

485.55

ng/l

0.01

296

2194

Contracture of muscle

246

2.67

7.55

3.5

3.2

194.00

406.04

ng/l

0.46

182

Dissection of cerebral arteries, nonruptured

461

2.15

7.53

3.9

3.2

329.06

276.78

ng/l

0.11

333

Congenital deformities of feet, including avohilmo

315

2312

1.45

7.53

3.1

3.4

708.10

477.61

ng/l

0.28

204

1505

Dermatopolymyositis

150

965

1.75

7.51

6.5

4.0

209.84

286.28

ng/l

0.37

129

747

Tibial collateral bursitis [Pellegrini-Stieda]

111

659

1.91

7.50

2.8

3.5

128.99

393.16

ng/l

1.23

497

Other congenital malformations of circulatory system

239

1688

1.54

7.46

3.6

3.8

342.97

455.22

ng/l

0.26

177

1259

Subarachnoid haemorrhage

968

8164

1.23

7.46

4.4

4.0

373.91

527.53

ng/l

0.52

811

6758

Exposure to unspecified smoke, fire and flames

101

587

1.99

7.46

5.4

4.0

116.37

339.43

ng/l

1.21

433

Malignant neoplasm of other connective and soft tissue

254

1820

1.53

7.45

3.6

4.4

199.13

471.12

ng/l

1.66

216

1505

Myopia

1028

8680

1.22

7.44

3.9

3.3

614.96

438.30

ng/l

0.40

677

5452

Autoimmune hepatitis

101

589

1.99

7.44

3.9

3.4

160.26

207.52

ng/l

0.21

431

115

677

1.81

7.43

3.4

2.7

303.68

863.63

ng/l

0.86

266

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

405

3108

1.39

7.42

3.7

3.8

307.08

471.43

ng/l

0.54

286

2344

Glaucoma suspect

3877

35649

1.11

7.39

4.4

4.2

441.75

394.40

ng/l

0.25

3163

29289

Contact with lifting and transmission devices, not elsewhere classified

175

1169

1.67

7.36

3.8

4.0

348.52

600.50

ng/l

0.83

126

900

Epiphora

221

1546

1.57

7.36

4.9

4.0

241.27

390.60

ng/l

0.66

183

1226

Other and unspecified vasculitis limited to skin

231

1629

1.56

7.36

5.4

4.1

256.73

364.48

ng/l

0.38

182

1299

Other superficial mycoses

206

1414

1.58

7.35

5.2

3.5

184.99

613.86

ng/l

1.99

140

977

Acquired absence of organs, not elsewhere classified

129

805

1.82

7.34

5.0

3.6

299.46

272.79

ng/l

0.06

111

650

Disorders of lacrimal system and orbit in diseases classified elsewhere

220

1533

1.56

7.32

4.4

3.5

205.16

332.52

ng/l

0.37

166

1094

Postprocedural disorders of ear and mastoid process, not elsewhere classified

559

2.06

7.32

5.9

4.2

23.94

277.08

ng/l

2.82

465

Adenocarcinoma and Papillary adenocarcinoma of kidney

132

836

1.84

7.31

4.6

4.2

72.68

467.81

ng/l

3.34

120

702

Cerebral oedema

115

3.81

7.28

4.4

2.8

144.00

440.89

ng/l

0.55

451

2.13

7.28

5.6

3.6

287.02

342.95

ng/l

0.09

319

Benign neoplasm: Parotid gland

735

6067

1.27

7.27

4.4

4.0

719.83

543.20

ng/l

0.27

599

4882

Other and unspecified mononeuropathies, also in other diseases

281

2052

1.48

7.27

4.3

3.8

168.46

429.45

ng/l

2.40

217

1637

Infective dermatitis

1053

8963

1.22

7.25

5.0

3.9

335.69

528.48

ng/l

0.85

817

7000

Inguinal hernia, unilateral

263

1902

1.50

7.23

4.9

4.0

253.12

372.13

ng/l

0.69

216

1561

Inguinal of femoral hernia, unilateral

263

1902

1.50

7.23

4.9

4.0

253.12

372.13

ng/l

0.69

216

1561

Femoral hernia, unilateral

263

1902

1.50

7.23

4.9

4.0

253.12

372.13

ng/l

0.69

216

1561

Benign neoplasm: Pituitary gland, craniopharyngeal duct

458

3582

1.35

7.22

3.5

3.8

226.62

446.85

ng/l

0.83

321

2647

Human immunodeficiency virus [HIV] disease

170

1130

1.66

7.21

3.1

3.9

96.99

652.48

ng/l

3.78

121

841

Demyelinating diseases of the central nervous system

670

5457

1.28

7.20

3.2

3.4

321.60

454.26

ng/l

0.54

394

3534

Crohn's disease of small intestine

568

4547

1.31

7.20

4.0

3.5

333.27

459.24

ng/l

0.26

369

3157

Chronic Coagulation defects

202

1387

1.58

7.19

4.0

3.5

367.76

352.21

ng/l

0.03

132

907

Sexual dysfunction

169

1121

1.65

7.15

4.7

3.6

253.33

697.24

ng/l

1.30

122

822

Other congenital malformations of urinary system

277

2.46

7.14

3.7

3.2

133.27

485.43

ng/l

1.49

185

Burn and corrosion of wrist and hand

319

2372

1.43

7.12

3.4

3.7

170.11

651.06

ng/l

3.80

208

1660

Lichen sclerosus et atrophicus

1074

9176

1.22

7.12

4.2

3.8

142.69

328.94

ng/l

3.75

766

6999

Tooth eruption problems

965

7832

1.22

7.10

3.5

3.0

476.20

428.14

ng/l

0.14

519

3993

Atopic conjunctivitis

367

2783

1.39

7.10

4.3

3.5

102.90

524.72

ng/l

5.91

244

1849

Dementia due to Parkinsons disease, excluding more controls

224

1577

1.54

7.08

4.5

3.9

148.95

676.06

ng/l

2.62

205

1420

Single delivery by forceps and vacuum extractor

677

4969

0.79

7.06

2.4

2.8

210.27

338.60

ng/l

0.65

253

2226

Cystic disease of liver

445

2.16

7.06

3.7

3.9

465.38

211.93

ng/l

0.40

345

Encephalopathy

106

637

1.92

7.04

4.7

3.8

270.47

415.86

ng/l

0.28

522

Pulmonary eosinophilia, not elsewhere classified

131

835

1.80

7.01

4.6

4.2

186.92

298.09

ng/l

0.58

110

689

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

607

4934

1.30

7.00

4.1

3.9

287.94

450.01

ng/l

1.07

485

3944

Other protozoal intestinal diseases, including avohilmo

191

1303

1.59

6.99

3.6

3.4

835.49

537.30

ng/l

0.16

128

872

Other and unspecified aplastic anaemias

120

746

1.84

6.99

4.6

4.0

1770.01

256.29

ng/l

0.58

112

595

Primary coxarthrosis, bilateral

3103

28364

1.12

6.99

4.5

4.3

248.95

424.24

ng/l

2.84

2663

24095

Papillary adenocarcinoma of thyroid gland

452

3545

1.35

6.98

4.4

3.7

78.28

410.35

ng/l

6.03

335

2557

Cerebral atherosclerosis

146

948

1.73

6.97

6.3

4.4

386.50

280.84

ng/l

0.14

134

844

Disorder of external ear, unspecified

314

2348

1.44

6.97

4.3

3.8

894.70

429.45

ng/l

0.49

242

1793

Malignant neoplasm of renal pelvis, including Hilmo

130

827

1.80

6.97

5.7

4.5

88.34

370.01

ng/l

2.72

119

723

Pigmented purpuric dermatosis

115

710

1.87

6.94

6.2

3.9

184.00

388.69

ng/l

0.68

568

Problems related to social environment

265

1924

1.48

6.94

5.6

3.9

329.02

284.15

ng/l

0.06

183

1457

Malignant neoplasm of oesophagus

273

2006

1.48

6.93

3.8

4.4

182.29

523.59

ng/l

3.08

244

1746

Drug-induced hypoglycaemia without coma

164

1095

1.67

6.93

5.2

3.8

266.87

393.95

ng/l

0.52

145

849

Graves disease, strict definition

837

7001

1.24

6.93

3.8

3.5

122.08

387.07

ng/l

4.68

565

4671

Haemolytic-uraemic syndrome

123

3.49

6.93

4.3

3.1

352.08

771.73

ng/l

0.50

Drug-induced systemic lupus erythematosus

388

2.22

6.91

6.9

3.5

323.21

139.69

ng/l

0.75

278

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

166

1104

1.64

6.89

4.1

3.6

136.93

535.72

ng/l

2.12

120

702

Pyoderma gangrenosum

482

2.06

6.89

4.1

3.8

294.45

238.23

ng/l

0.08

350

Other specified/unspecified deforming dorsopathies

151

984

1.67

6.87

4.2

3.2

249.99

385.89

ng/l

0.45

107

690

Secondary parkinsonism+Parkinsonism in other disease

277

2042

1.47

6.86

4.9

4.3

132.04

337.11

ng/l

2.92

226

1730

Endocrine disorders, other/unspecified

1188

0.50

6.85

3.5

3.8

29.66

310.47

ng/l

5.46

866

Renal tubulo-interstitial disorders in diseases classified elsewhere

104

628

1.92

6.84

6.7

3.7

396.82

359.20

ng/l

0.06

494

Traumatic cerebral oedema

152

3.02

6.83

5.0

3.0

8.65

483.84

ng/l

1.22

116

Foreign body in respiratory tract

440

3447

1.35

6.83

5.0

3.8

189.83

533.52

ng/l

3.57

318

2557

Supervision of high-risk pregnancy

1346

6978

1.18

6.82

2.8

274.76

298.39

ng/l

0.08

620

3465

Malignant neoplasm of tongue, including Hilmo

257

1874

1.50

6.82

4.7

4.3

402.53

477.58

ng/l

0.14

227

1556

Injury of muscle and tendon at ankle and foot level

224

1587

1.52

6.81

3.8

696.69

517.05

ng/l

0.16

155

1149

Brain glioblastoma

150

990

1.71

6.81

3.0

4.1

54.89

580.87

ng/l

4.46

122

794

Chronic nephritic syndrome

351

2678

1.40

6.80

5.4

3.9

364.65

453.77

ng/l

0.24

305

2108

Chronic myringitis

321

2.37

6.79

3.2

3.6

504.51

260.94

ng/l

0.27

249

Other complications of labour and delivery, not elsewhere classified

470

5290

0.77

6.76

2.4

2.5

104.07

292.82

ng/l

1.60

153

1908

N06DA Anticholinesterases

4023

28673

1.10

6.76

4.2

4.6

216.21

415.07

ng/l

4.56

3603

25548

Use of anticholinesterases

4023

28673

1.10

6.76

4.2

4.6

216.21

415.07

ng/l

4.56

3603

25548

Conductive hearing loss, unspecified

745

6192

1.25

6.76

4.0

3.8

382.91

614.45

ng/l

0.58

581

4730

Myasthenia gravis

171

1162

1.64

6.73

5.0

4.0

68.67

297.77

ng/l

3.31

139

919

Other misadventures during surgical and medical care

230

1648

1.52

6.73

5.0

4.0

304.71

398.54

ng/l

0.28

191

1271

Anxious personality disorder

155

1018

1.64

6.73

3.3

3.2

198.27

739.94

ng/l

1.75

599

Localized adiposity

315

2.37

6.70

3.2

3.5

32.62

379.67

ng/l

1.05

226

Retinal detachment with retinal break

1266

11018

1.19

6.69

4.1

445.33

524.08

ng/l

0.20

1055

9145

Fall on and from ladder

719

5978

1.26

6.69

5.2

4.2

852.81

649.17

ng/l

0.23

592

4979

Other factor of the environment

124

783

1.78

6.69

5.0

3.9

97.78

334.49

ng/l

1.79

580

Corns and callosities

618

5056

1.28

6.67

4.9

3.9

433.24

599.64

ng/l

0.31

481

4005

Chylothorax

147

3.41

6.66

4.7

3.8

801.03

524.67

ng/l

0.26

117

Myeloproliferative diseases

795

6676

1.25

6.65

4.2

4.1

530.01

551.53

ng/l

0.02

647

5509

Drug-induced adrenocortical insufficiency

178

1220

1.61

6.64

7.7

4.0

88.94

401.52

ng/l

3.00

134

907

Vitamin D deficiency

168

1131

1.62

6.64

5.1

3.7

144.21

420.63

ng/l

1.53

120

804

Coeliac disease

1043

8929

1.21

6.64

4.3

3.7

571.33

535.20

ng/l

0.06

743

6537

Other mycoses, not elsewhere classified/unspecified

249

2.61

6.63

7.6

3.8

340.18

300.36

ng/l

0.07

194

Postpartum hemorraghe, parous women as controls

1402

13433

0.86

6.62

2.7

2.8

281.92

264.09

ng/l

0.07

708

6476

Other disorders of thyroid

137

890

1.73

6.61

3.9

3.8

553.85

221.28

ng/l

0.27

669

Retinal haemorrhage

257

1885

1.49

6.61

5.6

4.2

215.53

348.37

ng/l

0.80

214

1566

Paranoid personality disorder

164

1102

1.63

6.60

4.5

3.6

206.44

551.50

ng/l

1.29

111

782

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

197

1378

1.57

6.59

4.6

4.0

104.17

326.59

ng/l

2.89

155

1066

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

504

4043

1.32

6.59

4.4

4.5

390.29

450.73

ng/l

0.15

437

3523

Myotonic disorders

489

2.02

6.58

3.9

3.7

186.61

281.23

ng/l

0.35

341

Impacted teeth

1003

10114

0.84

6.57

2.8

2.9

688.00

466.66

ng/l

0.44

476

4989

Hereditary deficiency of other clotting factors

509

1.97

6.57

4.1

3.4

287.69

301.24

ng/l

0.03

341

Hodgkin lymphoma, hilmo

249

1811

1.48

6.56

5.3

3.9

294.64

531.77

ng/l

0.85

193

1349

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

481

3841

1.33

6.55

4.5

373.65

473.06

ng/l

0.32

421

3333

Combinations of oral blood glucose lowering drugs

2865

26161

1.12

6.55

4.6

4.0

351.14

566.15

ng/l

2.74

2320

21677

Other and unspecified primary disorders of muscles

462

2.06

6.53

5.0

3.9

92.51

266.74

ng/l

1.45

344

Polymyositis

554

1.97

6.52

6.9

4.1

196.98

239.05

ng/l

0.13

452

Achalasia of cardia

170

1158

1.62

6.51

4.9

4.0

1742.70

329.16

ng/l

0.47

137

934

Other sexually transmitted chlamydial diseases

407

3152

1.34

6.50

2.8

279.39

416.56

ng/l

0.47

204

1512

Specific developmental disorder of motor function

103

597

1.81

6.49

5.6

3.2

778.92

1146.82

ng/l

0.50

308

Acne vulgaris

536

4284

1.28

6.48

3.4

2.8

209.61

497.00

ng/l

2.06

260

2070

Benign neoplasm: Anus and anal canal

271

2011

1.46

6.46

4.4

4.3

103.53

351.37

ng/l

3.76

226

1647

Disorders of synovium and tendon in diseases classified elsewhere

201

1414

1.55

6.46

5.0

3.6

434.25

574.71

ng/l

0.28

165

1126

Other disorders of optic disc

134

869

1.72

6.45

5.1

4.0

656.99

370.12

ng/l

0.27

639

Secondary parkinsonism

268

1986

1.46

6.45

4.9

4.3

125.78

316.37

ng/l

2.74

219

1671

Other facial nerve disorders

258

1893

1.47

6.45

3.9

3.6

76.20

419.37

ng/l

6.37

174

1425

Upper arm

135

3.31

6.44

4.3

3.2

74.55

428.41

ng/l

0.85

Graves ophthalmopathy, strict

199

1399

1.55

6.43

4.4

3.5

214.52

280.46

ng/l

0.16

156

1006

Benign neoplasm of other and unspecified intrathoracic organs

118

750

1.81

6.42

4.3

4.1

354.17

349.61

ng/l

0.01

606

Malignant neoplasm of breast, ER-positive, including Hilmo

3087

20990

1.11

6.42

3.5

3.7

123.51

285.56

ng/l

7.57

2429

15210

Peritonsillar abscess

1721

15264

1.15

6.41

3.6

3.5

491.52

563.06

ng/l

0.26

1125

10579

Mild mental retardation

205

1443

1.53

6.40

4.0

3.7

256.55

650.58

ng/l

1.81

142

979

Parkinson's disease, strict definition

1442

12712

1.17

6.40

4.6

4.5

152.75

455.91

ng/l

4.01

1248

11158

Effects of heat and light

502

2.00

6.40

5.6

3.8

208.52

186.95

ng/l

0.06

391

Parapsoriasis

176

1209

1.59

6.40

4.2

3.9

165.00

424.58

ng/l

1.54

122

893

Other localized connective tissue disorders

188

1312

1.57

6.39

5.2

3.8

75.14

356.29

ng/l

3.45

149

984

Crohn disease (strict definition, require KELA, min 2 HDR)

498

3984

1.30

6.39

3.7

3.5

361.35

484.51

ng/l

0.19

297

2685

Malignant neoplasm of breast, HER-positive

3079

20966

1.11

6.37

3.5

3.7

123.81

285.32

ng/l

7.50

2421

15195

Postmenopausal atrophic vaginitis

2452

12063

1.13

6.37

3.9

3.7

183.13

318.34

ng/l

2.35

1757

9410

Disorder of thyroid, unspecified

133

866

1.72

6.36

3.9

3.7

571.05

248.34

ng/l

0.25

651

Malignant neoplasm of anus and anal canal, including Hilmo

132

861

1.73

6.35

3.5

4.3

464.17

444.68

ng/l

0.02

112

713

Anaemia in chronic diseases classified elsewhere

240

1753

1.49

6.35

6.2

4.2

1142.05

331.56

ng/l

1.05

213

1463

Methotrexate

1255

10935

1.18

6.34

4.1

3.5

175.20

479.10

ng/l

2.65

1010

8295

Other forms of systemic lupus erythematosus

494

1.98

6.34

5.5

3.7

312.64

149.31

ng/l

0.63

351

Crohn disease (strict definition, require KELA)

506

4060

1.30

6.33

3.7

3.5

355.00

481.12

ng/l

0.20

303

2737

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

137

896

1.69

6.33

4.2

3.6

417.97

537.45

ng/l

0.17

649

Polyarteritis nodosa and related conditions

135

882

1.71

6.32

4.6

3.9

455.03

304.80

ng/l

0.26

106

685

Diseases of middle ear and mastoid

5456

41649

1.08

6.30

4.0

3.6

329.73

457.01

ng/l

1.49

3577

29024

All dysplastic lesions of the vulva

359

2772

1.37

6.30

4.1

3.5

117.99

325.95

ng/l

2.60

239

1884

Multifocal fibrosclerosis

411

2.14

6.28

5.0

3.8

116.27

224.18

ng/l

0.56

339

Torticollis

135

876

1.67

6.24

4.4

3.1

464.52

624.99

ng/l

0.25

594

Postpartum haemorrhage

1402

13192

0.86

6.22

2.7

2.8

281.92

263.93

ng/l

0.07

708

6586

Other specified/unspecified spondylopathies

236

1721

1.48

6.22

5.3

3.8

89.75

423.81

ng/l

4.64

203

1443

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

284

2.43

6.20

5.5

3.7

89.00

306.06

ng/l

1.15

223

Dysplasia of cervi uteri

1806

11280

1.15

6.20

3.2

231.56

340.20

ng/l

1.34

1025

7201

Congenital deformities of feet

206

1459

1.51

6.19

3.0

3.4

978.62

531.55

ng/l

0.41

142

933

Alzheimer’s disease (undefined)

649

0.37

6.18

4.1

4.7

170.40

169.52

ng/l

0.00

607

Struck by thrown, projected or falling objec

450

3579

1.32

6.18

4.4

3.8

476.26

509.79

ng/l

0.05

323

2607

Foreign body in alimentary tract

479

3845

1.31

6.16

4.9

4.0

653.46

479.92

ng/l

0.13

373

2986

Paralytic strabismus

656

5450

1.26

6.15

4.4

4.1

362.76

597.62

ng/l

0.50

539

4450

Arthropathic psoriasis

989

8495

1.20

6.15

3.9

3.8

346.08

560.60

ng/l

0.81

719

6377

Typhoid and paratyphoid fevers, including avohilmo

404

2.11

6.15

4.4

3.6

1313.37

254.82

ng/l

0.41

315

Polycystic ovarian syndrome

346

2642

1.36

6.14

3.1

2.6

290.50

222.41

ng/l

0.19

140

1017

Meningitis, viral

268

2.40

6.14

4.1

3.0

24.03

62.85

ng/l

0.88

170

Malignant neoplasm of rectum

963

8268

1.21

6.14

3.6

4.4

667.93

495.63

ng/l

0.37

811

7027

Calcaneal spur

123

791

1.73

6.13

3.9

3.6

140.00

387.69

ng/l

1.66

605

Schizotypal disorder

187

1305

1.54

6.13

3.7

3.4

76.19

673.53

ng/l

3.64

129

865

Transepidermal elimination disorders

4.14

6.13

7.9

2.9

123.81

93.88

ng/l

0.11

Other and unspecified corneal deformities and disorders

291

2194

1.42

6.13

5.1

3.8

213.88

518.45

ng/l

1.90

231

1661

Nail dystrophy

421

2.10

6.13

3.8

3.4

149.28

241.66

ng/l

0.41

319

Tarsal tunnel syndrome

105

654

1.83

6.12

5.1

3.8

176.66

270.78

ng/l

0.32

507

Mantle cell lymphoma

107

675

1.85

6.11

3.3

4.2

147.11

399.90

ng/l

1.80

579

Visual impairment including blindness (binocular or monocular)

656

5448

1.26

6.10

5.5

4.1

623.36

507.24

ng/l

0.13

520

4516

Shigellosis, including avohilmo

402

2.06

6.08

3.6

3.3

492.92

203.66

ng/l

0.30

277

Pilonidal cyst

664

5500

1.25

6.06

4.1

3.4

292.05

522.43

ng/l

1.20

423

3631

Carcinoma in situ of colon

284

2149

1.43

6.06

4.4

4.3

593.95

416.44

ng/l

0.38

251

1783

Cutaneous lupus erythematosus

218

1576

1.50

6.06

5.1

3.8

362.22

393.00

ng/l

0.09

176

1196

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

536

4351

1.28

6.05

3.7

3.5

339.90

474.32

ng/l

0.24

321

2943

Acute epiglottitis

138

912

1.66

6.03

4.1

3.5

132.72

599.71

ng/l

2.09

691

Other ulcerative colitis

479

3850

1.30

6.00

3.9

3.6

258.58

484.84

ng/l

1.97

307

2716

Corneal degeneration

174

1216

1.58

5.99

4.1

252.99

348.36

ng/l

0.44

144

982

Molar incisor enamel hypoplasia

231

1591

1.45

5.99

4.7

3.1

700.42

798.42

ng/l

0.19

136

810

Papilloedema, unspecified

196

1389

1.52

5.99

4.1

3.7

225.42

381.28

ng/l

0.90

143

989

Toxic effect of corrosive substances

290

2.28

5.99

4.5

3.1

226.45

295.49

ng/l

0.11

186

Calcific tendinitis of shoulder

473

3796

1.30

5.98

4.6

3.4

261.62

468.09

ng/l

0.76

321

2806

Other abnormalities of plasma proteins

161

1109

1.61

5.98

5.3

4.1

144.08

258.44

ng/l

1.10

137

910

Myotonic dystrophy (Steinert)

177

2.78

5.98

3.5

3.3

250.34

348.65

ng/l

0.16

121

L02BB Anti-androgens

907

7776

1.22

5.98

3.9

4.7

1241.77

521.76

ng/l

0.36

810

7046

Other menopausal disorders

2387

12029

1.13

5.97

3.1

3.5

274.39

330.11

ng/l

0.26

1621

8851

Coxarthrosis, primary, with hip surgery

5148

44752

1.08

5.97

4.4

4.2

326.15

455.02

ng/l

2.03

4427

37655

Horner syndrome

126

825

1.72

5.97

4.8

4.0

84.07

374.72

ng/l

2.41

635

Parkinson's disease, including avohilmo

1604

14299

1.16

5.96

4.5

4.4

205.89

453.01

ng/l

2.63

1380

12505

Hyperfunction of pituitary gland

376

2934

1.34

5.95

4.3

3.4

467.01

360.92

ng/l

0.15

246

1874

Central retinal artery occlusion

224

1638

1.49

5.95

6.3

4.4

588.57

843.22

ng/l

0.19

196

1425

Increased muscle tone

429

2.03

5.95

3.8

3.7

148.59

312.84

ng/l

0.57

302

Myeloproliferative diseases (CML excluded)

714

6004

1.25

5.94

4.0

4.1

579.33

537.37

ng/l

0.04

579

4952

Chronic suppurative otitis media, including avohilmo

668

5565

1.25

5.93

4.5

3.9

261.58

626.32

ng/l

1.14

505

4231

Motor disorders

103

627

1.76

5.91

5.6

3.5

778.92

1133.15

ng/l

0.49

325

Benign neoplasm: Skin of scalp and neck

232

1701

1.47

5.89

4.2

3.9

353.10

307.98

ng/l

0.13

180

1295

Malignant neoplasm of small intestine

228

1676

1.49

5.88

4.3

240.17

536.76

ng/l

1.29

192

1404

Certain conditions originating in the perinatal period

509

3633

1.28

5.87

3.6

3.1

619.38

497.18

ng/l

0.29

281

1810

Wide developmental disorders, excluding more controls

181

1220

1.51

5.87

3.0

2.7

181.29

858.59

ng/l

3.21

659

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

4.72

5.87

3.5

3.0

3496.13

113.70

ng/l

0.46

Use of antiglaucoma preparations and miotics

793

6737

1.23

5.86

4.8

4.5

286.43

450.93

ng/l

0.55

700

5876

Pediculosis, acariasis and other infestations

506

4106

1.29

5.84

4.8

3.7

235.95

491.08

ng/l

2.44

373

2990

Graves ophthalmopathy

217

1577

1.49

5.83

4.4

3.6

204.91

275.98

ng/l

0.19

164

1142

Brain glioblastoma, helper endpoint

150

1026

1.64

5.83

3.0

4.1

54.89

440.16

ng/l

4.23

122

841

Malignant neoplasm of retroperitoneum and peritoneum

526

1.94

5.83

3.7

4.4

124.29

311.20

ng/l

0.84

422

Osteopathy in diseases classified elsewhere

519

1.95

5.83

5.9

4.2

181.56

306.43

ng/l

0.52

425

Viral encephalitis, not elsewhere classified/unspecified

189

1344

1.53

5.82

4.7

4.0

107.88

333.51

ng/l

2.82

149

1041

Other obstructive and reflux uropathy

347

2690

1.36

5.82

3.8

3.5

670.77

389.85

ng/l

0.26

256

1911

Disorders of adrenal gland, other and/or unspecified

309

2.24

5.81

5.1

3.5

50.70

163.90

ng/l

0.62

233

Disorders of sphingolipid metabolism and other lipid storage disorders

192

2.64

5.80

5.9

3.5

375.29

428.94

ng/l

0.07

131

Collapsed vertebra, not elsewhere classified

549

1.90

5.80

6.3

3.8

89.82

360.23

ng/l

2.22

471

Drug-induced cataract

218

1591

1.49

5.79

7.0

4.0

353.57

424.18

ng/l

0.21

175

1227

Crushing injury of wrist and hand

150

1025

1.62

5.77

5.1

3.8

598.92

774.27

ng/l

0.17

117

839

Disorder of pancreatic internal secretion, other and/or unspecified

473

1.97

5.76

5.0

3.8

113.00

284.42

ng/l

0.89

363

Anterior Iridocyclitis

1846

16590

1.14

5.74

4.4

3.9

380.62

467.66

ng/l

0.35

1392

12650

Other nonthrombocytopenic purpura

103

651

1.81

5.74

5.5

4.2

126.35

328.42

ng/l

1.48

518

Contact with other and unspecified heat and hot substances

396

2.04

5.74

4.1

3.5

55.34

149.78

ng/l

1.11

289

Excessive earwax

6926

59383

1.07

5.71

4.2

4.1

323.40

476.56

ng/l

3.24

5355

47367

Vascular dementia (other)

530

1.92

5.70

4.9

4.7

104.84

225.03

ng/l

1.04

479

Exophthalmic conditions

106

673

1.78

5.70

4.7

3.9

581.30

309.88

ng/l

0.35

516

Maternal care for known or suspected abnormality of pelvic organs

1738

10446

1.14

5.69

2.7

2.9

151.73

274.67

ng/l

1.44

760

5342

L02BX Other hormone antagonists and related agents

569

4722

1.28

5.68

4.1

4.6

301.89

652.62

ng/l

1.17

509

4261

Alcoholic gastritis

138

929

1.64

5.67

8.0

3.9

446.97

512.10

ng/l

0.09

122

764

Muscular dystrophy

513

1.92

5.66

4.7

3.9

107.83

249.70

ng/l

1.17

386

Alzheimer’s disease (Early onset)

269

3542

0.73

5.66

3.5

4.6

323.55

315.42

ng/l

0.02

217

3110

Ankylosing hyperostosis [Forestier]

131

874

1.67

5.65

4.5

3.7

366.87

437.55

ng/l

0.18

105

719

Hepatomegaly and splenomegaly, not elsewhere classified

539

1.85

5.65

4.5

3.6

492.16

679.64

ng/l

0.22

432

Benign neoplasm of ovary

1545

13774

1.15

5.64

3.9

3.8

146.01

260.75

ng/l

1.99

1213

10368

Viral haemorrhagic fevers, not elsewhere classified/unspecified

688

5786

1.24

5.64

4.4

3.9

281.60

617.97

ng/l

0.95

527

4458

Brain meningioma, including Hilmo

468

3793

1.30

5.63

4.2

3.9

228.36

355.48

ng/l

0.64

365

2980

Femoral hernia

405

3231

1.33

5.62

5.4

4.0

300.90

383.67

ng/l

0.41

342

2698

Procedures for purposes other than remedying health state

203

1464

1.49

5.61

3.8

3.0

163.66

420.71

ng/l

1.16

137

1027

Contact with sharp glass

306

2344

1.37

5.61

4.5

3.6

241.98

566.06

ng/l

2.04

207

1565

Dermatophytosis

1311

11578

1.17

5.60

5.0

4.0

362.16

524.63

ng/l

0.86

1043

9251

Injury of urinary and pelvic organs

190

1360

1.51

5.60

4.1

3.8

724.10

576.27

ng/l

0.14

144

1054

Complications peculiar to reattachment and amputation

439

1.99

5.59

5.8

3.8

575.68

247.81

ng/l

0.31

348

Other disorders of iris and ciliary body

263

1986

1.42

5.58

5.4

4.1

330.20

398.63

ng/l

0.20

223

1594

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

204

1485

1.50

5.56

4.7

4.4

407.04

424.81

ng/l

0.03

178

1232

Malignant neoplasm of pancreas, including Hilmo

834

7142

1.21

5.55

4.0

4.4

181.46

423.66

ng/l

1.82

681

6137

Insulin, fast-acting (human)

1158

10122

1.17

5.54

5.1

3.6

897.13

524.37

ng/l

1.21

911

7139

Allergic purpura

254

1905

1.42

5.53

5.2

3.7

646.73

477.39

ng/l

0.14

186

1372

Disorders of male genital organs in diseases classified elsewhere

394

2.03

5.52

3.3

4.1

1810.63

761.52

ng/l

0.34

314

Other injuries of spine and trunk, level unspecified

593

1.82

5.52

4.9

4.1

134.80

416.48

ng/l

1.54

456

Examination and encounter for administrative purposes

732

6193

1.23

5.51

3.8

3.6

403.68

579.99

ng/l

0.86

600

5231

Pedestrian injured in other and unspecified transport accidents

123

815

1.68

5.50

4.6

4.0

42.70

248.07

ng/l

2.84

623

Thrombotic microangiopathy

405

2.05

5.50

4.1

4.0

198.42

277.35

ng/l

0.24

308

Torsion of testis

146

990

1.58

5.49

4.6

3.6

366.47

633.39

ng/l

0.69

673

Crohn's disease of large intestine

413

3300

1.31

5.48

4.2

3.5

154.85

494.49

ng/l

4.09

272

2304

Epileptic seizures related to alcohol

375

2.08

5.48

7.3

3.9

431.44

337.21

ng/l

0.09

297

Injury of heart

161

2.96

5.47

4.5

3.2

2638.61

143.03

ng/l

0.83

126

Herpesviral keratitis and keratoconjunctivitis

388

3090

1.33

5.46

4.3

3.9

550.28

433.42

ng/l

0.19

299

2404

Contact with blunt object, undetermined intent

373

2.05

5.45

4.0

3.7

21.56

232.61

ng/l

1.67

259

Injury of nerves at forearm level

120

789

1.68

5.45

4.5

3.8

338.31

454.87

ng/l

0.27

561

Family history of other specific disorders

116

754

1.68

5.45

4.4

2.9

247.28

286.01

ng/l

0.10

465

Pre-eclampsia

1465

13008

1.15

5.44

3.3

3.2

379.72

267.15

ng/l

0.61

873

7768

Helminthiases, including avohilmo

318

2459

1.36

5.44

3.2

3.6

530.25

438.53

ng/l

0.18

195

1610

Divergent concomitant strabismus

617

5145

1.25

5.44

3.9

3.6

314.74

482.24

ng/l

0.83

452

3600

Right side

389

0.26

5.43

1.7

4.2

20.17

288.04

ng/l

—

335

Marginal zone B-cell lymphoma

110

719

1.75

5.42

3.9

4.2

337.87

385.22

ng/l

0.06

587

Migraine with aura, drug-induced

100

633

1.77

5.42

4.4

3.5

131.84

305.89

ng/l

0.69

432

Intestinal malabsorption

405

3241

1.31

5.41

4.9

3.7

103.74

529.53

ng/l

7.29

311

2439

Complications of labour and delivery

4782

28381

0.92

5.40

3.2

3.4

281.79

257.77

ng/l

0.16

2940

18576

Chronic tubulo-interstitial nephritis

325

2531

1.36

5.40

4.7

3.7

137.69

383.02

ng/l

2.89

280

1957

Chalazion

991

8598

1.19

5.40

3.8

3.7

394.48

533.12

ng/l

0.39

695

6399

Gonococcal infection

277

2112

1.39

5.40

4.1

3.5

123.23

455.90

ng/l

2.79

198

1508

Hypoplasia of dental enamel , including avohilmo

217

1517

1.44

5.39

4.3

3.2

655.39

785.35

ng/l

0.25

125

777

Supervision of normal pregnancy

1413

7099

1.15

5.39

2.5

2.8

176.18

303.74

ng/l

1.21

625

3493

Bruxism

148

1014

1.57

5.39

4.8

3.1

202.83

299.86

ng/l

0.28

621

Tic and related disorders

530

1.78

5.37

3.4

2.8

232.51

1068.41

ng/l

2.01

320

Cerebral amyloid angiopathy

406

2.10

5.37

7.1

3.7

156.18

282.74

ng/l

0.48

352

Other symptoms and signs involving the digestive system and abdomen

1418

12587

1.15

5.35

4.7

3.3

472.36

529.38

ng/l

0.09

996

9869

Intentional self-harm by jumping from a high place

309

2.13

5.33

3.8

3.2

56.73

570.12

ng/l

0.86

203

Lifestyle-related condition

113

740

1.70

5.32

5.2

3.9

104.02

357.54

ng/l

1.78

549

Benign neoplasm of eye and adnexa

989

8609

1.19

5.32

4.4

4.0

410.83

488.31

ng/l

0.18

791

6858

Superficial injuries involving multiple body regions

231

1719

1.43

5.32

4.6

3.8

224.78

590.96

ng/l

1.82

171

1249

Acquired keratosis [keratoderma] palmaris et plantaris

315

2.22

5.31

4.1

3.7

818.29

253.29

ng/l

0.47

240

Gluteal tendinitis

362

2861

1.33

5.30

4.3

3.4

51.18

392.23

ng/l

6.00

245

2110

MS-disease / Multiple Sclerosis

544

4487

1.26

5.30

3.0

3.3

333.31

465.37

ng/l

0.44

311

2841

Selective deficiency of immunoglobulin G [IgG] subclasses

423

1.97

5.29

4.0

3.5

139.24

331.00

ng/l

0.74

292

Malignant neoplasm of rectosigmoid junction, including Hilmo

282

2174

1.39

5.28

3.5

4.5

737.24

466.82

ng/l

0.29

230

1862

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

515

1.87

5.28

6.7

3.9

406.79

315.03

ng/l

0.21

390

Deficiency of other B group vitamins

202

1479

1.48

5.27

4.3

4.0

116.94

339.76

ng/l

2.26

162

1186

Other bursitis of knee

133

902

1.62

5.25

4.4

3.7

604.78

593.35

ng/l

0.01

107

723

Endometriosis of ovary

1361

11357

1.15

5.23

3.4

191.34

332.96

ng/l

1.46

849

7979

Brain meningioma

451

3673

1.29

5.22

4.3

3.9

236.89

352.02

ng/l

0.53

350

2878

Spirochaetal infections, other/unspecified

808

6940

1.21

5.21

4.1

3.9

240.56

565.58

ng/l

1.29

615

5436

Impetigo

346

2720

1.33

5.19

4.9

3.5

206.45

570.27

ng/l

3.48

225

1812

Carcinoma in situ of rectum

136

938

1.63

5.17

3.9

4.3

487.84

392.32

ng/l

0.15

116

788

Thiazolidinediones

1088

9562

1.18

5.17

5.1

4.1

541.02

508.14

ng/l

0.07

927

8124

Congenital obstruction of the pelviureteric junction

518

1.85

5.16

3.5

4.0

170.75

217.13

ng/l

0.16

389

Spondylopathies in diseases classified elsewhere

125

845

1.65

5.15

5.2

3.6

55.40

380.29

ng/l

4.37

107

705

Toxic effect of alcohol

185

1339

1.49

5.14

5.7

3.9

172.44

467.79

ng/l

1.72

146

1028

Alzheimer’s disease (undefined), excluding more controls

579

0.40

5.13

4.1

4.2

170.40

240.20

ng/l

0.25

533

Other and unspecified haemorrhagic conditions

150

1049

1.57

5.12

4.2

4.0

368.90

367.77

ng/l

0.00

118

798

Raynaud syndrome

738

6289

1.21

5.11

4.2

3.6

306.60

414.32

ng/l

0.42

521

4393

Generalized epilepsy, strict definition

174

1241

1.49

5.10

3.7

3.4

140.62

681.76

ng/l

2.61

115

803

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Troponin I.cardiac [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS